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Abstract
The oral tissues, including gingiva and buccal mucosa, heal rapidly with minimal scar
formation. Although in the oral cavity, the palatal mucosa is associated with excessive
scarring in response to injury. In this thesis, first, I investigated the complex relationship
between cells and their microenvironment using wound healing models in which
extracellular matrix composition and mechanical stiffness affect cellular responses during
acute wound repair. I also determined how intrinsic differences of cells recruited during
healing contribute to wound resolution.
In Chapter 2, I first investigated cell-extrinsic factors, specifically the influence of the profibrotic matricellular protein periostin on palatal healing. Using a genetic deletion strategy,
it was determined that in the palate periostin modulates myofibroblast differentiation and
fibronectin synthesis in a manner dependent on the stiffness of the microenvironment
surrounding the cells.
In chapter 3, I focused on the role of extracellular periostin on periodontal ligament (PDL)
fibroblast phenotype using in vitro assays and gene-expression analyses. These findings
suggest that the influence of periostin is context dependent; matrix-bound periostin does
not promote or inhibit mineralization of the PDL, but the addition of exogenous periostin
to isolated PDL fibroblasts resulted in increased mineralization concomitant with changes
in gene expression.
In chapter 4, to explore cell-intrinsic differences, a lineage tracing approach was used to
trace populations of cells derived from embryonic Foxd1- and NG2- expressing progenitors
during development, homeostasis, and excisional wound healing. I show in the palate that
Foxd1-lineage progeny associate with blood vessels in development and adult tissues, after
injury, they expand but remain associated with neovascular structures. In contrast, NG2lineage progeny associate with fibroblasts in healthy adult tissues and post-injury
contribute to myofibroblast populations.
In conclusion, the studies in this thesis have further defined the complex interactions that
exist between resident cells and their micro-environment using the palate as a model
system. The data from this thesis provides important information for the design of future
therapeutics for oral wounds, and also contributes to a growing understanding of fibroblast
ii

heterogeneity and how divergent populations contribute to different processes during
wound repair.
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Proteins, Myofibroblasts, Palate, Periodontal ligament, Periostin, Tissue Repair, Wound
Healing
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Lay Abstract
In Canada, approximately 400-500 babies are born each year with cleft palate (1 in 790
live births, among the highest in the world). This condition occurs when tissues in the
baby's face and mouth do not fuse properly during pregnancy, leaving an opening (cleft) in
the roof of the mouth (palate). Surgery is required during infancy or childhood in order to
close the opening. Due to the specific characteristics of the palate, healing after surgery
typically results in the formation of a scar. This scar is very rigid and prevents proper
development of the face and mouth, which can dramatically affect a child’s appearance,
speech, teeth, eating, and the ability to develop socially. My research focuses on periostin,
a protein playing a prominent role during scar formation in human skin and in skin wound
repair. I found that this protein, as well as the stiffness of the hard palate, play a significant
role in the function of cells that participate in the healing process. This protein is also found
in the supporting structures around the tooth. Here, I showed that the role of periostin in
the periodontium is to support the maintenance of these structures. Lastly, I investigated
what types of cells are recruited during palatal healing and I found two distinct populations
that have unique roles: one population is primarily involved in the formation of new vessels
in the wound, and the other is involved in the formation of matrix that supports the growing
cells. In conclusion, studies in this thesis have further defined the complex interactions that
exist between cells and their environment using the palate as a model system. The data
from this thesis provides important information for the design of future therapeutics for
oral wounds, cleft palate reconstruction, and also contributes to a growing understanding
of fibroblast heterogeneity and how divergent populations contribute to different processes
during wound repair
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Chapter 1
1

Rationale, Literature Review and Thesis Overview
Rationale, Hypothesis and Objectives

Wound healing in soft connective tissues, such as skin and oral mucosal tissue, is defined
as a coordinated series of overlapping events leading to resolution of the injury or defect.
Passing through the phases of hemostasis, inflammation, proliferation and remodeling,
concomitant with re-epithelialization, barrier function is re-established (Karamanos et al.,
2019). However, different healing profiles have been described for different tissues. In
particular, wound healing in the oral mucosa is known to exhibit reduced scarring
compared with cutaneous injuries; injuries to the oral mucosa, including gingival tissue,
heal rapidly with minimal scar formation (Pereira & Sequeira, 2021; Politis et al., 2016;
Toma et al., 2021). However, while still part of the oral environment, the palatal mucosa is
associated with excessive scarring in response to injury (Larjava et al., 2011; Pereira &
Sequeira, 2021; Wijdeveld et al., 1987, 1991). Unlike skin and gingival connective tissue,
palatal soft tissue is a rigid mucoperiosteum; mucosa and the periosteum are merged and
tightly attached to the palatal bone (Nanci, 2013)
The outcome of the healing process is dependent on several different factors: extrinsic and
cell intrinsic factors. Extrinsic factors include the matrix stiffness surrounding the cells,
signaling molecules such as TGFβ1, or ECM components such as matricellular proteins,
e.g. Periostin, (Hinz, 2007; Serini et al., 2002a). In this thesis we build on previous work
from our lab to further explore the contrasting tissue-specific effects of periostin bioactivity
that could be partially responsible for the distinct healing patterns evident when skin,
gingiva and the palatal mucoperiosteum are compared (Nikoloudaki et al., 2020) and could
provide deeper understanding of how differences in molecular composition and physical
properties of these tissues lead to the different healing outcomes.

1

In addition to the above mentioned extrinsic factors, recent evidence also suggests that
resident cell-specific intrinsic differences can alter how they respond to extrinsic stimuli,
as well as the downstream effect of that response (Driskell et al., 2013; Jiang & Rinkevich,
2021.). While the majority of evidence emerges from studies done in skin, liver and other
organs, there are only few reports about the presence of embryonically distinct cell
populations within the oral environment (Byrd et al., 2019; Jiang & Rinkevich, 2021). The
discovery of distinct cell subpopulations in the oral cavity through lineage-tracing
techniques, and the understanding of their specific roles could provide new insights in the
differences between oral and skin fibroblasts in wound healing. Here, we build upon
previous work from our lab in order to further the understanding of how cell intrinsic and
extrinsic properties influence palatal healing, with a focus on fibroblast activation, and
differentiation into myofibroblasts, for the purpose of guiding the development of future
biomaterial development for wound healing applications.
This thesis explores the overarching hypothesis that fibroblast activation and
differentiation into myofibroblasts during an acute healing response in the palate relies on
cell-intrinsic differences stemming from a population’s embryonic lineage, and cellextrinsic factors present within the extracellular matrix (ECM). Specifically, it was first
hypothesized that modifying the ECM by deletion of the gene coding for the ECM protein
periostin would impair granulation tissue formation and cellular contraction during palatal
wound healing (Aim 1). Secondly, we hypothesized that periostin protein would inhibit
mineralization of the surrounding collagenous matrix in vivo and osteogenic differentiation
of periodontal ligament fibroblasts in vitro (Aim 2).

Finally, we hypothesized that

embryonic progenitors that express Foxd1 would contribute to myofibroblast progenitors
within the palatal mucoperiosteum, and that binary expression of Foxd1 and NG2 could be
used to stratify palatal fibroblasts to identify unexplored embryonic lineages of
myofibroblast progenitors present within the palatal mucoperiosteum of mice (Aim 3).

2

These were explored through the following three specific Aims:
1. To identify the expression profile of periostin in murine palate during development,
homeostasis and excisional wound healing and investigate the effect of genetic
deletion of periostin on palatal wound repair.
2. To investigate the role of periostin in the maintenance and inhibition of
mineralization of the periodontal ligament.
3. To assess Foxd1 expression in palatal progenitor populations during development,
and to determine how cells derived from Foxd1- and NG2- expressing progenitors
contribute to wound repair.

3

Wound Healing
Traumatic injury initiates a well-orchestrated cascade of cell and molecular events that
leads to repair. This wound healing process can be divided into distinct but overlapping
phases: hemostasis, inflammatory, proliferative and tissue remodeling/maturation phase,
with each part characterized by specific cellular and molecular events (Cañedo-Dorantes &
Cañedo-Ayala, 2019). Initially, hemostasis occurs to control blood loss and reduce the risk of
systemic infection. During this phase, the traumatized lining of blood vessels, the platelet
aggregation, and the activation of the coagulation cascade provide molecular signals that
initiate tissue repair (Cañedo-Dorantes & Cañedo-Ayala, 2019; Reinke & Sorg, 2012). The
inflammatory phase is characterized first by neutrophil infiltration, with a primary role in
targeting infection through their innate immune function. Temporally, macrophages migrate
into the wound, debriding damaged tissue, phagocytosing neutrophils, and stimulating
transition into the proliferative phase through the release of growth factors such as transforming
growth factor-β1 (TGFβ1), platelet derived growth factor (PDGF), and vascular endothelial
growth factor (VEGF) (Chazaud, 2014). During the proliferative phase, fibroblasts, which are
the primary effectors of tissue repair, migrate into the wound, proliferate, and begin producing
a temporary matrix called granulation tissue (Martin & Nunan, 2015; Sorg et al., 2017). Finally,
in the remodeling phase, fibroblasts turn over the granulation tissue into a type I collagen rich
scar (Cañedo-Dorantes & Cañedo-Ayala, 2019; Reinke & Sorg, 2012; Sorg et al., 2017)
Hemostasis is a rapid process that leads to cessation of bleeding from a blood vessel, while
at the same time it initiates the wound repair response (Cañedo-Dorantes & Cañedo-Ayala,
2019; Martin & Nunan, 2015). Vessel injury and disruption of the endothelial layer leads to
platelet activation due to their exposure to the underlying matrix and tissue factor. The matrix

releases cytokines and inflammatory markers that lead to adhesion of the platelets and their
aggregation at that site which leads to the formation of a temporary platelet plug. The
platelet adhesion is a complex process mediated by interactions between various receptors
and proteins including tyrosine kinase receptors, glycoprotein receptors, other G-protein
receptors as well as the von Willebrand Factor (vWF). The von Willebrand Factor functions
via binding to the Gp 1b-9 within the platelets (Periayah et al., 2017). Adhered and
4

aggregated platelets release their cytoplasmic granules that include ADP, thromboxane A2,
serotonin, platelet-derived growth factor (PDGF), vascular endothelial growth factor
(VEGF), serotonin, and coagulation factors. (Etulain, 2018; Periayah et al., 2017). Platelets
were also shown to produce a positive effect on mouse skin wound healing by enhancing
the angiogenic potential of mesenchymal stem cells (Levoux et al., 2021). If the platelet
plug is not enough to stop the bleeding, the third stage of hemostasis begins, which is the
activation of the coagulation cascade. Prothrombin, thrombin, and fibrinogen are the main
factors involved in the outcome of the coagulation cascade. Traumatized vessels and
activated platelets release prothrombin activator, which in turn activates the conversion of
prothrombin into thrombin. Thrombin then facilitates the conversion of a soluble plasma
protein fibrinogen into long, insoluble fibers of fibrin, which polymerizes and forms a
fibrin polymer mesh and results in a cross-linked fibrin clot that further stabilizes the clot.
Platelets in the clot then begin to shrink, tightening the clot and causing vasoconstriction
(thromboxane A2) to initiate the process of wound healing. Platelets also undergo a
transformation of their shape into a pseudopodal shape which in-turn leads to release
reactions of various chemokines (Periayah et al., 2017).

Platelet aggregation and

degranulation also assist the recruitment of circulating neutrophils and monocytes through
cytokine and growth factor release, inducing their presentation of adhesion molecules to
promote cellular homing to the site of injury(Etulain, 2018; Greaves et al., 2013; Martin &
Nunan, 2015). Moreover, many of the factors released by platelets have been reported to have
direct antimicrobial effects (Etulain, 2018; Y.-Q. Tang et al., 2002; Yeaman, 2010)

The inflammatory response is further supported by resident macrophages and dendritic
cells. In response to tissue damage and platelet degranulation, neutrophils are next to
populate the wound bed, followed by the recruitment of circulating monocytes, which
differentiate into macrophages (Greaves et al., 2013; Reinke & Sorg, 2012). Neutrophils
and macrophages participate in the innate immune response through their release of
inflammatory mediators and bactericidal factors. They also release proteases and enzymes
for the debridement of the inflamed tissue and they are removing bacteria and cellular
debris from the damaged tissue via phagocytosis (Ellis et al., 2018; Wang, 2018). Finally,
neutrophils and macrophages innate immune response through their release of
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inflammatory mediators, advancing the wound beyond the inflammatory phase
(Mahdavian Delavary et al., 2011; Rodero & Khosrotehrani, 2010).

In tissues such as skin or oral mucosa that are covered by epithelium, keratinocytes begin
to migrate laterally between the non-viable, dried fibrin clot, and the viable fibrin rich layer
infiltrated by the fibroblasts to cover the wound bed and maturing granulation tissue (Arora
et al., 2016; Rousselle et al., 2019). Injured keratinocytes also contribute to the
inflammatory response during healing by releasing high-mobility group box protein 1
(HMGB1), heat shock protein (HSP), antimicrobial peptides (defensins, cathelicidin,
calgranulin A/B), cytokines (IL-1a, IL-33) and chemokines (IL-8)(Juráňová et al., 2017;
Piipponen et al., 2020). These endogenous molecules are considered to be a subgroup of
host-derived damage-associated molecular patterns (DAMPs) that signal tissue and cell
injury via Toll-like receptors (TLRs), which in turn initiate immune responses (Juráňová
et al., 2017; Piipponen et al., 2020; Xiao et al., 2020).

Following the inflammatory response, the proliferation phase of wound healing is initiated
to restructure the wound site towards repair or regeneration. During the proliferation phase,
fibroblasts deposit ECM, which initially is mainly collagen III, forming highly vascularized
granulation tissue that replaces the fibrin clot (Rognoni et al., 2018). This vascularized
tissue results from endothelial cell and perciyte migration into the wound bed in response
to the release of pro-angiogenic stimuli, such as VEGF and bFGF, released by
keratinocytes, platelets, fibroblasts, and inflammatory cells (Cañedo-Dorantes & CañedoAyala, 2019; Martin & Nunan, 2015; Tonnesen et al., 2000). These newly formed blood
vessels contribute in the further maturation of the granulation tissue and provide nutrition
in addition to oxygen for cell infiltration into the wound space (Tonnesen et al., 2000).
Fibroblasts and other mesenchymal populations including pericytes are recruited to the
developing granulation tissue in response to chemotactic stimuli, including platelet-derived
growth factor (PDGF) and basic fibroblast growth factor (bFGF) where they assume a
matrix secreting, contractile phenotype known as a myofibroblast, primarily in response to
TGFβ1(Hinz, 2007, 2010a). More specifically, fibroblasts transition to the myofibroblast
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phenotype is associated with α-smooth muscle actin (α-SMA) expression and its
incorporation to stress fibers, concomitant with extracellular matrix production, and wound
contraction (Hinz, 2007, 2007, 2015a). Wound contraction initiates a positive feedback
mechanism through which increased matrix stiffness enhances myofibroblast differentiation
through both mechano-sensing and activation of latent TGFβ1(Hinz, 2015b).

The final and longest phase of wound repair, the remodeling phase, takes place from
months to years following the initial injury (Velnar et al., 2009). During this phase
secretion of MMPs from fibroblasts, macrophages and endothelial cells contributes to the
remodeling of type III collagen to type I collagen by fibroblasts (Martins et al., 2013). The
wound bed becomes less cellular as cells like fibroblasts and macrophages undergo
apoptosis (Dg, 1998). The previous provisional ECM transitions from loose fibronectin
tissue networks to larger and denser collagen bundles (Glim et al., 2015; Politis et al., 2016;
Toma et al., 2021). Large networks of blood vessels start to develop and the fibrillar
network of the ECM becomes more aligned and organized (Velnar et al., 2009).
Temporally, resident cells including keratinocytes and macrophages continue to remodel
the remaining permanent ECM as the repaired tissue return to homeostasis (Velnar et al.,
2009; Xue & Jackson, 2015).
During the different phases of wound healing, it is known that several different factors
affect the healing outcome, including growth factors, the composition of the ECM, cellular
origin, and spatiotemporal recruitment of different cell populations during these phases.
The focus of this thesis is to investigate how cell-extrinsic factors, such as ECM
composition, and cell intrinsic factors regulate the wound healing process in the oral cavity.
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Soft Tissue Healing: Compare and contrast skin
and oral tissues
While cutaneous and oral tissues follow a similar macroscopic healing process, it has been
demonstrated that they in fact exhibit many variations at the cellular and molecular level
in relation to processes resulting in the restoration of tissue architecture and function.
Wounds in the oral mucosa heal significantly faster, with minimal scar formation in
comparison to skin wounds (Glim et al., 2013.; Iglesias-Bartolome et al., 2018; D. Pereira
& Sequeira, 2021; Wong et al., 2009). This difference has been attributed to several factors,
including the presence of saliva in the oral cavity, the embryonic origin of the cells
involved, the elicited inflammatory response, variable presence of growth factors,
phenotypic differences between oral and cutaneous fibroblasts, differences in ECM
composition, as well as the presence of bacteria that stimulate wound healing (Figure 1.1)
(Häkkinen et al., 2000; Iglesias-Bartolome et al., 2018; Lepekhin et al., 2002; Pereira &
Sequeira, 2021).
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Figure 1-1 Schematic diagram of factors affecting the wound healing in the oral
environment

One of the most notable differences between skin and tissues in the oral cavity is that the
latter are in constant contact with saliva and the oral microbiome (Bodner et al., 1993;
Hutson et al., 1979; Y. Su et al., 2018). Saliva could contribute to the wound repair process
by providing a pool of growth factors such as epidermal growth factor (EGF), VEGF and
FGF, and compound and peptides with antimicrobial function, such as mucins, lactoferrin,
lysozyme, lactoperoxidase, statherin, histatins and antibodies (secretory immunoglobin A,
sIgA) (Hof et al., 2014; Lynge Pedersen & Belstrøm, 2019). Saliva components are also
responsible for improved oral keratinocyte and fibroblast migration (Boink et al., 2016).
Experimentally reduced and arrested salivary gland activity in animals resulted in
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prolonged inflammatory response and delayed wound healing, with saliva modulating
aspects of oral wound healing by regulating the inflammatory response and myofibroblast
recruitment (Bodner et al., 1993; Dayan et al., 1992; Oudhoff et al., 2008). The oral
microbiome is essential for the oral cavity homeostasis. Healthy oral biofilm was found to
result in an increased expression of antimicrobial peptides and improved barrier function
in reconstituted human gingiva (Shang et al., 2018). Altered microbiome was found to
negatively impact wound healing and gingival mesenchymal stem cell functions through
secretion of lipopolysaccharides and subsequent stimulation of miRNA-21/Sp1/telomerase
reverse transcriptase pathway (Y. Su et al., 2018).

In mucosal and cutaneous injury, after hemostasis, granulation tissue forms and matures
through the inflammatory phase (Cañedo-Dorantes & Cañedo-Ayala, 2019; Pereira &
Sequeira, 2021). In the oral mucosa, during the inflammatory phase of the healing process
reduced recruitment of neutrophils, macrophages, and T-cells is observed when compared
to cutaneous wounds (Dipietro, 2003; Häkkinen et al., 2000; Wong et al., 2009). The
reduced numbers of immune cells observed in oral wounds is associated with reduced
levels of inflammatory cytokines, such as interleukin (IL)-23, IL-24, IL-6, IL-8, tumor
necrosis factor alpha (TNF-α) and pro-fibrotic cytokines (TGF-β1), leading to decreased
recruitment of inflammatory cells, and elevated anti-fibrotic cytokine TGF-β3(L. Chen et
al., 2010; Glim et al., 2013.; Schrementi et al., 2008; Szpaderska et al., 2003). The reduced
inflammation observed in the oral tissues during wound healing might be an indication of
a more efficient mechanism or response (Caetano et al., 2021; Moutsopoulos & Konkel,
2018; Williams et al., 2021).

At the end of the inflammatory stage, proliferation and migration of keratinocytes and
fibroblasts occurs into the wound bed (Cañedo-Dorantes & Cañedo-Ayala, 2019; Pereira
& Sequeira, 2021). Fibroblasts secrete extracellular matrix and remodel the granulation
tissue, while keratinocytes restore barrier function to the damaged tissue. In the oral cavity
epithelial cells start migrating and proliferating 24h post-wounding and, for excisional
wounds up to 5 mm, a complete re-epithelialization is reached by day 2 to 3 in oral mucosa,
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while in skin it could take up to 7 days (Bodner et al., 1993; L. Chen et al., 2010; Harrison
& Jurosky, 1991a, 1991b; Iglesias-Bartolome et al., 2018; Larjava, 2013; Szpaderska et al.,
2003).

Following the inflammatory response, the proliferation phase of wound healing
commences, to restructure the wound site towards repair or regeneration. In cutaneous
wounds it starts from 2 to 10 days after injury and can last for up to 3 weeks, depending on
the location and the type/extent of injury. In contrast, in oral mucosa wounds the
inflammation peaks at days 2 to 3, but it is resolved by day 6 (Bodner et al., 1993; Harrison
& Jurosky, 1991a; Iglesias-Bartolome et al., 2018; Szpaderska et al., 2003). Fibroblasts
and mesenchymal stem cells play a central role during the proliferating phase of wound
healing. Strong evidence suggests that multiple fibroblast phenotypes exist within one
tissue (Giannopoulou & Cimasoni, 1996; Moulin et al., 1998), but it also has been shown
that cellular phenotypes can be substantially variable among the same tissues but in
different anatomical regions (Gabbiani, 1996; Giannopoulou & Cimasoni, 1996).
Moreover, it is now becoming evident that not all fibroblasts in a tissue arise from the same
embryonic origin (Driskell et al., 2013; Rinkevich et al., 2015a, 2015c; Sriram et al., 2015).
From a developmental perspective, dorsal skin and oral mucosal fibroblasts have different
origins, which could partially explain the phenotypic differences between oral and
cutaneous fibroblasts: while the non-cranial dorsal skin dermis has an Engrailed1-lineagepositive somitic origin, the oral mucosa lamina propria and cranial skin dermis originates
from Wnt1-lineage-positive neural crest cells (Ishii et al., 2012; Janebodin et al., 2011;
Rinkevich et al., 2015b). Mah and colleagues found that CD26+ skin fibroblasts associate
with higher expressions of profibrotic genes and transforming growth factor-β persist in
hypertrophic-like scars formed after skin wound healing, whereas in gingiva CD26+
fibroblasts are only residually present (Mah et al., 2017). Oral mucosal fibroblasts express
higher levels of hepatocyte growth factor (HGF) compared to dermal fibroblasts (Stephens,
Hiscox, et al., 2001), therefore the former might more effectively resist to TGF-β1-driven
myofibroblast differentiation when compared to dermal fibroblasts (Dally et al., 2017).
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Several studies have investigated how different fibroblast lineages contribute to oral and to
skin wound healing (Jiang et al., 2020; Jiang & Rinkevich, 2021; Rinkevich et al., 2015b)
Apart from the Engrailed1-lineage-positive fibroblast subpopulation, the study from
Rinkevich and colleagues reports a Wnt1-lineage-positive population in the oral dermis
tightly linked to the non-fibrotic healing that characterizes the oral mucosa. A reciprocal
transplantation of these oral mucosal- and skin-derived fibroblast populations performed
in mice revealed that the cells mimic the response of their tissue of origin. The grafting of
Wnt1-lineage-positive oral fibroblasts in skin resulted in decreased scar tissue formation
while skin fibroblasts contributed to a scar-like tissue formation in the oral wound site,
proving that the oral fibroblast lineage is a determinant for the scarless healing of the oral
mucosa (Rinkevich et al., 2015b), Mah et al. investigated the relation between the distinct
phenotypes of gingival fibroblasts and skin fibroblasts and their different wound healing
patterns, in 3D cell cultures. Of significance, they observed that gingival fibroblasts
proliferate faster and express higher levels of molecules involved in modulation of
inflammation and ECM remodeling (MMP-1, -3, -10, TIMP-4) compared to dermal
fibroblasts (Mah et al., 2014). In contrast, dermal fibroblasts exhibited significantly higher
expression of fibrillar (collagens and elastin) and non-fibrillar (SLRPs and matricellular
proteins) ECM proteins, as well as molecules involved in TGF-β induction of the
myofibroblast phenotype and cell contractility (TGF-β1, TGF-β2, TGF-β3, Smad, α-SMA,
CXCL12, Cadherin-2, -11). Their findings are indicative that gingival fibroblasts display
a phenotype that may promote faster resolution of inflammation and ECM remodeling,
which is associated with reduced scar formation, while skin fibroblasts have a profibrotic,
scar-prone phenotype (Mah et al., 2014). Faster invasion of granulation tissue in vivo could
increase the maturation of the defect, which secondarily could also enable faster reepithelialization by providing an appropriate ECM for epithelial migration (Shannon et al.,
2006).
Oral fibroblasts have also been reported to be highly responsive to TGFβ-1, the major
profibrotic cytokine expressed during healing, with TGFβ-1 increasing proliferation rates
as well as collagen synthesis, when compared to dermal fibroblasts (H. G. Lee & Eun,
1999). The ECM composition of oral wounds is different than in cutaneous wounds: ECM
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composition have been quantified between oral mucosa and skin, with the former showing
increased expression of fibronectin, fibronectin ED-A, hyaluronic acid and chondroitin
sulphate, and decreased expression of elastin (Glim et al., 2014). It has been shown that
Fibronectin ED-A, an alternative spliced isoform de novo which is expressed during wound
healing and fibrotic changes, is highly upregulated in myofibroblasts (Zent & Guo, 2018a).
Earlier reports from Serini et al. (Serini et al., 2002b) suggested that fibronectin ED-A acts
as a necessary ECM component for TGFβ induction of myofibroblast differentiation.
Additional evidence for the role of fibronectin ED-A in myofibroblast activation has been
demonstrated via the latent TGFβ binding protein-1 (LTBP-1)/EDAFN/ integrin
interaction network, where fibronectin immobilizes LTBP-1 and thus stores TGF-β1 in the
ECM (Klingberg et al., 2018).

During the remodeling phase, MMPs mediate the reorganization and turnover of the ECM,
and in turn are regulated by TIMPs, the balance of which has been found to affect the
outcome of wound healing process (Caley et al., 2015; Martins et al., 2013). In oral wounds
MMP tissue inhibitors (TIMP-1 and TIMP-2) production is reduced, therefore allowing for
increased MMP-2 activity in the remodeling phase of oral wound healing(Glim et al.,
2013.; Stephens et al., 2001). Other differences in the wound ECM between the two tissues
include the collagen III to collagen I ratio, which is increased in oral wounds (Glim et al.,
2013.), and the pro-fibrotic matricellular protein periostin. Our lab has shown that periostin
is involved in regulation of ECM synthesis in gingival wound healing, while in skin it
appears as a mediator of myofibroblast differentiation through β1 integrin-focal adhesion
kinase (FAK) signaling (Elliott et al., 2012a; Kim, Nikoloudaki, Michelsons, et al., 2019;
Nikoloudaki et al., 2020).

Focusing on oral keratinocytes, more recent methods involving transcriptomic analysis
have uncovered molecular differences between skin and oral mucosal wound healing
(Iglesias-Bartolome et al., 2018). Sox2 and Pitx1 transcription factors were shown to be
the master regulators of the oral mucosal wound healing response in the keratinocytes when
compared to skin keratinocytes (Iglesias-Bartolome et al., 2018).
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To conclude, the ability of the oral mucosa to heal without scarring cannot be attributed to
a single feature but to several extrinsic and intrinsic factors present in the different stages
of the wound healing process, which are crucial to the final non-scar outcome.
Interestingly, while still part of the oral environment, the palatal mucosa is associated with
excessive scarring after cleft palate reconstructive surgery (Larjava et al., 2011; Wijdeveld
et al., 1987, 1991). Unlike skin and gingiva, palatal soft tissue is a rigid mucoperiosteum
with the mucosal tissue and periosteum merged and tightly attached to the palatal bone
(Nanci, 2013). The investigation of distinct healing patterns among skin, gingiva and the
palatal mucoperiosteum could provide deeper understanding of how differences in
molecular composition and physical properties of these tissues lead to the different healing
outcomes.

Extracellular Matrix and Matricellular proteins
In recent years a plethora of research has demonstrated that the extracellular matrix (ECM)
composition is an important determinant of soft tissue healing (Wells et al., 2016). In
particular, matricellular proteins have seen increasing attention due to their role in the direct
modification of cell behaviour. Defined by Paul Bornstein in 1995 (Bornstein, 1995),
matricellular proteins were classified initially on their ability to modify cell adhesion to the
ECM. Surprisingly, initial analysis of matricellular proteins through genetic deletion,
revealed that many of the mice lacking individual matricellular proteins developed
normally and exhibited no major phenotypes in adulthood (Murphy-Ullrich & Sage, 2014;
H. F. Rios et al., 2008). However, when challenged in injury models, these same mice
lacking specific matricellular proteins exhibited significant defects in healing, which
highlighted a potentially important role for matricellular proteins in wound healing
processes.
While fibrin, collagen and fibronectin are required to provide structural support to tissues
during healing, matricellular proteins typically are upregulated in the granulation tissue
where they modulate the adhesion, migration, proliferation and differentiation of pericytes,
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fibroblasts and epithelial cells up to 15 days post-wounding (Kyriakides & Bornstein, 2003;
Midwood et al., 2004). As a class of proteins, matricellular proteins specifically modulate
cell-matrix interactions and cell function (adhesion, spreading, migration, proliferation and
differentiation) (Bornstein & Sage, 2002a) by interacting with cell-surface receptors (e.g.,
integrins) and other bioeffector molecules, as well as with structural matrix proteins such
as collagens. Certain matricellular proteins exhibit affinity for binding TGF-1, a growth
factor which is important for fibroblast recruitment and differentiation during wound repair
(Barrientos et al., 2008; Hinz, 2007, 2016). In general, matricellular proteins act in a
temporal and spatial manner to control different aspects of wound repair (Basu et al., 2001;
Hamilton, 2008a; Jackson-Boeters et al., 2009; Kyriakides & Bornstein, 2003; Midwood
et al., 2004; Puolakkainen et al., 2005; Zhou et al., 2010).
Due to the relative ease of creating experimental skin injuries, much of the research on the
role of matricellular proteins in the regulation of healing have focused on skin, rather than
tissues such as gingiva. Over the last 12 years, Dr. Hamilton’s lab has investigated how
matricellular proteins, and in particular periostin, regulate processes underlying the healing
of soft connective tissues. Periostin was explored previously by the Hamilton lab as an
important modulator of mesenchymal cell behavior during the proliferative and remodeling
phases of soft tissue healing. More specifically, the contrasting effects of periostin on
dermal and gingival fibroblasts demonstrate the specificity of matricellular protein
bioactivity in relatively homologous tissues (Elliott et al., 2012a; Kim, Nikoloudaki,
Michelsons, et al., 2019; Nikoloudaki et al., 2020; J.-Y. Su et al., 2021).

Periostin as a Modulator of Cell-ECM interactions
Matricellular proteins are transiently-expressed non-structural proteins (Bornstein & Sage,
2002b). First described in 1995, periostin (POSTN) was identified as an 811 amino acid
protein secreted by murine osteoblasts that is required for cell adhesion (Takeshita et al.,
1993). Originally termed osteoblast specific factor 2 (OSF-2), due to it localization to the
periodontal ligament and periosteum of mice, it was renamed periostin in 1999 and
subsequently classified as a matricellular protein in 2007 by Norris and colleagues (Litvin
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et al., 2004). Structurally, periostin is a secreted 90 kDa N terminus-glycosylated protein
containing four tandem fasciclin domains (A. Kudo, 2011), with several different isoforms
described (Bai et al., 2010; Cai et al., 2019; Gadermaier et al., 2018; Morita & Komuro,
2016). The physiological significance of periostin expression in adult systems has been
mainly identified in collagen-rich biomechanically active tissues (Hamilton, 2008b) such
as the skin, bone, and heart, periodontium, periodontal ligament and within developing
teeth (Kruzynska-Frejtag et al., 2004), highlighting a subtle, but complex role for periostin
in tissue homeostasis, healing and pathology.
Like many matricellular proteins, periostin has been defined as a non-structural ECM
component, although as research has continued, evidence has accumulated demonstrating
that it can modify the biomechanical properties of collagenous based tissues (Conway et
al., 2014; Norris et al., 2007). The multi-domain structure of periostin allows for numerous
interactions with extracellular/secretory proteins (Kii & Ito, 2017). Specifically, periostin
has been shown to modulate cross-linking and stabilization of the extracellular matrix,
including through regulation of collagen fibrillogenesis and cross-linking (Hwang et al.,
2014; Norris et al., 2007). Periostin is also known to act as a scaffold for assembly of
several extracellular matrix proteins (type I collagen, fibronectin, tenascin-C, and laminin
γ2) as well as accessory proteins (BMP-1 and CCN3) (Amizuka et al., 2009; Elliott &
Hamilton, 2011; A. Kudo & Kii, 2018; Maruhashi et al., 2010; Rogers et al., 2008),
although the binding site for collagens has not been yet identified (Kii & Ito, 2017; Norris
et al., 2007) Among the structural domains of periostin, the EMI region has attracted
significant scientific interest, as it is involved in cellular signaling and protein–protein
interaction (Kii & Ito, 2017). The EMI domain, named after its presence in proteins of the
EMILIN family of extracellular matrix glycoproteins, is a cysteine-rich sequence of ∼80
amino acids that is most often found at the amino terminus of extracellular proteins that are
forming or are compatible with multimer formation (Callebaut et al., 2003; Doliana et al.,
2000). Extracellularly, periostin directly binds to fibronectin through the EMI domain (Kii
et al., 2009; Norris et al., 2007). Fibronectin has several sites for interacting with collagens,
suggesting that the EMI domain of periostin may indirectly interact with collagens (Fig.
1.2) (Kii & Ito, 2017). Intracellularly, a proximal localization between periostin and
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fibronectin in the endoplasmic reticulum of fibroblastic cells has been observed, indicating
that the two proteins interact prior to fibronectin’s secretion (Kii et al., 2016), and evidence
suggests that periostin enhances secretion of fibronectin from the endoplasmic reticulum
into the extracellular environment (Kii et al., 2016). In totality, this information
demonstrates a critical role for periostin in extracellular matrix homeostasis and the
regulation of cell phenotype.

Figure 1-2 Periostin and its interacting proteins.
The known interacting proteins of periostin are depicted based on the multi-domain
structure of periostin. CTD carboxyl-terminal domain, HBD heparin-binding domain
(Adapted from Kii et al. 2017).
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Periostin in the Oral Cavity
Originally described in the oral cavity within the periodontal ligament, periostin has now
been shown to also be highly expressed in developing teeth at epithelial-to-mesenchymal
interaction sites and the periosteum (H. Rios et al., 2005; Wen et al., 2010). Periostin is
also associated with several pathological conditions, including our analysis of the stroma
and differentiated odontogenic epithelium of human ameloblastic fibromas, ameloblastic
fibro-odontomas and odontomas (Chau et al., 2013), in peripheral and central ossifying
fibromas, focal cemento-osseus dysplasia, fibrous dysplasia (Chau et al., 2013) as well as
oral squamous-cell carcinoma (Siriwardena et al., 2006).

Periostin in orofacial tissue development
In developing teeth, POSTN mRNA and protein are asymmetrically localized to the
lingual/palatal and buccal regions during early epithelial-mesenchymal interaction sites,
where it could be linked with deposition and organization of other ECM adhesion
molecules (Kruzynska-Frejtag et al., 2004; Romanos et al., 2014). During tooth
morphogenesis, at the cap and early bell stage of the tooth germs, periostin is expressed at
the interface between the inner enamel epithelium and pre-odontoblasts, as well as in
mesenchymal tissues around the cervical loop and dental follicles which then disappear in
advance of tooth development. During late bell and mineralization phases of tooth
development, periostin is expressed in dental papilla cells and trans-differentiating
odontoblasts (Suzuki et al., 2004).

Periostin in postnatal orofacial tissues
In the adult rodent, periostin expression is predominantly identified in the periodontium
(Romanos et al., 2014). Immunoelectron microscopic observation of the mature PDL
verified the localization of periostin between the cytoplasmic processes of periodontal
fibroblasts and cementoblasts and the adjacent collagen fibrils in mice. This finding
suggests that periostin participates in various cellular events that are involved in
maintaining the integrity of adult teeth, particularly at the sites of hard–soft tissue interface,
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serving as adhesive equipment for bearing mechanical forces, including occlusal force and
tooth eruption (Romanos et al., 2014; Suzuki et al., 2004). In situ hybridization and
immunohistochemical analysis of rodent mandibles revealed the presence of periostin on
the alveolar bone surface (Suzuki et al., 2004). The importance of periostin in the
maintenance of the PDL integrity is also highlighted by studies using transgenic mice
where periostin is genetically deleted. Although periostin knockout (Postn-/-) mice are
viable, the deletion results in defective collagen fibrillogenesis, due to reduction in fibril
diameter and defective collagen crosslinking (Norris et al., 2007; Sata et al., 2008),
resulting in loss of architecture and functional disruption of several collagenous-based
tissues, particularly those subject to constant mechanical loading, such as the PDL, heart,
and bone (H. Rios et al., 2005). Micro-computed topography imaging analysis of Postn-/mice skulls revealed the early onset of severe periodontal disease, significant reduction in
bone density, structural defects in the incisors resulting in enhanced tooth wear, and
showed that orbital bones are completely missing or fail to fuse properly (Hamilton,
2008b). Removal of masticatory forces reduced this damage, showing that the loss of
periostin likely impairs the ability of the tissue to withstand mechanical loading (H. F. Rios
et al., 2008). Additionally, the PDL of Postn-/- mice demonstrated an uneven, irregular
distribution of several crucial ECM proteins, such as type-I collagen, fibronectin, and
tenascin C (Tabata et al., 2014).
Periostin also plays a role in controlling postnatal tooth formation. In wild-type mice,
periostin is expressed in pre-odontoblasts, odontoblasts and ameloblasts, but genetic
deletion of periostin in Postn-/- mice resulted in a massive increase in dentin formation after
mastication and significant enamel defects (H. Rios et al., 2005). Deletion of periostin also
resulted in the alteration of expression profiles of many non-collagenous proteins such as
dentin sialophosphoprotein (DSPP), dentin matrix protein 1 (DMP1), bone sialoprotein
(BSP), and osteopontin (OPN) in incisor dentin (Ma et al., 2011), as well as to
morphological changes of the osteocytes (from spindle to round shape) in the jaws as
shown by acid-etched scanning electron microscopy (Ren et al., 2015). FAM20C, a
member of “Family with sequence similarity 20” also known as DMP4 in mice (Hao et al.,
2007), is required for maintenance of healthy periodontal tissues and functions as an
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intracellular protein kinase in the secretory pathway (P. Liu et al., 2014). Recently it was
shown that FAM20C directly binds to periostin via the Fas-I domain and phosphorylates
periostin in vitro. In addition, immunohistochemical analysis demonstrated that
immunolocalization of FAM20C in murine PDL overlapped with that of periostin (Lin et
al., 2020). Taken together, periostin plays a crucial role in the remodeling of collagen
matrix and induction of various non-collagenous proteins in dental tissues, showing that
periostin is critical for the postnatal tooth and periodontium development, as well as the
maintenance of PDL integrity (Du & Li, 2017; Romanos et al., 2014).

Periostin in periodontal inflammation & oral wound healing
Controlled degradation of the ECM is essential in physiological situations involving
connective tissue remodeling, such as tissue morphogenesis, repair, and angiogenesis
(Petreaca & Martins-Green, 2020). However, excessive breakdown of connective tissue
components plays an important role in destruction of overall tissue architecture, e.g. the
irreversible destruction of periodontal support tissues in periodontitis, such as the alveolar
bone, PDL, and root cementum leading to tooth loss (Ravanti et al., 1999). The first to
investigate the influence of spatial and temporal periodontal inflammation on the levels of
the periostin in an inflammatory-induced periodontal disease model in vivo was PadialMolina and colleagues in a series of animal and clinical studies (Padial-Molina et al., 2012).
Using a ligature periodontal inflammatory disease model in rats they found that periostin
immunoreactivity is reduced in the presence of inflammation on the PDL and is correlated
with detrimental changes to the periodontium over time (Padial-Molina et al., 2012). In
vitro, human PDL (hPDL) cells had lower periostin protein levels when treated with TNFα
and/or bacterial endotoxin. However, these changes were only observed when cells were
cultured in a mechanically challenged environment but not in the un-loaded control
condition, and the high variability among the groups with an unclear pattern makes it
difficult to draw conclusions (Padial-Molina et al., 2013). When exogenous periostin was
added to the experimental conditions, hPDL cells exhibited increased proliferation and
migration (Padial-Molina et al., 2014). A separate study demonstrated that while IL-4 and
IL-13 cytokines significantly induced periostin production in human periodontal ligament
20

(hPDL) and human gingival fibroblasts (hGF) cultures, no stimulatory effect was observed
by TNF-α or bacterial endotoxin on the production of periostin. Additionally, exogenous
periostin did not have a significant effect on the production of inflammatory cytokines by
hPDL or hGF cells, suggesting that although these cells may be a source of periostin in
periodontitis lesions, its role in the inflammatory response or in matrix-protein metabolism
might be limited (Nakajima et al., 2014). Tang et al. using human periodontal ligament
stem cells (PDLSCs) investigated the role of periostin under inflammatory conditions in
the periodontum and found that periostin promoted both the migration and osteogenic
differentiation potential of PDLSCs via the JNK signaling pathway with TNFα treatment
(Y. Tang et al., 2017).
In clinical studies investigating periostin levels in the gingival crevicular fluid (GCF) (Aral
et al., 2016; Balli et al., 2015) and Postn mRNA in tissues (Sankardas et al., 2019) at
different stages of periodontal disease, it was shown that the total amount and concentration
of periostin in the GCF, as well as Postn mRNA levels, are reduced with the progression
and severity of the disease from healthy controls to chronic periodontitis groups and
correlate negatively with clinical parameters of disease (Sankardas et al., 2019). When
looking at the expression profile of periostin in GCF/wound fluid over time after
periodontal surgery, it was shown that periostin levels increase after surgery, peak at 48 h
and are higher in patients with periodontal disease when compared to healthy controls. For
both groups periostin levels returned to baseline levels within 2 weeks. This transient local
increase of periostin in the GCF after eliminating the chronic inflammatory stimuli and
bacterial challenge by periodontal surgery in periodontally affected sites suggests the
potential role of periostin in the maturation and stability of the connective tissue (PadialMolina et al., 2015). Similar results were also reported in healthy patients and patients with
chronic periodontitis post non-surgical low-level laser therapy (Kumaresan et al., 2016).
Extracellular matrix molecules are actively remodeled during wound healing and chronic
inflammatory diseases, such as periodontitis (Birkedal-Hansen, 1993). Wound healing in
soft connective tissues, such as the oral mucosa and the gingival tissue, is defined as a
coordinated series of overlapping phases: hemostasis, inflammation, proliferation and
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remodeling, concomitant with epithelial barrier formation, which lead to the resolution of
the injury (Karamanos et al., 2019).
The oral mucosa and gingival tissues typically heal with minimal scarring, with many
similarities evident to the healing described for fetal tissue (Häkkinen et al., 2014; Larjava,
2013). Using a gingivectomy model in rats, it has been shown that periostin regulates ECM
synthesis, upregulating fibronectin and collagen synthesis via integrin β1, FAK and JNK,
but it is not associated with myofibroblast differentiation during gingival wound healing
(Kim, Nikoloudaki, Michelsons, et al., 2019). The low number of myofibroblasts, as shown
by the absence of α-smooth muscle immunoreactivity in the wounded tissues, is postulated
as an underlying reason for the reduced scar formation in healing of the gingival tissue
(Kim, Nikoloudaki, Michelsons, et al., 2019). In vitro, treatment with exogenous
recombinant human periostin (rhPSTN) to gingival fibroblasts derived from human tissues
resulted in increased fibronectin and collagen synthesis, an effect which was attenuated by
pharmacological inhibition of FAK and JNK signaling. In support of the in vivo
observations, the addition of rhPSTN did not induce myofibroblast differentiation or
proliferation of gingival fibroblasts, in contrast to its effect on skin and hypertrophic scar
fibroblasts as reported by other studies (Crawford et al., 2015; Elliott et al., 2012b; Maeda
et al., 2019). In addition, gingival fibroblasts predominantly attach to periostin through β1integrins (Kim, Nikoloudaki, Michelsons, et al., 2019). The inability of gingival fibroblasts
to transition to myofibroblasts even in the presence of periostin may provide a possible
explanation of scarless healing that is evident in attached gingiva compared to other tissues,
such as skin (Nikoloudaki et al., 2020).
While gingival tissue typically heals without scarring, it is still associated with several
fibrotic conditions including drug-induced gingival enlargement (DIGE). DIGE is a
pathological condition that develops as a side effect from the systemic administration of
the antihypertensive drug nifedipine and anti-seizure drugs, and it is classified as a fibrotic
lesion (Brown et al., 1991; Nyska et al., 1994). As such, it is characterized by imbalance
in the remodeling and deposition of ECM. Gingival connective tissue from patients with
DIGE showed increased immunoreactivity of periostin when compared to healthy
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individuals, but absence of α-smooth muscle actin (α-SMA) expressing cells (Kim et al.,
2013, 2015). In vitro, periostin mRNA and protein levels were up-regulated in response to
nifedipine treatment via a TGFβ−dependent mechanism (Kim et al., 2013). Treatment of
human gingival fibroblasts in vitro with different concentrations of phenytoin also resulted
in increased periostin protein levels, which correlated with phospho-Smad3 (p-SMAD3)
phosphorylation, suggesting common mechanisms are responsible for DIGE irrespective
of the drug (Kim, Nikoloudaki, Darling, et al., 2019). Based on the fact that DIGE is
defined as a fibrotic lesion, the molecular pathology is in direct contrast to skin scarring,
in that no differentiation or persistence of myofibroblast is associated with the condition.
The palatal mucoperiosteum, even though part of the oral cavity, has been shown to exhibit
significant scarring after surgical procedures. It remains critical to fully understand the
underlying molecular and cellular mechanisms responsible for ECM accumulation in the
palate during the wound healing process. Verstappen et al., using a rat model, found that
there are significantly more myofibroblasts in the wounded mucoperiosteum than are
evident in skin wounds, which they attributed to the different contractile abilities that these
tissues possess and correlated their findings with the different wound healing patterns of
these tissues (Verstappen et al., 2012). The investigation of distinct healing patterns among
skin, gingiva and the palatal mucoperiosteum could provide deeper understanding of how
differences in molecular composition and physical properties of these tissues lead to the
different healing outcomes. It would therefore be intriguing to assess the role of periostin
in palatal tissues, which - while still in the oral cavity- is strongly associated with scarring
after injury.

Periostin in oral pathology
Periostin has also been identified in several pathological, non-neoplastic conditions,
including our analysis of the stroma and differentiated odontogenic epithelium of human
ameloblastic fibromas, ameloblastic fibro-odontomas and odontomas (Chau et al., 2013),
in peripheral and central ossifying fibromas, focal cemento-osseus dysplasia, fibrous
dysplasia (Chau et al., 2013), oral lichen planus (Zhang et al., 2018) and ameloblastomas
(Kang et al., 2018).
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Studies on periostin expression in human cancers have demonstrated an increased
expression in a variety of solid tumors where it is associated with their malignant behavior
(Extensively reviewed by: (Cui et al., 2017; González-González & Alonso, 2018)).
Specifically in oral leukoplakia (Guan et al., 2019) and head and neck squamous cell
carcinomas (HNSCCs), increased periostin expression appears to be directly proportional
to the invasiveness and aggression of the disease (Y. Kudo et al., 2006; Qin et al., 2016;
Siriwardena et al., 2006; Sundar et al., 2018). The serum periostin level in head and neck
squamous cell carcinoma patients correlates well with that of VEGF-C and with malignant
tumor behavior, including increased tumor stage and lymph node metastasis. Periostinpromoted lymphangiogenesis is mediated by the increased secretion of VEGF-C in cancer
cells and by migration and tube formation via Src and Akt activity (Y. Kudo et al., 2012).
TGF-β3 signaling promotes periostin expression by cancer-associated fibroblasts (CAFs)
resulting in growth, migration and invasion of cancer cells (Qin et al., 2016). Periostin
secreted by CAFs also promotes cancer stemness in HNSCCs by activating protein tyrosine
kinase 7 (Yu et al., 2018). Furthermore, bone marrow mesenchymal stem cells promoted
proliferation, invasion, survival, tumorigenicity and migration of head and neck cancer
through periostin-mediated PI3K/Akt/mTOR activation (C. Liu et al., 2018). Based on
these findings, periostin could be considered a biomarker with prognostic value of
malignant behaviors in HNSCC and a potential target for future therapeutic intervention of
HNSCC patients (Yang et al., 2020).

24

Figure 1-3 Functions of periostin in maintaining health of oral and dental tissues
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Therapeutic Applications of Periostin
The use of neutralizing antibodies against periostin has been mainly investigated in the
context of cancer invasion and metastasis. Several reports provide promising results for the
potential use of highly-specific anti-periostin antibodies to inhibit metastatic and migratory
properties of periostin expressing cells and stroma in ovarian (Zhu et al., 2011) and breast
cancer (Van Snick et al., 2016).
More recently, efforts have shifted to the utilization of aptamers as a therapeutic target for
periostin. Aptamers are single-stranded oligonucleotides that bind to specific target
molecules. Once bound to a specific target, some aptamers are capable of inhibiting its
activity (Song et al., 2012). Data from in vivo and in vitro studies demonstrated favorable
results for the application of periostin-binding aptamers for the specific inhibition of
periostin in peritoneal (Nam et al., 2017) and renal (Um et al., 2017) fibrosis. Local
administration of molecules that target and block periostin during wound healing could
also be achieved through tissue bioengineering techniques. Biomaterials, such as different
types of scaffolds, can be designed to achieve temporal and spatial control over the release
of such inhibiting molecules (Rambhia & Ma, 2015), and provide a promising therapeutic
solution for cutaneous fibrosis and scarring post-wounding.

βigh3
TGF-β-induced protein (βigh3) and periostin are considered paralogs because of their
structural similarity, as they both contain a single emilin (EMI) and four fasciclin-1 (FAS1)
domains (Fig. 1.4). Similar to periostin, βigh3 is also induced by TGFβ signaling in areas
of tissue injury and is secreted by activated fibroblasts in the ECM (García-Castellanos et
al., 2017). βigh3 binds directly to collagens type I, II and IV (Hashimoto et al., 1997) as
well as to proteoglycans, such as biglycan and decorin (Reinboth et al., 2006), where it
modulates cell growth, adhesion and migration, tumorigenesis, wound healing, and
apoptosis (Mosher et al., 2015). βigh3 is expressed in various tissues, including the bone,
cartilage, cornea, heart, liver, and skin (LeBaron et al., 1995; Schwanekamp et al., 2017).
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βigh3 in orofacial tissues development
During murine embryogenesis βigh3 is expressed in craniofacial cartilage and growth
plates (Ferguson et al., 2003), and the developing tongue (Choi et al., 2009). Han and
colleagues found that βigh3 plays a role in chondrocyte and osteoblast differentiation
during endochondral ossification (Han et al., 2008). Genetic deletion of βigh3 in Tgfbi
knockout mice resulted in reduced skeletal size and alterations in cartilage and bone,
characterized by matrix degradation (J. M. Lee et al., 2014).

βigh3 in Postnatal tissues
βigh3 is also expressed in human PDL tissues. In vitro mineralization assay of hPDL
showed that exogenous addition of βigh3 has an inhibitory effect on their mineralization
(Ohno et al., 2002). The same research group also showed that during experimental tooth
movement of human premolars, βigh3 expression was significantly increased in the PDL
(Doi et al., 2003). Recently, βigh3 was also found to be expressed in rat pulp, where it
could be associated with reparative dentinogenesis pointing to the potential therapeutic role
of βigh3 in the pulpal repair process (Serita et al., 2017).

Figure 1-4 Periostin and βigh3 multi-domain structure.
As a matricellular protein, βigh3 is considered a paralog of Postn because of their
structural similarity.
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Cell recruitment and origin
During wound healing myofibroblast progenitors proliferate and migrate into the newly
formed granulation tissue and differentiate into contractile myofibroblasts that secrete
ECM proteins, especially collagens (Hinz, 2007). Different factors have been found to
trigger the differentiation of the cells to a myofibroblastic phenotype, including the
microenvironmental matrix stiffness, signaling molecules such as TGFβ1, or ECM
components such as matricellular proteins, e.g. Periostin, or the ED-A splice variant of
fibronectin (Hinz, 2007; Serini et al., 2002a). Apart from the above mentioned extrinsic
factors, recent evidence also suggests that myofibroblast progenitor-specific intrinsic
differences can alter how they respond to extrinsic stimuli (Driskell et al., 2013; Jiang &
Rinkevich, 2021). Extrinsic factors can be inducive to myofibroblast differentiation, but
intrinsic cell characteristics can ultimately control the degree to which a myofibroblast
progenitor responds, as well as the downstream effect of that response. While the majority
of evidence emerges from studies done in skin, liver and other organs, there are only few
reports about the presence of embryonically distinct cell populations within the oral
environment (Byrd et al., 2019; Jiang & Rinkevich, 2021). The discovery of distinct cell
subpopulations within different areas of the oral cavity assessed through lineage-tracing
techniques, and the understanding of their specific roles could provide new insights in the
differences between oral and skin fibroblasts in wound healing.

Lineage tracing technology has been used to identify several distinct myofibroblast
progenitor populations that play a role in skin repair and fibrosis, including fibroblasts,
perivascular cells, adipogenic lineages, and bone-marrow derived populations (Driskell et
al., 2013; Dulauroy, Carlo, et al., 2012; Jiang & Rinkevich, 2021; LeBleu & Neilson, 2020;
Rinkevich et al., 2015b). Potential sources of myofibroblast progenitors include epithelial
cells and endothelial cells, derived through a process termed epithelial-mesenchymal
(Kalluri & Weinberg, 2009) or endothelial-mesenchymal transition (Zeisberg et al., 2007);
circulating bone marrow–derived fibrocytes, tissue-resident fibroblasts, and other
mesenchymal cells related to blood vessels, including pericytes, adventitial cells, and
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mesenchymal stem cells (Figure 1.5) (MSCs) (Crisan et al., 2008; Di Carlo & Peduto, 2018;
Hinz, 2010b; Zent & Guo, 2018b).

Figure 1-5 Myofibroblasts can differentiate from a variety of precursor cell types
(Schematic adapted from Kendal et al. 2014)

Pericytes are peri-endothelial cells found encircling the endothelial cells of the
microvasculature (Greenhalgh et al., 2013), and their contribution in fibrosis of different
organs still remains controversial (Guimarães-Camboa et al., 2017b; Kramann et al., 2013;
Lemos & Duffield, 2018). Different markers have been used to detect pericytes, such as
Rgs5, Pdgfrβ, nestin Tbx18, CD146 and NG2 (Neuron-glial antigen 2, which encodes
chondroitin sulfate proteoglycan expressed in oligodendrocytes progenitor, myeloid, and
perivascular cells) (Cathery et al., 2018; Yamazaki & Mukouyama, 2018). Lineage tracing
experiments have identified cell populations associated with the perivascular space which
are activated upon tissue injury and exhibit profibrotic phenotypes, characterized by
expression of αSMA and production of fibrillar collagen and other ECM proteins
(Dulauroy, Di Carlo, et al., 2012). Genetic fate mapping has shown that resident pericytes
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in the liver (hepatic stellate cells) (Mederacke et al., 2013), the kidney (Y.-T. Chen et al.,
2011; Humphreys et al., 2010a) and the lungs (Hung et al., 2013) account for the major
sources of myofibroblasts post-injury and contribute significantly to fibrotic repair. On the
contrary, another study using lineage tracing in a model of murine kidney fibrosis found
that pericytes are not a source of myofibroblasts (LeBleu et al., 2013). More specifically,
they used lineage tracing of the commonly accepted pericyte markers PDGFRβ and NG2
and found that, upon injury, these cells expanded but contributed to only a small fraction
of α-SMA positive myofibroblasts. Moreover, ablation of proliferating PDGFRβ+ or
NG2+ cells using a thymidine kinase/ ganciclovir strategy, did not alter matrix deposition
following unilateral ureteral obstruction induced kidney fibrosis (LeBleu et al., 2013). In
another study, a lineage tracing strategy using expression of the T-box 18 (Tbx18)
transcription factor to label smooth muscle cells and pericytes throughout the mouse
provided strong evidence that these cell types are not progenitors of myofibroblasts during
muscle or cardiac fibrosis (Guimarães-Camboa et al., 2017a). Overall, these studies suggest
that various resident cells are likely the major contributors of matrix producing cells during
wound healing response, and recent lineage tracing studies highlight that some of the
heterogeneity exhibited by adult fibroblast populations arises from distinct embryonic
lineages.

Analysis of cell populations through lineage tracing experiments in the oral cavity or the
hard palate is sparse in the literature. Utilizing lineage tracing techniques in Wnt1Cre;Zsgreenfl/fl mice it was demonstrated that all the tendons and mesenchyme embedding
the soft palate muscles are neural crest-derived, proposing that the posterior attachment of
the soft palate to the pharyngeal wall is an interface between the neural crest- and
mesoderm-derived mesenchyme in the craniofacial region (Grimaldi et al., 2015).
Although regional clonal diversity was also recently demonstrated in the cells of the
epithelium that covers the hard palate in mice (Byrd et al., 2019; Jones et al., 2019; Yuan
et al., 2019), there is limited analysis of the stromal cells of the palatal mucoperiosteum.
Lineage tracing experiments have identified that neural crest-derived cells persist in adult
tissues in some areas of the oral mucosa and that Lgr5-lineage-positive cells participate in
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the maintenance of the stroma (Boddupally et al., 2016). Exploring the presence and roles
of distinct cell subpopulations with different embryologic signatures within the oral tissues
may shed light on why some areas in the oral cavity heal with minimal scarring (buccal
mucosa, gingiva) when compared to the skin, while others are more prone to scarring after
reconstruction surgery, such as the palate.

Foxd1 and NG2 as markers for myofibroblast progenitors
Foxd1 is a transcription factor expressed primarily during development, in paraxial
mesoderm-derived populations (Guillaume et al., 2009). Using a Foxd1-Cre knock-in
mouse crossed with a Rosa26-loxp-stop-loxp(lsl)-lacZ reporter mouse, Humphreys et al.
(2010) were able to provide evidence for a mesenchymal source of myofibroblasts during
kidney fibrosis (Humphreys et al., 2010b). This group used this same model to demonstrate
that Foxd1-progenitor– derived pericytes expand after bleomycin lung injury, and activate
expression of collagen-I(a)1 and the myofibroblast marker α-SMA in fibrotic foci, showing
that 68% of α-SMA-expressing cells in fibrotic lungs are pericyte-derived (Hung et al.,
2013). A recent study using a murine cutaneous wounding model showed that Foxd1lineage progeny cells expand upon injury and contribute to the stromal population and
αSMA-positive myofibroblasts, but did not contribute to perivascular and endothelial cells
(Walker et al., 2021). In skin, Foxd1-derived progeny account for a subset of dermal
fibroblasts and myofibroblasts during wound healing (Walker et al., 2021). In excisional
wounds in skin Foxd1-lineage positive (FLP) and Foxd1-lineage negative (FLN)
fibroblasts were both found to produce α-SMA contributing to activated myofibroblasts
during tissue repair. Interestingly, these cell populations appeared to have unique
expression profiles, with FLP cells showing enhanced expression of genes associated with
ECM synthesis and remodelling, while FLN populations are associated with
signalling/microenvironment, indicating that they have unique specializations and
potentially work together in concert during homeostasis and repair (Walker et al., 2021) .

Pericyte function could be tissue-specific as it be influenced by the organ in which the cells
reside: In lung two pericyte populations arise from the same Foxd1 progenitor, one of
which co-expresses fibroblast and pericyte markers (Col1+ Pdgfrα+ Pdgfrβ+ Ng2+)
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(Barron et al., 2016). Type-1 pericytes (Nestin-negative, NG2-positive), produce collagen
and contribute to fibrosis in skeletal muscle, but not in the kidney or the heart (Birbrair et
al., 2014). In the skin, lineage tracing showed that NG2-positive cells did not give rise to
any dermal fibroblast subpopulations during wound healing (Goss et al., 2021), contrary to
other perivascular populations (Dulauroy, Carlo, et al., 2012). NG2-positive cells remained
associated only with blood vessels, restricted to forming NG2+ blood vessel associated
cells, most of which express Pdgfrα and/or Pdgfrβ. (Goss et al., 2021). The same study also
showed that NG2-positive perivascular cells were primarily derived from interfollicular
papillary and reticular fibroblasts during skin development as well as during regeneration,
supporting a potential relationship between pericyte and fibroblast lineages (Goss et al.,
2021). This evidence suggests that multiple subpopulations of pericytes may exist within
different tissues and differentially contribute to myofibroblast formation and fibrosis. To
date, evidence of perivascular cell recruitment and differentiation into myofibroblasts
appears to be organ specific (Di Carlo & Peduto, 2018; Gomes et al., 2021; LeBleu &
Neilson, 2020; Lemos & Duffield, 2018), and, currently, whether this process occurs within
the palatal mucoperiosteum has yet to be tested. Since myofibroblasts contribute to palatal
wound healing and are considered largely responsible for fibrotic tissue formation, we
investigate their origin and recruitment during palatal wound healing in Chapter 4.

Thesis Overview
The overall focus of this thesis is to expand upon our understanding of fundamental
mechanisms involved in the homeostasis and wound repair in oral tissues, with the ultimate
goal of applying the findings to development of novel approaches and biomaterials with
specific biochemical and biomechanical properties targeted to accelerate and enhance the
healing process, while suppressing fibrosis, after dental and maxillofacial surgical
procedures. We provide further evidence for tissue-specific effects of periostin’s
bioactivity, and cell-intrinsic differences that could provide deeper understanding of how
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differences in cellular, molecular composition and physical properties of these tissues lead
to the different healing outcomes.

First, the matricellular protein periostin was determined to be associated with fibronectin
production, myofibroblast differentiation and infiltration of macrophages in wounded
palatal tissues. The effects of periostin on contractile ability and fibronectin synthesis of
palatal fibroblasts were also modulated by the stiffness of the microenvironment via
integrin-β1/RhoA pathway, providing further evidence that periostin and the stiffness of
the ECM act as modulators of matrix synthesis and myofibroblast differentiation during
palatal healing. Next, progress is made to determine the role of periostin in the homeostasis
of the periodontal ligament under normal and osteogenic conditions, highlighting the
diverse and tissue-specific bioactivity of periostin. Finally, a cell lineage tracing strategy
previously used to identify profibrotic populations in the kidney, lung and skin was
determined to label a vascular cell population in the palatal mucoperiosteum, providing
further evidence about the intrinsic differences of cell populations that lead to distinct
healing patterns among different tissues.

Through these diverse studies, insights into effects of the ECM microenvironment in the
context of palatal repair and the intrinsic cell differences of populations contributing to the
healing process have been made. Application of this translatable knowledge could be
utilized in the future for development of biomaterials that can be targeted and guided to
enhance healing outcomes while inhibiting undesired effects, such as scarring and fibrosis
in a tissue-specific manner.
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Chapter 2
2

Periostin and Matrix Stiffness Combine to Regulate
Myofibroblast Differentiation and Fibronectin Synthesis
During Palatal Healing
Introduction

Wound healing in soft connective tissues, such as skin, is defined as a coordinated series
of overlapping events leading to resolution of the defect. Through the phases of hemostasis,
inflammation, proliferation and remodeling, concomitant with re-epithelialization, barrier
function is re-established (Karamanos et al., 2019). Much of the research related to acute
healing has utilized excisional skin wounding, primarily due to ease of defect creation and
the use of genetically modified mouse lines (Smith et al., 2012). However, different healing
profiles have been described. In particular, wounds in the oral mucosa are known to exhibit
significant differences compared with cutaneous injuries (Glim et al., n.d.; Politis et al.,
2016; Wong et al., 2009). In contrast to skin, injuries to the oral mucosa, including gingival
tissue, heal rapidly with minimal scar formation (Dipietro, 2003; Glim et al., n.d.; Häkkinen
et al., 2000; Wong et al., 2009). Interestingly, both skin and oral mucosa are characterized
by the presence of keratinized epithelium and underlying collagen dense connective tissue.
However, while still part of the oral environment, the palatal mucosa is associated with
excessive scarring in response to injury (Larjava et al., 2011; Wijdeveld et al., 1987, 1991).
Unlike skin and gingiva however, palatal soft tissue is a rigid mucoperiosteum; mucosa
and the periosteum are merged and tightly attached to the palatal bone (Nanci, 2013).
In recent years, the role of matricellular proteins in each of these phases of healing has
become established (Walker et al., 2015; Wells et al., 2016). As a class of proteins,
matricellular proteins (MPs) specifically modulate cell-matrix interactions and cell
function (adhesion, spreading, migration, proliferation and differentiation) (Bornstein &
Sage, 2002) by interacting with cell-surface receptors, including integrins. While fibrin,
collagen and fibronectin provide structural support to the matrix, defined roles for MPs in
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the adhesion, migration, proliferation and differentiation of macrophages, fibroblasts, and
keratinocytes have been identified post-wounding (Walker et al., 2015).
Periostin is a secreted matricellular protein associated with wound healing in several
connective tissues, with the cell and molecular roles of periostin mainly investigated in
collagen-rich biomechanically active tissues (Hamilton, 2008). Although knockout mice
are viable, periostin deletion results in disruption of several collagenous-based tissues,
particularly those subject to constant mechanical loading, exhibiting severe periodontal
disease, significant reduction in bone density, and structural defects in the incisors (Rios et
al., 2005). Although periostin was defined as a non-structural ECM component, it has been
shown to modulate cross-linking and stabilization of the extracellular matrix, including
collagen fibrillogenesis (Hwang et al., 2014; Norris et al., 2007). Additionally, periostin
acts as a scaffold for assembly of several extracellular matrix proteins (type I collagen,
fibronectin, tenascin-C, and laminin γ2) and accessory proteins (BMP-1 and CCN3)
(Amizuka et al., 2009; Elliott & Hamilton, 2011; Kudo & Kii, 2018; Maruhashi et al., 2010;
Rogers et al., 2008). This demonstrates a critical role for periostin in extracellular matrix
(ECM) homeostasis and the regulation of cell phenotype.
In skin, we have shown that periostin plays a pivotal role in excisional wound repair, where
it facilitates myofibroblast differentiation through a β1 integrin/FAK dependent
mechanism (Crawford et al., 2015; Elliott et al., 2012; Walker et al., 2015; Zhou et al.,
2010). In contrast, in gingival healing periostin regulates extracellular matrix synthesis,
upregulating fibronectin and collagen synthesis via integrin β1, FAK and JNK, but it is not
associated with myofibroblast differentiation (S. S. Kim, Nikoloudaki, Michelsons, et al.,
2019). The low number of myofibroblasts evident during gingival healing is postulated as
an underlying reason for the reduced scar formation evident in healing of the gingival tissue
(S. S. Kim, Nikoloudaki, Michelsons, et al., 2019). These contrasting effects on dermal and
gingival fibroblasts demonstrate the tissue-specificity of matricellular protein bioactivity
in relatively homologous tissues (Nikoloudaki et al., 2020). The palatal mucoperiosteum,
even though part of the oral cavity, has been shown to exhibit significant scarring after
surgical procedures. The investigation of distinct healing patterns among skin, gingiva and
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the palatal mucoperiosteum could provide deeper understanding of how differences in
molecular composition and physical properties of these tissues lead to the different healing
outcomes. It would therefore be intriguing to assess the role of periostin in palatal tissues,
which while still in the oral cavity, is strongly associated with scarring after injury.
However, the role of periostin in palatal mucoperiosteum has yet to be investigated.
It remains critical to fully understand the underlying molecular and cellular mechanisms
responsible for ECM accumulation in the palate during the wound healing process.
Verstappen et al., using a rat model, found that there are significantly more myofibroblasts
in the wounded mucoperiosteum than are evident in skin wounds, which they attributed to
the different contractile abilities that these tissues possess and correlated their findings with
the different wound healing patterns of these tissues (Verstappen et al., 2012). We
hypothesized that periostin would be transiently upregulated following palatal wounding,
modulating fibroblast differentiation and matrix synthesis. Using a periostin-knockout
(Postn-/-) mouse (Rios et al., 2005), we show that the loss of periostin results in altered
wound closure kinetics. In contrast to gingiva, α-SMA myofibroblasts are present during
palatal healing, and genetic deletion of periostin resulted in reduction of α-SMA and
fibronectin in the newly formed granulation tissue. Furthermore, murine palatal fibroblasts
isolated from Postn-/- mice showed an impaired contraction of a collagen matrix, which can
be rescued by the exogenous addition of periostin. Furthermore, using silicon substrates
of different elastic modulus, we show that Acta2/α-SMA is upregulated in stiff substrates
and fibronectin is upregulated in low stiffness conditions, and that these effects were
attenuated by the genetic deletion of periostin, suggesting that the ECM stiffness is an
important modulator of cell behaviour.

70

Materials and Methods
Animals
All animal procedures were in accordance with protocols approved by the University
Council on Animal Care at The University of Western Ontario. Postn-knockout mice
(Postn-/-) were generated and maintained on soft diet in order to reduce malnutrition, which
was previously observed under a standard diet due to the enamel and dentin defects of the
incisors and molars (Rios et al., 2005). Heterozygous mice were crossed with C57BL/6J
(JAX Mice and Services, Bar Harbor, Maine) for a minimum of six generations to ensure
an incipient congenic strain. Backcrossed heterozygous mice were used for breeding and
all offspring were genotyped as described previously described (Rios et al., 2005).

Palatal wounds
For experiments, Postn-/- mice (KO) and littermate Postn+/+ (WT) mice (20weeks of age)
were anesthetized with an intraperitoneal injection of buprenorphine (0.05 mg/kg),
followed by an injection of ketamine (90 mg/kg) and xylazine (5 mg/kg). One fullthickness excisional wound was made with a 1.5 mm disposable biopsy punch (Integra™
Miltex®, Integra York PA, Inc.) on the hard palate. The localization of the palatal punch
biopsy was standardized with the anterior edge of the wound to be aligned with the first
molar (Keswani et al., 2013) (shown in Appendix Figure A-1) to avoid traumatizing the
palatal arteries which run on either side of the wound. The animals received 0.05 mg/kg
Buprenorphine by subcutaneous injection twice daily for 48 hours post-surgery as an
analgesic. Animals were maintained on a standard lab chow powdered food diet and were
allowed food and water ad libitum for the duration of the experiment. Excised tissue was
considered day 0 and was retained as normal healthy tissue. Wounds were photographed
immediately after wounding and at time-points selected according to the defined phases of
repair: early (day 3), inflammation and granulation tissue formation (day 3, 6), reepithelialization (completed by day 9) (Cornelissen et al., 1999), and tissue remodeling
(day 12-15). Wound area was assessed from photographs using ImageJ software. Animals
were euthanized at 3, 6, 9, 12 and 15 days post-wounding by carbon dioxide inhalation.
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Tissue Preparation
Post euthanasia, mice were decapitated, and the maxillae were fixed in 10% neutral
buffered formalin (Sigma Aldrich,St. Louis, MO) for 24 hours and decalcified in 20%
EDTA (ethylenediminetetraacetic acid) for 10 days at 4 °C. The maxillae were dehydrated
through a graded series of ethanol, processed and embedded in paraffin, and sectioned at 5
μm thickness for various staining.

Histological analysis
Wounds from WT and Postn-/- mice were histologically analyzed (n=5) for the extent of
re-epithelialization. Sections from the center of the wounds were stained with Masson’s
Trichrome (University Hospital, London, ON) and wound size as well as epithelial
migration distance were calculated using ImageJ software. Epithelial migration distance
was defined as the unilateral distance between the wound border and the migrating front of
keratinocytes and percentage of epithelialization was determined from bilateral epithelial
migration distance, normalized to wound size. Images were taken with a DM1000 light
microscope (Leica, Concord, Ontario) and Leica Application Suite Software (version 3.8).

Immunohistochemistry & Immunofluorescence
Immunohistochemistry was performed as previously described (Elliott et al., 2012). In
brief, tissue sections were deparaffinized, blocked with 10% horse serum, and immunelabeled using primary antibodies against α-smooth muscle actin (α-SMA) (ab5694, 1:200,
Abcam plc, Cambridge, United Kingdom) and phosphorylated Smad2/3 (pSmad2/3)
(sc11769-R, 1:100, Santa Cruz Biotechnology, Santa Cruz, CA). Sections were
counterstained with haematoxylin. Negative controls excluded the primary antibody.
Primary antibodies were detected using the ImmPRESS Reagent Kit Peroxidase (Vector
Laboratory; Burlingame, CA) and visualized with 3,3-diaminobenzidine DAB reagent
(Vector Laboratories) following the manufacturer’s instructions. All sections were
counterstained with haematoxylin (Sigma Aldrich).
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Immunofluorescence

staining

carried

out

as

above

excluding

haematoxylin

counterstaining. Tissue sections were incubated with primary antibodies against periostin
(sc49480, 1:100, Santa Cruz Biotechnology), fibronectin (ab23750, 1:150, Abcam),
fibroblast-specific protein-1 was with anti-FSP1/S100A4 (1:100, Millipore, Billerica,
MA), Arginase-1 (V:20, sc18354, 1:100, Santa Cruz Biotechnology), iNOS (ab15323,
1:100, Abcam) and Vimentin (ab92547, 1:200, Abcam). Primary antibodies were detected
using Alexa Fluor IgG secondary antibodies (Invitrogen, Thermo Fisher Scientific). All
sections were counterstained with Hoechst 33342 dye (1:1000, Invitrogen, Thermo Fisher
Scientific) for nuclei. Images were taken on Carl Zeiss Imager M2m microscope (Carl
Zeiss, Jena) using ZenPro 2012 software.

RNA isolation and real-time quantitative PCR
Palatal wounded tissues from WT and Postn-/- mice (N=7 per timepoint) were dissected
using a 1.5 mm diameter punch biopsy, homogenized using BeadBug™ prefilled tubes
(0.5mm zirconium beads, Z763772, Sigma-Aldrich) in 1.5 ml of TRIzol reagent (Thermo
Fisher Scientific), and purified using RNeasy mini kits (Qiagen, Valencia, CA). The area
that was excised for mRNA extraction is shown in Figure 2.1 C by a white box. Taqman
real-time PCR was performed using qSCRIPT XLT one-step real-time quantitative PCR
ToughMix (Quanta Biosciences, Gaithersburg, MD) per the manufacturer’s instructions.
All samples were run in triplicate and normalized to endogenous 18S rRNA (Thermo
Fisher Scientific).

In situ hybridization (ISH)
In situ hybridization for periostin and βigh3 message using antisense and sense (control)
Postn and βigh3 cDNA probes (as described Lindsley et al. (Lindsley et al., 2005)) was
performed on 10 μm paraffin serial sections. For both probes, serial sections were examined
using at least three individual palates of each genotype.
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Isolation of murine primary palatal fibroblasts (mPFBs)
The soft tissue covering the whole hard palate of six mice was excised and immediately
transferred to sterile PBS supplemented with 10% fetal bovine serum and 7x AA (200 U
penicillin, 200 mg streptomycin, 0.5 mg/ml amphotericin B) (Gibco, Carlsbad, CA). The
tissue was washed 3 times in PBS, 3 times in DMEM, cut into smaller pieces (approx.
1cm2), and allowed to attach on tissue culture plastic for a few minutes. DMEM, 10% FBS,
1x AA was added and the explants were incubated at 37 °C, 5% CO2 to allow fibroblasts
to migrate onto the culture surface. The pieces of palatal tissue were removed, and cells
were used at passage 1 and 2 for all experiments.

Cell treatment
mPFBs were seeded in DMEM containing 10% FBS at 8000 cells per cm2 surface area for
RTqPCR and immunocytochemistry, and at 16000 cells per cm2 for western blot
experiments in 6-well plates of different elastic modulus: 64 kPa, 8 kPa, 0.2 kPa (CytoSoft
6 well plate, Advanced BioMatrix). Tissue culture plastic plates (VWR) served as control.
The plates were previously coated with 100μg/ml collagen type I (PureCol, Advanced
BioMatrix, Carlsbad, CA) in DPBS as per manufacturer’s instructions. After 24 hours,
cells were transferred into serum-free DMEM for an additional 16 hours. Then 5 ng/mL
TGF-β1 (R&D Systems, Minneapolis, MN) was added to cells and incubated for 24 to 72
hours, depending on the assay. For assessing the influence of FAK pathway inhibition,
starved mPPFs were treated with PF-573,228 (10 mM), and DMSO (1:1000) served as a
control for PF-573,22. All experiments were run in triplicate.

CyQUANT Proliferation Assay
After mPFBs from WT and periostin KO animals were seeded on collagen type I pre-coated
tissue culture plastic plates as previously described (section 2.2.9) for 1, 3, 5, and 7 days,
media was completely aspirated, and the plates were frozen at -80 °C. Once all time-points
were captured, DNA contents were determined by performing CyQUANT® Cell
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Proliferation Assay Kit (C7026, Molecular Probes). Cell numbers were extrapolated using
a standard curve, as per manufacturer’s instructions.

Western Blotting
mPFBs were cultured on plates of different elastic modulus (8 kPa, 0.2 kPa) coated with
100μg/ml collagen type I (PureCol, Advanced BioMatrix, Carlsbad, CA) in DPBS for 24
hours. Cell lysates were harvested with RIPA buffer (Sigma Aldrich) containing protease
and phosphatase inhibitor cocktails. Protein concentration was determined by Pierce®
BCA Protein assay kit (Pierce; Waltham, MA). 12 μg proteins of each sample were
separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred to nitrocellulose membranes. Membranes were washed with Tris-buffered
saline containing 0.05% Tween-20 (TBS-T) and blocked with 5% dried milk in TBS-T or
5% bovine serum albumin (BSA) in TBS-T. Primary antibodies for fibronectin (ab1954,
1:2000, Millipore), α−SMA (A5228, 1:2000, Sigma Aldrich), pFAK Y397 (ab81298,
1:1000, Abcam), FAK (ab40794, 1:1000, Abcam), Vinculin (MAB3574, 1:1000,
Millipore), β1-integrin (SAB5600100, 1:1000, Sigma-Aldrich), GAPDH (MAB374,
1:1000, Millipore) were used to incubate the membranes for 12 hours. Detection was with
appropriate

peroxidase-conjugated

secondary

antibodies

(1:2500,

Jackson

ImmunoResearch; West Grove, PA), which were developed with Clarity Western ECL
substrate (Bio-Rad; Hercules, CA). Densitometry analysis was performed using Image Lab
Software (Bio-Rad).

Immunocytochemistry
mPFBs were cultured on plates coated with 100 μg/ml collagen type I (PureCol, Advanced
BioMatrix, Carlsbad, CA) are previously described (section 2.2.9) for 24 and 72 hours.
Cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100 and
blocked with 1% BSA (Thermo Fisher Scientific). Fixed and permeabilized cells were
labeled with mouse anti-α-SMA (A5228, 1:100, Sigma-Aldrich), anti-fibronectin
(ab23750, 1:100, Abcam), vinculin (MAB3574, Millipore), β1-integrin (AF2405, R&D
Systems) which was detected with appropriate IgG conjugated to Alexa Fluor secondary
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antibodies (1:100, Invitrogen, Thermo Fisher Scientific). The cells were double
immunolabeled with rhodamine-conjugated phalloidin (1:100, Invitrogen) for filamentous
actin. Nuclei were counterstained using Hoechst 33342 dye (1:1000, Thermo Fisher
Scientific). Images were taken on Carl Zeiss Imager M2m microscope (Carl Zeiss) using
ZenPro 2012 software.

Fixed Gel Contraction Assay
In vitro, contractility of mPFBs was evaluated by employing collagen gel matrix
contraction assays as previously described (Elliott et al., 2012; S. S. Kim, Nikoloudaki,
Michelsons, et al., 2019). mPFBs suspended in 0.5% FBS DMEM were mixed 1:1 with
collagen mix [10% 0.2 M HEPES buffer (4-(2-hydroxyethyl)-1 piperazineethanesulfonic
acid; pH = 8], 40% bovine collagen type I (Advanced BioMatrix), and 50% 2X high
glucose DMEM (Gibco)) to a final density of 100,000 cells/ml. In parallel, either 5 μg/ml
rhPSTN (R&D Systems) or an equivalent volume of PBS was incorporated into the
collagen and cell mix. 24 well tissue culture plates were pre-coated with 1% BSA for 12
hours and washed with PBS. 1 ml of the cell and collagen mix was plated to each well and
allowed to set at 37 °C. Following polymerization, 1 ml of 0.5% FBS DMEM was added
to the wells. After 24 hours, the gels were detached from the plate and they were left to
contract for 24 hours at 37 ºC. As contraction of the collagen matrix excluded growth
medium, thereby reducing the gel weight, loss of gel weight was used to measure the extent
of contraction. This accounted for contraction of gels horizontally and vertically.

Statistical Analysis
Statistical analysis was by one-way or two-way ANOVA, as appropriate, followed by a
Bonferroni correction, using Graphpad Software version 5 (Graphpad Software, La Jolla,
CA) (P<0.05 was considered significant). For wound healing experiments, data are
expressed as a fraction of the original wound area (mean ± SD). In vivo gene expression
data represents the mean ± standard deviation of seven Postn+/+ and seven Postn-/- wounds
for each time point. For quantification of phosphorylated Smad2/3 in the wounds in vivo,
data are expressed as the percentage of positive cells/total cells per field of view ± standard
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deviation. For in vitro study, data are expressed as the mean ± standard deviation of three
individual experiments with independent primary cultures from different animals.
Individual experiments included three replicates. For quantification, RT-qPCR, western
blot densitometry, gel contraction statistical analysis by two-way ANOVA with Bonferroni
multiple comparisons test was used.
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Results

Periostin mRNA and protein are up-regulated after excisional
palatal wounding and peak 12 days after wounding
To temporally investigate the palatal healing process, we quantified the closure of the
palatal mucoperiosteum in C57Bl/6 WT mice at 3, 6, 9, 12 and 15 days post-wounding,
with unwounded palatal mucoperiosteum serving as a structural baseline control (day 0)
(Fig. 2.1). Analysis of in vivo Postn gene expression during palatal wound healing in wildtype (WT) mice by real-time quantitative polymerase chain reaction (RT-qPCR) showed
that Postn mRNA levels were significantly increased during palatal wound repair at day 6
(P < 0.05), peaking at day 12 (P < 0.01) (Fig. 2.1 A). Using in situ hybridization (ISH) (Fig.
2.1 B) and immunofluorescent staining (Fig. 2.1 C) in normal unwounded palatal mucosa
periostin signal was weakly detected in the basal lamina and periosteum covering the
palatal bone, with intense signal at the periodontal ligament of neighbouring teeth (arrowFigure 2.1 B, white arrowheads Figure 2.1 C). After wounding, periostin was detected
throughout the ECM of the granulation tissue at days 6, 9, 12 and 15 (Fig. 2.1 B, C).
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Figure 2-1 Periostin mRNA and protein are up-regulated after excisional palatal
wounding
1.5mm full-thickness excisional wounds were created on the hard palate of periostinknockout (Postn-/-) and wild-type (WT) mice. (A) Postn mRNA expression was quantified
in tissues from 0 to 15 days post wounding using quantitative PCR. Values are given as
mean±SD. Data was analyzed using one-way ANOVA N=7 for each time-point (*P < 0.05;
***P < 0.001 comparisons to d0). All samples were run in triplicate and normalized to
endogenous 18S rRNA (B) Periostin mRNA message detection in d0, d3, d6, d9 wounds
of WT and Postn-/- mice by in situ hybridization (C) Immunofluorescent staining for
Periostin from d0 to d15 post-wounding. White box indicates the area that was excised for
mRNA extraction. White arrows indicate the length of the open wounds. White arrowheads
indicate the periodontal ligament of the teeth. Scale bar: 200 μm
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Genetic deletion of periostin results in altered wound-closure
kinetics during excisional palatal healing in mice
To investigate the contribution of periostin to palatal wound repair process, full-thickness
excisional wounds were created in Postn-/- (KO) and Postn+/+ (WT) mice. To assess
differences in the rate of wound closure between Postn-/- and WT mice, we measured
wound size based on gross appearance up to 12 days after wounding. Genetic deletion of
Postn significantly reduced wound closure rates compared to WT mice. Wounds in WT
mice were macroscopically resolved by day 6, with wound size in Postn-/- animals reduced
by 80% of the initial wound area (Fig. 2.2 B). Histological analysis of sections from the
center of the wounds at day 6 (Fig. 2.2 C-F) confirmed that Postn-/- wounds were
significantly larger than those of their WT littermates (P < 0.05) with decreased reepithelialization at day 6 evident in Postn-/- mice (P < 0.01), although epithelial tongue
length was similar in both genotypes (P > 0.05). Wounds in both WT and Postn-/- were
closed by day 12.
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Figure 2-2 Genetic deletion of periostin results in altered wound-closure kinetics
during excisional palatal healing in mice
(A) Wound size was measured up to 12 days post wounding in 1.5-mm wounds from 7
Postn-/- and 7 WT animals. Representative wounds are shown at 0, 3, 6, and 9 days post
wounding (top to bottom). Bar= 1 mm. Masson’s trichrome-stained sections were used to
analyze wound size (B), re-epithelialization (C, D) and the epithelial tongue length (E). 5
Postn-/- and 5 WT mice were quantified. Data are expressed as mean ± standard deviation.
*P < 0.05; **P < 0.01. (F) Representative images from sections stained with Masson’s
Trichrome Stain. WT wounds have completely closed by day 6. However, Postn-/- wounds
present delayed healing as at day 9 re-epithelialization has not been completed. Black
arrows indicate edge of the wound. Yellow arrows indicate the periodontal ligament of
neighbouring teeth. (PB= Palatal Bone, Epi= oral Epithelium, GT= Granulation Tissue)
Scale bar= 125 μm
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Absence of Postn alters transcriptional regulation of genes
associated with repair and wound healing
α-SMA expression is attenuated in the granulation tissue of Postn-/- mice
Acta2 is expressed by mesenchymal cell types including pericytes and myofibroblasts
(MF). MFs are key during wound healing, responsible for ECM synthesis, remodeling and
tissue contraction (Gabbiani et al., 1971; Hinz, 2016; Tomasek et al., 2002). Assessment
of α-SMA in Postn-/- and WT wounds using immunohistochemistry showed α-SMA was
evident at the wound edge and within the granulation tissue of WT wounds at days 6 and
9. At day 6, increased immunoreactivity of α-SMA was detected at the wound border in
WT mice, throughout the granulation tissue and in blood vessel walls (Fig. 2.3A). In day 6
Postn-/- wounds, α-SMA immunoreactivity was reduced when compared with that in WT.
Quantitative PCR (RT-qPCR) on RNA isolated from WT and Postn-/- wounds at 3 ,6 ,9, 12
and 15 days post wounding demonstrated that Acta2 mRNA levels were increased in both
genotypes, but was significantly reduced in the granulation tissue of Postn-/- mice at day 6
(Fig. 2.3 B) (P<0.05). Double immunofluorescence staining was used to detect the spatial
relationship between α-SMA and periostin signal in the wound matrix. We observed that
α-SMA positive cells, indicating the presence of myofibroblasts, were in the granulation
tissue and periostin matrix, indicating that periostin might have an effect to myofibroblast
differentiation by direct contact (Fig. 2.3 D). To determine whether the reduction in α-SMA
mRNA levels was due to impaired fibroblast recruitment into the granulation tissue,
sections were labeled for fibroblast-specific protein-1 (FSP-1) (Fig. 2.4 A, B) and vimentin
(Fig. 2.4 C). While no significant differences in FSP-1 immunoreactivity in Postn-/- tissue
compared to WT at days 6 and 9 post-wounding, we observed decreased vimentin signal
in Postn-/- wounds at day 6 when compared to WT wounds indicating impaired granulation
tissue formation and reflecting the delay in wound healing kinetics (Fig. 2.4 D).
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Figure 2-3 α-SMA expression is reduced, but not absent, in the granulation tissue of
Postn-/- mice
(A) Immunohistochemical staining for α-smooth muscle actin (α-SMA). Sections of
normal (day 0) tissue and day 3,6 and 9 wounds of WT and Postn-/- animals. The area
highlighted in the red rectangle is magnified below in panel (C). (B) Acta2 expression was
quantified in tissue from 3 to 15 days post wounding using RTqPCR. Values are given as
mean±SD. N=7 animals per time point. *P < 0.05. (D) Double immunofluorescent staining
to detect α-SMA (green) and periostin (red) signal at day 6 and day 12 wounds of WT and
Postn-/- animals. Scale bar: 100 μm. White dashed lines indicate the border between the
epithelium and the granulation tissue.
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Figure 2-4 Reduction in SMA mRNA levels was not due to impaired fibroblast
recruitment into the granulation tissue
(A) Immunofluorescent staining to detect fibroblasts using fibroblast-specific protein-1
antibody. Bar: 200μm. (B) Quantification presented as percentage of FSP-1-positive
cells/DAPI-positive cells of wounds at days 6 and 9 post-wounding, in four WT and four
Postn-/- mice. (C) Immunofluorescent staining for Vimentin. (D) Quantification presented
as percentage of Vimentin positive area/wound area of wounds at days 6, 9 and 12 postwounding, in four WT and four Postn-/- mice. Bar: 200μm. (P < 0.05) White arrows indicate
the leading wound edge.
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Genetic deletion of Postn is associated with reduced fibronectin expression and
deposition during palatal healing.
Using immunofluorescence, we next assessed localization of fibronectin, a glycoprotein
important in ECM organization and stability, as well as attachment sites for fibroblasts and
keratinocytes, to facilitate their migration into the wound bed (Pereira et al., 2002;
Zollinger & Smith, 2017). Fibronectin immunoreactivity was evident in the basal lamina
and at the granulation tissue of WT wounds at day 6 and 9. However, in Postn-/- wounds
the granulation tissue at the wound edge had reduced fibronectin labeling (Fig. 2.5 A).
Analysis of in vivo Fn1 mRNA levels by RT-qPCR confirmed that copy number of Fn1
was significantly lower in Postn-/- wounds compared to WT at day 9 post-wounding (P <
0.001) (Fig. 2.5 C). Using double immunofluorescence staining we found that fibrillar
fibronectin and periostin partially colocalize within the wound environment, further
supporting the direct interaction if these biomolecules (Fig. 2.5 B)
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Figure 2-5 Genetic deletion of Postn is associated with reduced fibronectin
expression and deposition during palatal healing
(A) Representative images of immunoreactivity for Fibronectin of unwounded (day 0) and
wounded mice palate. White arrows indicate the leading wound edge and white arrowheads
indicate fibronectin labeling in the granulation tissue at the wound edge. Scale bar: 200
μm. (B) Double immunofluorescent staining to detect periostin (green) and fibronectin
(red) localization in the granulation tissue day 12 wounds of WT animals. Scale bar: 100
μm (C) FN1 mRNA expression was quantified in tissues from 0 to 15 days post wounding
using quantitative PCR. Values are given as mean±SD. Data was analyzed using one-way
ANOVA N=7 for each time-point (***P < 0.001).

90

Genetic deletion of Postn affects immune cell infiltration
Inflammatory cell infiltration in the wounds was assessed by characterizing the
macrophages populations in the granulation tissue of the wounds using antibodies specific
for iNOS (M1 polarization), and arginase-1 (arg-1) (M2 polarization) (Jablonski et al.,
2015). Overall, WT wounds appeared to have increased M1 and M2 macrophages than
Postn-/- during wound healing at day 3, 6 and 9 post wounding. The presence of iNOSpositive cells was more abundant in day 6 and 9 WT wounds throughout the granulation
tissue, as well as at the epithelial layers. However, Postn-/- wounds had significantly less
iNOS-positive cells (WT, 30%; Postn-/-, 12%; P < 0.001), which were located at the edge
of the wound (Fig. 2.6). Similar observations were also found for Arginase-1-positive cells.
These observations suggest that the reduced number of macrophages in palatal healing
likely results from genetic deletion of periostin.
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Figure 2-6 Genetic deletion of Postn affects immune cell infiltration.
(A) Double Immunofluorescent staining to detect macrophages markers Arginase-1 (M2
polarization-green) (Arg-1, V:20 sc18354) and iNOS (M1 polarization-red) (iNOS
antibody ab15323). White arrows indicate the leading edge of the wound. White dashed
line indicates the border between the epithelium and the granulation tissue. Scale bar:
200μm. (B) Quantification presented as percentage of Arginase-1-positive cells/DAPI
positive cells of wounds at days 3, 6 and 9 post-wounding, in six WT and four Postn-/- mice.
(C) Quantification presented as percentage of iNOS-positive cells/DAPI positive cells of
wounds at days 3, 6 and 9 post-wounding, in six WT and four Postn-/- mice.
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βigh3 does not have a compensatory role for the loss of
periostin in Postn-/- animals
Also defined as a matricellular protein, transforming growth factor-β-induced gene
product-h3 (TGFBI/βigh3) is considered a paralog of Postn because of their structural
similarity (Kawamoto et al., 1998). In vitro studies showed that βigh3 promotes adhesion
and migration of dermal fibroblasts and keratinocytes (Bae et al., 2002; LeBaron et al.,
1995; Mosher et al., 2015). Thus, we hypothesized that βigh3 might play compensatory
roles in the adhesion and migration of keratinocytes/fibroblasts at wound sites. We
therefore assessed the levels of TGFBI/βigh3 by ISH and RT-qPCR in WT and Postn-/embryonic tissues as well as its expression in normal and wounded tissues. ISH
demonstrated that βigh3 mRNA is present in normal, uninjured palate and is upregulated
during wound healing. βigh3 showed increased expression in comparison to Postn in day
3 wounds, where it is present in granulation tissue filling the wound site (Fig. 2.7). At day
6 post-wounding both Postn and βigh3 are present in WT granulation tissue at the wound
site, after which they are gradually reduced. RT-qPCR analysis confirmed that the mRNA
level of βigh3 in day 6 Postn-/- wounds is significantly reduced compared to WT wounds
(P < 0.05). The different wound-response spatiotemporal expression patterns of these two
matricellular proteins might be an indication that βigh3 may not compensate for the loss of
Postn during palatal wound healing or that Postn and βigh3 are differentially regulated via
divergent upstream signaling pathways. This is supported by our observations in
embryonic tissues where Postn mRNA message is present in the developing palatal shelves
of the secondary palate and tongue at E15, while βigh3 mRNA message is only present in
the tongue (Fig. 2.7 C). Thus, βigh3 can play an independent role and exhibit nonoverlapping expression and function with Postn in the development of the hard palate in
mice.
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Figure 2-7 βigh3 does not have a compensatory role for the loss of periostin in Postn/-

animals.

(A) βigh3 message detection in days 0 (normal tissue), 3, 6 and 9 WT wounds by in situ
hybridization. White arrows indicate the leading wound edge. (B) βigh3 expression was
quantified in tissue from 3 to 15 days post wounding using RTqPCR. Values are given as
mean±SD. N=7 per time point. *P < 0.05. (C) Postn and βigh3 message detection at E15
mice.
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Canonical TGFβ signaling is not altered in Postn-/- fibroblasts
TGFβ is known to cause an increase in α-SMA expression through phosphorylation of
Smad3 (Gu et al., 2007), and plays a major role in myofibroblast differentiation
(Desmoulière et al., 1993). Therefore, to determine whether the reduction in α-SMA
expression and immunoreactivity in Postn-/- granulation tissue was due to defective TGFβ–
Smad3 signaling, we assessed the number of nuclei positive for phosphorylated Smad2 and
Smad3 (pSmad2/3) within the granulation tissue of palatal wounds at day 3, 6, 9, 12 and
15 post-wounding (Figure 2.8A). The number of pSmad2/3-positive nuclei was similar in
both WT and Postn-/- wounds, suggesting that canonical TGFβ signaling is active in Postn/-

wounds and unaffected by the absence of periostin (Figure 2.8B).

Exogenous periostin is sufficient to induce a contractile
phenotype in Postn-/- fibroblasts
To examine the functional role of periostin in palatal healing, we utilized in vitro assays to
investigate how genetic deletion of periostin affects the proliferation rate and myofibroblast
differentiation of murine palatal fibroblasts (mPFBs). Periostin is known to modulate
expression of α-SMA during skin healing (Elliott et al., 2012), but not in gingival healing
(S. S. Kim, Nikoloudaki, Michelsons, et al., 2019). In our in vivo experiments we observed
a reduced levels of α-SMA on Postn-/- wounds (0) which indicates that a defect might exist
in differentiation of fibroblasts to myofibroblasts in Postn-/- wounds. When cells where
cultured for 24 and 72h on tissue culture plastic (TCP), Acta2 mRNA levels were
significantly higher in WT mPFBs in comparison to Postn-/- mPFBs (P < 0.01, P < 0.001)
(Figure 2.8 C). Exogenous stimulation of the cells with TGFβ (5 ng/ml) did not have a
significant effect on Acta2 mRNA levels in either cell type (Fig. 2.8 D), indicating that the
cells might have already become maximally differentiated.
WT and Postn-/- mPFBs were isolated and cultured for 1,3,5 and 7 days to assess their
proliferation rates. Both cell types exhibited a 4-fold increase in cell number by day 7 with
no significant difference in cell number evident between the genotypes (p > 0.05) (Fig. 2.8
E). To assess the contractile ability of the cells we utilized in vitro assays to determine
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their ability to contract a floating collagen gel. Quantification of contraction through
measurement of gel weight showed that WT palatal fibroblasts were able to significantly
contract the collagen matrix in comparison with Postn-/- palatal fibroblasts, indicating that
periostin is required for contraction of a collagen matrix by palatal fibroblasts (P < 0.01)
(Fig. 2.8 F). To further investigate this finding, 5 mg/ml recombinant human periostin
(rhPSTN) was added to the collagen matrix and was found to be sufficient to induce
contraction of the gels by Postn-/- palatal fibroblasts.
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Figure 2-8 Canonical TGFβ signaling is not altered in Postn-/- fibroblasts & Exogenous
periostin is sufficient to induce a contractile phenotype
(A) Immunohistochemical staining for phosphorylated Smad2/3 (Santa Cruz sc11769).
Detection was with peroxidase-conjugated secondary antibodies- chromogen DAB.
Representative images of wounds at day 6 post-wounding in WT and Postn-/- animals. (B)
Numbers of positively stained nuclei per field of view were not significantly different
between WT and Postn-/- (KO) wounds. (C, D) WT and Postn-/ mPFBs (KO) were seeded
on TCP, with or without TGFβ (5 ng/ml). At 24- and 72-hours Acta2 expression was
quantified using RTqPCR. Data represents mean fold gene expressions ±SD relative to
control 24h (without TGFβ-control) of 3 independent experiments in triplicates (N=3, n=3
per time point. *P < 0.05, **P<0.01, ***P<0.001, two-way AVONA) (E) WT and KO
mPFBs cultured for 1, 3, 5, and 7 days were assessed for proliferation using CyQUANT
assay kit to determine DNA contents. A standard curve was used to extrapolate cell
number. Data represents fold cell number increase ± SD relative to day 1. Data was
analyzed via two-way ANOVA (p > 0.05). (F) Gel contraction was quantified by loss of
gel weight, compared with gels lacking cells. KO fibroblasts were unable to significantly
contract collagen gels. WT fibroblasts were able to contract collagen gels. Exogenous
addition of 5 mg/ml rhPSTN to the collagen gels rescued the contractile ability of Postn-/fibroblasts. Data is expressed as a fraction of the initial gel weight; error bars represent SD
(N=3, n=3, *P < 0.05, **P < 0.01, two-way ANOVA).
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Periostin expression in mPFBs is regulated by matrix stiffness
To evaluate whether Periostin is differentially regulated by the stiffness of the underling
substratum, mPFBs were seeded for 24- and 48 hours on substrates of different stiffness.
Up to 24 hours post seeding, Postn expression levels were similar across different stiffness
substrates (Fig. 2.9). At 48 hours, Postn mRNA levels were significantly higher in very
stiff substrates (TCP) (P < 0.01, P < 0.05) (Fig.2.9 B), reducing gradually as the stiffness
of the substrate decreases.
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Figure 2-9 Periostin expression in mPFBs is regulated by matrix stiffness
(A, B) WT mPFBs were cultured on silicone substrates of different stiffness, with or
without TGFβ, for (A) 24- and (B) 48-hours, and Postn mRNA levels were quantified using
RTqPCR. Values are given as mean±SD from 3 independent experiments. Data was
analyzed using ANOVA, (*P < 0.05; **P < 0.005). (C) Matrix stiffness alone is not
sufficient to restore the contractile phenotype of Postn-/- cells: mPFBs were cultured on
silicone substrates of different stiffness and analysed for α-SMA incorporation in stress
fibers. (D) Quantification of α-SMA positive stress fiber-cells. (E) mPFBs were treated
with 5ng/ml TGFβ and α-SMA positive stress fiber-cells were quantified using
immunofluorescence. (F) Acta2 expression was quantified RTqPCR. (G) Western blot was
used to assess α-SMA protein level of WT and Postn-/- mPFBs. GAPDH was used as a
loading control. Values are given as mean±SD from 3 independent experiments. Data was
analyzed using ANOVA, (*P < 0.05; **P < 0.005). Scale bar: 20μm.

101

Matrix stiffness is not sufficient to restore the contractile
phenotype of Postn-/- cells
Differentiation of fibroblasts into myofibroblasts requires TGFβ-dependent signaling, but
also depends heavily on increased matrix stiffness (Hinz, 2015; Humphrey et al., 2014;
Tomasek et al., 2002). To explore the contribution of microenvironment stiffness on
cellular behavior, WT and Postn-/- mPFBs were seeded on silicone substrates with different
Young’s elastic modulus simulating different scar maturation stages, and Acta2/α-SMA
expression was evaluated using RTqPCR, immunolabeling and western blotting. Murine
palatal fibroblasts seeded on collagen-coated tissue culture plates (TCP) adopted a planar,
well-spread morphology typical of fibroblasts in culture (Figure 2.9 C). These cells
developed very distinct stress fibers, which often incorporated α-SMA, indicating
myofibroblast differentiation. Depending on the stiffness of their environment, after 24h
culture cells assume differentiated myofibroblast characteristics on tissue culture plastic
(TCP-control) and ‘‘fibrosis-rigid’’ (65 kPa) substrate, formed α-SMA-negative stress
fibers on ‘‘normal tissue soft’’ (8 kPa) substrates, while on very soft “granulation tissue
soft” (0.2 kPa) substrates the cells were characterized by poor spreading and exhibited no
contractile bundles (Fig. 2.9 C).
The percentage of fibroblasts with positive-α-SMA stress fibers increased with an increase
in substrate stiffness (P < 0.001). The proportion of WT mPFBs with α-SMA-positive
stress fibers peaked on TCP at 76%, while on substrates of low stiffness (0.2 kPa) that
proportion accounted only for the 26% of the cells (Fig. 2.9 C, D). Compared with WT
mPFBs, the proportion of Postn-/- cells with α-SMA-positive stress fibers was significantly
lower on TCP (54%) (P<0.01) and 0.2 kPa (9%) (P<0.05) substrates. These observations
were further supported by Acta2 expression levels and α-SMA protein levels (Fig. 2.9 F,
G), showing that the absence of periostin in Postn-/- cells resulted in reduction of acta2/αSMA expression which was mainly manifested in very stiff conditions (TCP). When cells
were treated with 5 ng/ml TGFβ, the proportion of Postn-/- cells with α-SMA-positive stress
was similar to WT cells on 0.2 kPa substrates (WT, 20%; Postn-/-, 23%) (Fig. 2.9 E).
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Fibronectin secretion is regulated by Periostin and Matrix
stiffness
To mimic the in vivo conditions and validate our observations regarding the deficit in
fibronectin deposition in Postn-/- wounds, WT and Postn-/- mPFBs were seeded on silicone
substrates with different Young’s elastic modulus. Low stiffness substrates (0.2 kPa)
resulted in upregulation of fibronectin in WT cells, when compared to control (TCP)
(p<0.05). Similar to our in vivo observations, genetic deletion of periostin in Postn-/- mPFBs
resulted in a trend of reduced fibronectin mRNA levels across all different substrates, a
difference which was significant at low stiffness substrates (0.2 kPa) (P<0.05), indicating
two important regulators of fibronectin synthesis during palatal healing: periostin and
microenvironment stiffness (Fig. 2.10).
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Figure 2-10 Fibronectin secretion is regulated by Periostin and Matrix stiffness.
Fibronectin secretion using immunofluorescence. (B) FN1 expression was quantified using
RTqPCR. (C) Western blot was used to assess fibronectin protein level of WT and Postn/-

mPFBs. GAPDH was used as a loading control. Values are given as mean±SD from 3

independent experiments. Data was analyzed using ANOVA, (*P < 0.05). Scale bar: 20μm.
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Periostin modulates myofibroblast differentiation in Palatal
fibroblasts via RhoA/ROCK pathway
Periostin has been shown to increase focal adhesion formation, α-SMA levels and collagen
contraction in fibroblasts from hypertrophic scars, effects which were dependent on Rhoassociated protein kinase (Crawford et al., 2015). To identify the signaling pathway
intermediates that are activated by periostin and/or matrix stiffness and control
myofibroblast differentiation and fibronectin synthesis, we utilized pharmacological
inhibitors for RhoA, Y-27632, and Rac1, Z62954982. We found that both WT and Postn/-

cells on an extremely stiff environment (TCP) exhibit well spread morphology with

formation of stress fibers, although in Postn-/- cells the incorporation of α-SMA in the stress
fibers is reduced (53%) when compared to the WT (72%) (P<0.01). Rho inhibition (Y27632) resulted in cytoskeleton remodeling characterized by a dendritic phenotype with
large cytoplasmic protrusions, and complete loss of α-SMA in both cell genotypes (WT,
17%; Postn-/-, 14%). Interestingly, the inhibition of RhoA on 0.2 kPa conditions did not
have as prominent effect on the cytoskeletal configuration as is evident on TCP, suggesting
that Rho is not active in highly elastic environments (Fig. 2.11 A). When the
pharmacological inhibitor for Rac1 was used to drive ROCK activation, the development
of α-SMA-positive fibers was restored in both WT (78%) and Postn-/- (70%) (P>0.05) cells
seeded on TCP, suggesting that periostin modulates myofibroblast differentiation in stiff
matrices via RhoA pathway (Fig. 2.11 A, B). On 0.2 kPa substrates, the addition of the
pharmacological inhibitor to Rac1 was not sufficient to stimulate the formation of α-SMA
stress fibers and myofibroblast differentiation in either cell type (WT, 2%; Postn-/-,1.8%)
(Fig. 2.11 A, C).
We next investigated the effect of RhoA or Rac inhibition on fibronectin synthesis. RhoA
inhibition resulted in reduced fibronectin matrix assembly in both WT and Postn-/- cell
types (shown in Figure A-2). In contrast, direct activation of RhoA through Rac inhibition
restored fibronectin matrix assembly and protein levels similar to control levels (DMSO)
in both WT and Postn-/- mPFBs, supporting that fibronectin matrix synthesis and assembly
requires Rho kinases (ROCK). However, these results suggest that the mechanism through
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which Periostin regulates fibronectin synthesis in mPFBs does not depend on RhoA/ROCK
pathway.
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Figure 2-11 Periostin modulates myofibroblast differentiation in mPFBs via RhoA
pathway
(A) mPFBs were cultured on TCP (top row) or silicon substrates with 0.2 kPa Young’s
modulus of elasticity (bottom row), treated with pharmacological inhibitors for RhoA, Y27632 (10 μM), and Rac1, Z62954982 (50 μM), and analysed for α-SMA incorporation
in stress fibers using immunofluorescence and western blotting. Western blot was used to
assess α-SMA protein level of WT and Postn-/- mPFBs on TCP (B) and 0.2 kPa substrate
(C) GAPDH was used as a loading control. Values are given as mean±SD from 3
independent experiments. Data was analyzed using ANOVA, (*P < 0.05; **P < 0.005).
Scale bar: 20μm.
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Periostin is required for the formation of focal and fibrillar
adhesions in mPFBs
Organization of adhesion sites is controlled not only by the integrin-ligand interactions, but
also the physical properties of the extracellular matrix which modulate local tension at the
adhesion sites (Katz et al., 2000). To investigate how a change in the stiffness of the cell
microenvironment (using culture substrates) affects the assembly of different types of
adhesion complexes in the presence or absence of periostin, WT vs Postn-/- cells were
seeded on substrates of different elastic modulus. To determine whether the absence of
periostin in Postn-/- mPFBs result in defective adhesion complexes formation, we
visualized

focal

(vinculin)

and

fibrillar

adhesions

(integrin-β1)

using

immunocytochemistry, and we quantified the number of adhesions/cell, the total adhesion
area/cell and the average adhesion area/cell adhesion using ImageJ. The number and the
size of focal adhesions as well as the total focal adhesion area increased with an increase
in substrate stiffness (Fig. 2.12, 13A-C). In the absence of periostin the number of focal
adhesions per cell, the size of the focal adhesions and the focal adhesion area per cell were
significantly reduced across all different substrates. More specifically, on very stiff
substrates (TCP) Postn-/- cells had significantly less focal adhesion sites/cell (n= 383±99)
when compared to WT cells (n= 672±111) (P<0.05), and their average size was smaller
(WT, 5±1μm2; Postn-/-, 4±0.7μm2) resulting in a significantly smaller total adhesion area
per cell in Postn-/- cells (WT, 3238±686μm2; Postn-/-, 1535±645μm2) (P<0.05). On low
stiffness substrates (0.2 kPa) the average size of the focal adhesions (1.9±0.1μm2) and the
number of adhesion sites per cell (n= 117±63) were significantly smaller when compared
to WT cells (3.2±0.4μm2; (P<0.01), n=267±81; P<0.05). Investigating the effect of the
genetic deletion of periostin in fibrillar adhesion formation, we found that the percentage
of β1-integrin-positive adhesion area/cell (Fig. 2.13 E) and the levels of β1-integrin
expression (Fig. 2.13 F) were significantly reduced in Postn-/- cells when compared to WT
cells. These effects were more prominent when the cells were cultured on substrates of low
stiffness and could provide a potential explanation of reduced fibronectin synthesis by
Postn-/- mPFBs under these conditions.
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Figure 2-12 Periostin is required for the formation of focal and fibrillar adhesions in
mPFBs.
mPFBs were cultured on silicone substrates of different stiffness and analysed for focal
(Vinculin) and fibrillar (integrin-β1) adhesions formation using immunocytochemistry.
Representative images of immunoreactivity for Vinculin (magenta) and integrin-β1
(green). Nuclei are stained with Hoechst 33342 dye (blue) F-actin with white. Scale bar:
20μm
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Figure 2-13 Periostin is required for the formation of focal and fibrillar adhesions in
mPFBs
Immunostaining for focal (Vinculin-positive) adhesions was used to quantify: (A) the
number of focal adhesions/cell, (B) the average focal adhesion size, (C) the total adhesion
area (μm2), and (D) the % of focal adhesion area/cell. (E) Fibrillar adhesion formation
expressed as % of adhesion area/cells was quantified using immunostaining for integrinβ1, (F) Integrin-β1 levels were quantified using Western Blotting. Values are given as
mean±SD from 3 independent experiments. Data was analyzed using ANOVA. (*P<0.05,
**P<0.005)
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Discussion
Periostin, a secreted ECM protein, is transiently expressed during normal cutaneous (Elliott
et al., 2012) and gingival wound repair (S. S. Kim, Nikoloudaki, Michelsons, et al., 2019),
but is overexpressed and persistent in abnormal scars and other benign fibroses that are
characterized by fibroblast proliferation and myofibroblast differentiation (Crawford et al.,
2015; Elliott & Hamilton, 2011; Zhou et al., 2010). Excessive scarring as a consequence
of cleft palate reconstruction surgery results in restriction of the normal maxillary
development in transversal width when the patient is in their growing phase, leading to
serious functional and aesthetic problems (Larjava, 2013). The expression profile and
potential roles of periostin in palatal healing have never been investigated. The distinct
healing patterns among skin, gingiva and the palatal mucoperiosteum, and the contrasting
tissue-specific effects of periostin’s bioactivity (Nikoloudaki et al., 2020), could provide
deeper understanding of how differences in molecular composition and physical properties
of these tissues lead to the different healing outcomes. Applying this translatable
knowledge in the fields of biotechnology, these specific biomechanical cues can be targeted
and guided to enhance healing outcomes while inhibiting undesired effects, such as
scarring and fibrosis (Urbanczyk et al., 2020).
In this study, we show that the loss of Postn by use of the Postn-/- mouse (Rios et al., 2005)
results in altered palatal wound-closure kinetics, especially during the proliferation phase
of wound healing. The alteration in wound closure corresponds with the onset at day 6, but
not the peak of Postn expression at day 12 post-wounding in WT animals. Wounds in WT
mice were considered closed by day 6, but wounds in Postn-/- were completely closed at
day 12 post-wounding (Fig. 2.2 A-B, Fig. 2.3). Although the histological analysis of
sections from the centre of the wounds at day 6 showed decreased re-epithelialization in
Postn-/- mice, the epithelial tongue length (epithelial migration distance) was similar in both
genotypes (Elliott et al., 2012; Gorin et al., 1996). Periostin has been shown to regulate
myofibroblast differentiation, matrix synthesis and re-epithelialization in skin (Elliott et
al., 2012; Norris et al., 2007; Zhou et al., 2010). Previous studies, including by our group,
have shown that following excisional skin wounding in mice, periostin is upregulated at
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day 3, levels peak at day 7, after which expression eventually returns to baseline (Elliott
CG, Kim SS, 2012). In gingival wound healing, using gingivectomy defects in rats (S. S.
Kim, Nikoloudaki, Michelsons, et al., 2019), periostin expression was increased at day 7,
with protein levels increased yet further at day 14 in the ECM of the connective tissue.
While the assessment of gingival healing in the Postn-/- mice would be the most direct
method, it is technically challenging due to the size of the gingiva and that any defect
created in the gingival tissue heals rapidly limiting timepoints for analysis. In a similar
manner to skin and gingival healing, periostin upregulation in palatal mucoperiosteum
coincides with the proliferative and remodeling phases of healing, but not the inflammatory
phase. Interestingly, periostin protein levels are not increased at day 3 as is seen in skin
healing (Jackson-Boeters et al., 2009), highlighting a difference in expression profile
between the two tissue types.
We have previously shown that during skin healing myofibroblast differentiation mediates
contraction of the wound edges and is modulated by periostin in mice (Elliott et al., 2012),
but during gingival healing we observed a very low level of myofibroblasts, suggesting
that adoption of a contractile myofibroblast phenotype is not a significant event in gingival
wound healing (S. S. Kim, Nikoloudaki, Michelsons, et al., 2019), providing a potential
explanation of the scarless healing of the latter. After formation of actin-myosin contractile
bundles, stress fibers, it is the neo-expression and incorporation of α-SMA that
significantly augments the contractile activity of activated myofibroblasts (Hinz et al.,
2001). In the current study, immunohistochemistry and RT-qPCR reveal that α-SMA/Acta2
is up-regulated in the palatal wounds during wound healing, but it was significantly reduced
in the granulation tissue of Postn-/- mice at day 6 when compared with that in WT controls.
These results further support that the palatal mucoperiosteum has different healing
potential than the gingival tissue and could provide a potential therapeutic target for palatal
scarring.
To determine whether the reduction in α-SMA expression was due to impaired fibroblast
recruitment into the granulation tissue, wound sections were labeled for fibroblast-specific
protein-1 and vimentin. Cell numbers showed no significant differences in FSP-1
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immunoreactivity in Postn-/- wounds compared to WT, suggesting that genetic deletion of
periostin does not affect fibroblast recruitment, but rather result in deficient contractility.
To further investigate this finding, we sought to determine whether reduced α-SMA within
Postn-/- granulation tissue was the result of a defect in differentiation of fibroblasts into
myofibroblasts. Supporting this hypothesis, isolated palatal fibroblasts (mPFBs) from
Postn-/- animals did not have any differences in their proliferation rate when compared to
cells isolated from WT animals and showed significant reduction in their ability to contract
a collagen gel. Addition of exogenous rhPSTN, however, fully rescued the phenotype of
the Postn-/- fibroblasts suggesting that periostin is required for gel contraction and its
presence in the extracellular matrix is sufficient to induce a contractile myofibroblast
phenotype. While similar observations have been reported in murine dermal fibroblasts
isolated from Postn-/- animals, highlighting the role of periostin in skin healing as a
modulator of myofibroblast differentiation and contraction (Elliott et al., 2012), in gingival
fibroblasts the exogenous addition of rhPSTN does not increase α-SMA protein nor induce
gel contraction (S. S. Kim, Nikoloudaki, Michelsons, et al., 2019), further supporting the
behavioral and phenotypic differences between gingival, palatal and dermal fibroblasts
observed in vitro. Interestingly, in spite of the relative similarity of fibroblasts in connective
tissues, not only is there strong evidence about the existence of different phenotypes, but
also it has been proven that these phenotypes are substantially variable among different
anatomical regions (Gabbiani, 1996; Giannopoulou & Cimasoni, 1996). These phenotypic
differences have been proposed to be partially responsible for the different healing patterns
of the tissues (DeLeon-Pennell et al., 2020a; Lepekhin et al., 2002). Recently, Mah et al.
2014 tried to shed light on the relation between the distinct phenotypes of gingival
fibroblasts and skin fibroblasts and their different wound healing patterns in 3D cell
cultures. They found that gingival fibroblasts proliferate faster and express higher levels of
molecules involved in modulation of inflammation and ECM remodeling (MMP-1, -3, 10, TIMP-4), while skin fibroblasts displayed significantly higher expression of fibrillar
(collagens and elastin) and non-fibrillar (SLRPs and matricellular proteins) ECM proteins,
and molecules involved in TGF-β signaling, regulation of myofibroblast phenotype and
cell contractility, such as TGF-β1,-β2, -β3, Smad, α-SMA, CXCL12, Cadherin-2, -11.
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Their findings are indicative that gingival fibroblasts display a phenotype that may promote
faster resolution of inflammation and ECM remodeling, which is characteristic to reduced
scar formation, while skin fibroblasts have a profibrotic, scar-prone phenotype (Mah et al.,
2014). On the contrary, our results provide evidence for the fibroblast heterogeneity among
oral mucosa tissues, the absence of myofibroblast differentiation during both healing and
scarring of the gingiva (S. S. Kim, Nikoloudaki, Darling, et al., 2019; S. S. Kim,
Nikoloudaki, Michelsons, et al., 2019) suggest significant epigenetic differences compared
to palatal fibroblasts.
Mechanical tension (Hinz et al., 2001; Pakshir & Hinz, 2018; Talele et al., 2015) and TGFβ
secretion and activation during wound healing and ECM remodeling (Desmoulière et al.,
1993; Walraven & Hinz, 2018) determine the percentage of differentiated, α-SMA-positive
myofibroblasts (Desmoulière et al., 1993; Hinz, 2015; Tomasek et al., 2002). For the
induction of α-SMA by TGFβ, phosphorylation of FAK is required, which is a central
molecule activated in adhesive signaling (Leask, 2013). We have previously shown that
in murine skin, periostin modulates α-SMA expression in a FAK and integrin-β1
engagement dependent manner (Elliott et al., 2012). To determine whether the reduction
in α-SMA expression and immunoreactivity in Postn-/- granulation tissue was due to
defective TGFβ–Smad3 signaling, we assessed the number of nuclei positive for
phosphorylated Smad2 and Smad3 (pSmad2/3) within the granulation tissue of palatal
wounds. No differences were observed in the number of pSmad2/3-positive nuclei between
WT and Postn-/- wounds, suggesting that canonical TGFβ signaling is active in Postn-/wounds. In mPFBs, pharmacological inhibition of FAK pathway did not have any effect
on α-SMA/Acta2 expression (shown in Figure A-3) suggesting that periostin modulates αSMA expression through an alternative mechanism. These observations shift our focus to
investigate the role of ECM stiffness and adhesive signaling as potential modulators of
periostin-induced myofibroblast differentiation.
Mechanical stress exerted by the stiffness of ECM positively feedback on the development
and progression of fibrotic conditions by directly promoting myofibroblast activation and
persistence through various mechanotransduction pathways (Achterberg et al., 2014;
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Goffin et al., 2006; Hinz, 2015; Pakshir & Hinz, 2018; Rousselle et al., 2019). Building
on our previous studies (Elliott et al., 2012; S. S. Kim, Nikoloudaki, Michelsons, et al.,
2019), the differences observed in skin, gingival and palatal healing processes suggest that
the ECM of these tissues may possess different level of stiffness. Changing the stiffness
of the cell substrate is an efficient method to control myofibroblast activation in vitro
(Pakshir & Hinz, 2018; Talele et al., 2015; Tomasek et al., 2002). To explore how periostin
and microenvironment stiffness influence cellular behavior, cells isolated from WT and
Postn-/- palates were seeded on collagen-coated silicon substrates with different Young’s
elastic modulus. Here we show that myofibroblast differentiation of mPFBs is stimulated
by culture on stiff culture substrates (TCP, 64 kPa) but suppressed on substrates mimicking
normal tissue (8 kPa) or granulation tissue (0.2 kPa) ECM stiffness, which is in agreement
with other reports (Achterberg et al., 2014). Our results are consistent with studies
demonstrating that mesenchymal stem cells, different fibroblasts, and hepatic stellate cells
all remain relatively inactive on culture substrates mimicking the stiffness of normal tissue
(Hinz, 2010; Olsen, Abby L.Uemura et al., 2011; Winer et al., 2008). Postn-/- mPFBs
showed lower expression Acta2/α-SMA levels suggesting impaired myofibroblast
differentiation capacity when compared to WT cells, which was manifested in rigid,
collagen-coated tissue culture plates (TCP). We then sought to investigate whether α-SMA
is incorporated in stress fibers of the cells using immunocytochemistry and we found
significantly lower proportion of Postn-/- cells with α-SMA-positive stress fibers on TCP
and 0.2 kPa substrates when compared to WT cells, but these differences where not
observed in the intermediate stiffness conditions (64 kPa, 8 kPa). These observations
indicate that in palatal fibroblasts periostin modulates myofibroblast differentiation in
cases of extreme stiffness and in very compliant microenvironments. Our observations
from the in vivo experiments in the palate show that α-SMA is still present but reduced in
the granulation tissue of Postn-/- wounds, indicating that the loss of periostin is partially
compensated by the stiffness of ECM environment which is sufficient to drive
myofibroblast differentiation in Postn-/- wounds. During healing of excisional wound in
murine skin, genetic deletion of periostin does not affect α-SMA expression in high-tension
areas at the wound edge, while α-SMA is completely absent in the relatively low-tension
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granulation tissue, suggesting that in skin periostin modulates myofibroblast differentiation
in relatively compliant tissue (Elliott et al., 2012). On the contrary, in gingival healing the
presence of periostin is not sufficient to induce α-SMA (S. S. Kim, Nikoloudaki,
Michelsons, et al., 2019). Our observations in the palate highlight the distinct
characteristics of the palatal soft tissue, which is an environment of increased stiffness,
where, as a rigid mucoperiosteum, the mucosa and the periosteum are merged and tightly
attached to the underlying palatal bone.
We next examined whether genetic deletion of periostin alters the production of
fibronectin, a key ECM component. Fibronectin is a glycoprotein found in plasma and in
the ECM of tissues and is expressed by multiple cell types and comes in different splice
variants. It is involved in myofibroblast and TGFβ1 activation (Klingberg et al., 2018;
Serini et al., 2002; Zollinger & Smith, 2017), plays a key role in cell adhesive and migratory
behavior, is a regulator of collagen organization and tissue phenotype (Mao &
Schwarzbauer, 2005; Singh et al., 2010; Zollinger & Smith, 2017), and is elevated in
fibrosis (Koli et al., 2005). Extracellularly, periostin directly binds to fibronectin through
the EMI domain (Kii et al., 2009; Norris et al., 2007). Intracellularly, it has been observed
a proximal localization between periostin and fibronectin in the endoplasmic reticulum of
fibroblastic cells indicating that the two proteins interact before fibronectin’s secretion (Kii
et al., 2016), and evidence suggests that periostin enhances secretion of fibronectin from
the endoplasmic reticulum to the extracellular environment (Kii et al., 2016; Kudo & Kii,
2018).

Our in vivo data from RT-qPCR and immunolabeling assays showed that

fibronectin is increased during palatal healing, but Postn-/- wounds had significantly less
fibronectin than WT wounds. This observation further supports our previous finding, where
human gingival fibroblasts cultured in the presence rhPSTN had increased fibronectin
production, an effect which was attenuated by pharmacological inhibition of FAK and JNK
signaling (S. S. Kim, Nikoloudaki, Michelsons, et al., 2019). In mPFBs, pharmacological
inhibition of FAK pathway did not have any effect on fibronectin expression (shown in
Figure A-3 A, B).
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To explore whether the microenvironment stiffness influences fibronectin expression, we
cultured mPFBs isolated from WT and Postn-/- animals on silicon substrates of different
stiffness. On very stiff substrates the cells acquired a contractile phenotype with
upregulation of α-SMA and down-regulation of fibronectin. Fibronectin synthesis was upregulated in conditions of low stiffness (0.2 kPa), but genetic deletion of periostin in Postn/-

cells resulted in significantly reduced fibronectin expression compared to WT cells.

Taken together, our findings provide further evidence of the role of periostin as a modulator
of fibronectin synthesis. A potential mechanism of fibronectin synthesis modulation by
periostin is via integrin β1. Cells mediate fibronectin matrix assembly through integrin
binding to the RGD binding domain (Singh et al., 2010). The primary receptor for
fibronectin matrix assembly is α5β1. Receptor binding stimulates fibronectin selfassociation and organizes the actin cytoskeleton to promote cell contractility. Fibronectin
conformational changes expose additional binding sites that participate in fibril formation
and in conversion of fibrils into a stabilized, insoluble form. Once assembled, the
fibronectin matrix impacts tissue organization by contributing to the assembly of other
ECM protein (Singh et al., 2010; Zollinger & Smith, 2017). Our in vitro results show that
β1-integrin expression is significantly reduced in Postn-/- cells compared to WT cells when
cultured on low stiffness substrates, providing an additional explanation of reduced
fibronectin synthesis by Postn-/- mPFBs under these conditions.
Cells are subjected to mechanical stresses and receive and respond to stimuli from the ECM
through integrins. The coupling of internal and external forces through integrins allows the
cells to structurally modify the ECM through cytoskeletal forces that pull on integrins and
to respond to external forces by remodeling their cytoskeleton (Moore et al., 2010; Schwarz
& Gardel, 2012). β1 integrins are the primary plasma membrane receptors transmitting
tensional forces from the actin cytoskeleton to the extracellular matrix (Danen et al., 2002;
Guilluy et al., 2011). Myosin-II-mediated contractility is required for cells to actively sense
changes in the rigidity of the extracellular matrix (Engler et al., 2006; Pelham & Wang,
1998). The action of myosin II along actin stress fibers maintains the basal tension on the
cell-matrix adhesions. This basal tension enables mechanosensitive focal adhesion proteins
to sense the increase in resistance, which results when the basal actomyosin tension pulls
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on a more rigid extracellular matrix. The increased tension at focal adhesions can cause
calcium influx through stretch-activated calcium channels, trigger the integrin-dependent
activation of FAK and Src, and change the conformation of certain mechanosensing
proteins, such as p130Cas, talin and vinculin, to initiate intracellular signaling and
mechanotransduction (Moore et al., 2010). In this study we found that focal adhesion
formation and size are increased with an increase in the stiffness of the cell
microenvironment, and that the genetic deletion of periostin resulted in a significant defect
in focal adhesion formation in Postn-/- cells. This finding provides a possible explanation
of the reduced contractility and fibronectin synthesis in the absence of periostin.
Collectively, we found that in the absence of periostin, the formation of both focal and
fibrillar adhesions is defective demonstrating the direct functional role of periostin in
adhesion properties of the cells.
Rho signaling also plays key roles in mechanotransduction: The RhoA–ROCK–myosin-II
signaling axis is capable of sensing changes in the structure of the extracellular matrix and
responding to it by increasing actomyosin contractility (Maekawa et al., 1999). Activation
of RhoA (ROCK) promotes stress fibers maintenance, increases ECM tension, integrin
clustering and the formation of large focal adhesion complexes (Maekawa et al., 1999).
Further, a recent study shows that β1 and β3 integrins binding and interaction regulate in a
reciprocal, antagonizing manner each other’s activities in the regulation of intercellular
adhesion and collective cell migration by Rho GTPase activities (van der Bijl et al., 2020).
Also, it has been shown these kinases (ROCK I & II) play a significant role in fibronectin
matrix assembly and are implicated in microfilament bundle assembly and smooth muscle
contractility (Yoneda et al., 2005, 2006). An important feature of this mechanical signaling
network is the crosstalk between Rac1 and RhoA signaling that potentially regulates the
mechanosensing of matrix rigidity, as well as the contribution of extrinsic soluble factors,
such as growth factors or cytokines, which can modulate RhoA activity to increase or
decrease actomyosin contractility independently of matrix rigidity (Ridley & Hall, 1992).
The actin-binding motor protein myosin II maintains a low level of tension on actin fibers
that are coupled to the extracellular matrix through cell–matrix adhesions. This basal
tension enables myosin II to respond to changes in matrix rigidity or elastic behavior by
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increasing the tension on cell–matrix adhesions to activate the GEFs (guanide-exchange
factors). These GEFs activate RhoA, which in turn activates ROCK to phosphorylate
myosin actin chain (MLC) phosphatase, resulting in an increase of MLC phosphorylation,
thereby further increasing myosin II activity and actomyosin-based contractility (Nakano
et al., 2013). This mechanical feedback loop can increase integrin clustering as well as
adhesion maturation and might increase intracellular pressure and plasma membrane
tension to prevent lamellipodia formation and bleb-based motility. In these experiments,
we examined the hypothesis that Rho is activated when cells are in a very stiff substrate,
while Rac is activated in environment of low stiffness (0.2 kPa). To test our hypothesis, we
used the RhoA pharmacological inhibitor Y-27632, and we examined whether its effect
results in Rac1-activation effects on the cells, such as loss of stress fibers and formation of
lamellipodia, using immunocytochemistry for α-SMA and fibronectin. We then used the
pharmacological inhibitor Z62954982, to test whether Rac1 inhibition forces cells to
activate Rho and consequently drives the cells to form stress fibers and become contractile
even at environments of low stiffness (0.2 kPa), as it has been shown that RhoA and Rac1
suppress one another’s activity (Higashida et al., 2002). RhoA activity prevents Rac1stimulated formation of lamellipodia. On the other hand, RhoA-induced contractility is
suppressed while Rac1 activity suppresses actomyosin contractility and drives the
formation of lamellipodia via enhanced actin-mediated protrusions(Huveneers & Danen,
2009). Here, we have shown that myofibroblast differentiation in Postn-/- cells was rescued
with the addition of Rac inhibitor, suggesting that periostin modulates myofibroblast
differentiation in stiff matrices via RhoA/ROCK pathway.
In this study, we also showed that periostin likely influences the immune response, as
shown by the reduced inflammatory cells infiltration in Postn-/- wounds. Quantification of
macrophage subpopulations during palatal healing shows a significant reduction in both
iNOS and arginase-I macrophage populations in Postn-/- animals when compared to wild
type at day 6 post wounding. During wound healing, macrophages play various roles in
addition to clearing debris by phagocytosis. They secrete enzymes important for collagen
production (Hesse et al., 2014) and crosslinking (Lupher & Gallatin, 2006), and ECM turn
over and resolution (Sprangers & Everts, 2017). Macrophages also stimulate fibroblast-to122

myofibroblast activation (Pakshir & Hinz, 2018), a crucial function in tissue repair and
fibrosis. On the other hand, myofibroblasts indirectly establish mechanical communication
with macrophages by creating stiff ECM as an important environmental cue. Recently,
Pakshir & Hinz proposed that contracting (myo)fibroblasts directly transmit mechanical
signals through fibrillar ECM that have the potential to attract migratory macrophages
(Pakshir & Hinz, 2018). Thus, it is plausible that the reduced recruitment of macrophages
in Postn-/- is a consequence of reduced myofibroblast differentiation. There is considerable
evidence in the literature to support the hypothesis that there is a reduction in macrophage
recruitment as a result of periostin deletion. Using a model of arteriosclerosis, it has been
shown that wild type macrophages showed enhanced migration in the presence of
recombinant periostin protein, an effect not evident in Postn-/- macrophages. Moreover,
they concluded that Postn-/- macrophages show an impaired ability to migrate toward TGFβ (Schwanekamp et al., 2016), which could account for reduced macrophage numbers
during wound healing. In addition, it has been demonstrated that periostin itself can act as
a chemoattractant for macrophages in a model of glioblastoma (Squadrito & De Palma,
2015). Furthermore, in a renal ischemia-reperfusion injury model, it has been shown that
periostin-overexpressing mice exhibit diminished expression of proinflammatory
molecules and accumulate more F4/80+ macrophages when compared to periostin
knockout mice. Interestingly, both coculturing macrophages with hypoxia-treated primary
tubules that overexpress periostin, or alternatively treating macrophages with recombinant
periostin, directly induced macrophage proliferation and expression of proregenerative
molecules (Kormann et al., 2020). Periostin has also been strongly implicated in the
recruitment of tumor associated macrophages in both intrahepatic cholangiocarcinoma
(Zeng et al., 2018) and ovarian cancer (Tang et al., 2018). In summary, the reduced number
of macrophages in palatal healing likely results from genetic deletion of periostin. Whether
this occurs as a result of chemoattraction or as a result of macrophages expressing periostin
is yet to be elucidated in wound healing systems. This will be an area of further
investigation for our lab in the future.
Periostin and TGF-β-induced protein (βigh3) are considered paralogs because of their
structural similarity.Here we showed that levels of βigh3 are upregulated during palatal
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healing, but its expression is reduced in day-6 Postn-/- wounds. The alteration in wound
closure kinetics in Postn-/- animals corresponds with the onset- but not the peak- of Postn
expression in WT animals, as well as with the peak of βigh3 expression, indicating that
βigh3 may not compensate for the loss of Postn during palatal wound healing. This is
further supported by our observations in embryonic tissues where periostin and βigh3 did
not exhibit overlapping expression, suggesting that they have independent roles in the
development of the hard palate in mice. Recently, Schwanekamp et al. also showed that
βigh3 has a distinct function during cardiac healing. After myocardial infarction, deletion
of βigh3 does not alter cardiac disease, unlike loss of Postn in Postn-/- mice, and its loss is
fully compensated by the more prominently expressed periostin (Schwanekamp et al.,
2017).
In conclusion, in this study we demonstrated that periostin is upregulated during palatal
healing in mice, where it is associated with fibronectin production, myofibroblast
differentiation and infiltration of macrophages to the wound site. In vitro, Postn-/fibroblasts show reduced contractile ability and fibronectin synthesis, effects which were
also modulated by the stiffness of the microenvironment via integrin-β1/RhoA pathway
(Figure 13), providing further evidence that periostin and the stiffness of the ECM act as
modulators of matrix synthesis and myofibroblast differentiation during palatal healing.
These findings could provide new insights for the development of novel approaches and
biomaterials with specific biochemical and biomechanical properties targeted to accelerate
and enhance the healing process (Urbanczyk et al., 2020), while suppressing fibrosis, after
dental and maxillofacial surgical procedures.
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Figure 2-14 Proposed Mechanism
The biomechanical properties of a tissue in terms of stiffness (modulus of elasticity) vary
across the different phases of wound healing. During the early phases of wound healing,
the loose newly formed granulation tissue exhibits low stiffness, while, as the healing
process progresses, the stiffness of the tissue increases with the deposit and remodeling of
the ECM. Here, we demonstrate how the cellular behavior is modulated by the matrix
stiffness, the molecular events that govern this process, as well as the role of periostin in
palatal wound healing.
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Chapter 3
3

Role of periostin in the maintenance and mineralization
of the periodontal ligament
Introduction

The periodontium is the name given to the teeth-supporting tissues, consisting specifically
of the alveolar bone, gingiva, periodontal ligament (PDL) and cementum. In particular, the
PDL is a principal tissue as it transmits forces between the tooth and adjacent tissues.
Dispersion of stress is achieved through the PDL collagen fiber network, that inserts into
both the cementum and the alveolar bone through Sharpey’s fibers (Liang et al., 2020;
Nanci, 2017). The PDL is highly cellular and well vascularized, containing fibroblasts that
remodel and maintain the PDL, as well as populations of pericytes, cementoblasts,
osteoblasts and multipotent mesenchymal stem cells (T. R. Gould, 1983; T. R. L. Gould et
al., 1980; Komaki, 2019; Lekic & McCulloch, 1996; McCulloch, 1985; Seo et al., 2004).
The PDL is central to maintenance of tooth health and the homeostasis of periodontal
tissues by facilitating transmission of mechanical loading between the tooth and the bone.
(Beertsen et al., 1997).
The extracellular matrix of the periodontal ligament is composed of a loose plexus of
crimped collagen fibrils embedded in a highly hydrated interfibrillar matrix. Only close to
their cemental insertion points do these fibrils gather into thick, parallel fascicles
(Sharpey’s fibres). As the collagen fibrils cross the mineralization front, they become
infiltrated by the mineral phase and continue directly with the cementum matrix. Sharpey’s
fibres, “extrinsic” and “intrinsic” fibres all appear to be the same fibres, which bend and
branch repeatedly during their course within the thickness of the cementum (Raspanti et
al., 2000). Collagen fibrils are continuous between the PDL and cementum, yet there is an
extremely sharp interface between mineralized and unmineralized tissues. Collagen fibrils
in the PDL have a mostly parallel arrangement, especially where they insert into the
cementum at approximately right angles to the root surface. The PDL fibrils form closely
packed bundles. As the PDL fibrils insert into cementum, they merge together and exhibit
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an increase in diameter of up to 40% (Quan & Sone, 2015). The processes that regulate
mineralization of the cementum-PDL junction is attributed to the unique extracellular
matrix composition of the constituent tissues of the periodontium: dentin, cementum,
periodontal ligament, and bone.
The non-collagenous protein (NCP) compositions of these tissues differ significantly
which likely controls where mineralization occurs. For instance, in dentin the most
abundant NCPs are dentin sialophosphoprotein (DSPP), dentin matrix protein-1 (DMP- 1),
bone sialoprotein (BSP), and osteopontin (OPN). BSP and OPN are also found in fibrillar
cementum, along with osteocalcin and osteonectin (Nanci, 2017). In the PDL, the main
non-collagenous components are hyaluronan and proteoglycans aggregates, the latter
representing decorin, biglycan (chondroitin sulfate PGs) (Häkkinen et al., 1993; Lausch &
Sone, 2015; Wojtas et al., 2020). Despite better characterization of the components of the
PDL ECM, the molecular mechanism that regulate the spatial mineralization of tissues in
the periodontium is still unclear. Significantly, several matricellular proteins are now
known to be prominently expressed in the PDL, including periostin, matrix gla protein and
SPARC (Nikoloudaki, 2021). Despite being heavily expressed in healthy PDL, the exact
biological function of periostin in tissue homeostasis has not been determined.
Periostin was initially named and classified based on its apparent restricted expression and
localization to the PDL and periosteum of adult mice (Horiuchi et al., 1999).
Immunoelectron microscopic observation of the mature PDL verified the location of
periostin to be between the cytoplasmic processes of periodontal fibroblasts and
cementoblasts with adjacent collagen fibrils. In adult humans, our laboratory demonstrated
that periostin is highly also expressed in the PDL and periosteum of alveolar bone (Wen et
al., 2010), closely mirroring the distribution evident in mice.
Further research focusing on the investigation of periostin in maintenance of PDL integrity
assessed using transgenic mice where periostin is genetically deleted showed that knockout
(Postn-/-) mice exhibit defective collagen fibrillogenesis, evident through reductions in
fibril diameter and defective crosslinking (Norris et al., 2007; Sata et al., 2008). This
manifest in loss of architecture and functional disruption of several collagenous-based
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tissues, including the PDL (H. Rios et al., 2005). Micro-computed topography imaging
analysis on Postn-/- mice skulls revealed the early onset of severe periodontal disease,
significant reduction in bone density, and structural defects in the incisors resulting in
enhanced tooth wear (Hamilton, 2008). Removal of masticatory forces reduced periodontal
and enamel defects, showing periostin can alter PDL structural or mechanical properties
allowing dispersion of applied loading stresses (H. F. Rios et al., 2008).
While periostin has been shown to organize the ECM at the tooth interface of the alveolar
bone and PDL (Kruzynska-Frejtag et al., 2004), possibly through its regulation of collagen
fibrillogenesis (Norris et al., 2007), evidence suggest that it can also act directly on cell
populations within the PDL (Tkatchenko et al., 2009). Previous studies have reported that
periostin promotes cell mobility, adhesion and survival in periodontal ligament cells by
binding to integrin αvβ3 and αvβ5 via the Integrin/FAK/AKT signalling pathway
(Matsuzawa et al., 2015). Recently, it was also shown that periostin promotes migration,
proliferation, and differentiation of human periodontal ligament mesenchymal stem cells
in vitro (Z. Wu et al., 2018), and promotes osteogenic differentiation of human periodontal
ligament mesenchymal stem cells via the Jun amino-terminal kinases (JNK) pathway under
inflammatory conditions in vitro in these cells (Tang et al., 2017).
Despite our extensive knowledge of periostin expression in the periodontium,
comparatively little is known about its role in the maintenance of periodontal structures or
on cellular phenotype, particularly of PDL resident cell populations. The aim of this chapter
was to investigate the potential role of periostin in the maintenance and mineralization of
the periodontal ligament cells in vitro via functional and gene-expression analyses.
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Materials and Methods
Animals
All animal procedures were in accordance with protocols approved by the University
Council on Animal Care at The University of Western Ontario. Postn-knockout mice
(Postn-/-) were generated and maintained on soft diet in order to reduce malnutrition, which
was previously observed under a standard diet due to the enamel and dentin defects of the
incisors and molars (H. Rios et al., 2005). Heterozygous mice were crossed with C57BL/6J
(JAX Mice and Services, Bar Harbor, Maine) for a minimum of six generations to ensure
an incipient congenic strain. Backcrossed heterozygous mice were used for breeding and
all offspring were genotyped as described previously described (H. Rios et al., 2005).

Ex vivo remineralization assay (Performed by Laboratory of Eli
Sone, University of Toronto)
Formalin fixed and EDTA-decalcified hemimandibles from adult periostin WT and Postn/-

mice were trimmed and processed for 210 nm thick sections and exposed the dentin-

cementum-PDL junction at the apical portion of the tooth root. The ultrathin tissue sections
were remineralized as previously reported (Lausch et al., 2013). Briefly, mineralizing
solution was prepared immediately before remineralization by combining equal volume of
four previously prepared solutions (stored at 4 °C). One milligram of polyaspartic acid
(pAsp, Alamanda Polymers, AL, USA; MW = 14 kDa) was dissolved in 2 mL of 50 mM
Tris buffer by vortex mixing. Two milliliters of pAsp solution, NaCl (0.5M), NaHPO4 (36
mM), and CaCl2 (6.8 mM) solutions (all buffered by 50 mM Tris buffer and adjusted to pH
7.4) were combined in this order, vortexed and filtered through a 0.2 μm syringe filter, and
warmed to 37 °C. The resulting solution was 133 mM Na+, 3.5 mM K+, 1.7 mM Ca2+, 123
mM Cl−, 9.1 mM Pi (inorganic phosphate), and 125 μg/mL pAsp at pH 7.4. Grids were
floated on 1 mL of mineralizing solution in open 1.5 mL microcentrifuge tubes, at 37 °C
and 100% relative humidity. After remineralization, grids were removed after 3−8 h,
washed in three changes of ultrapure water, wicked dry, and stored in a grid box.
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Electron Microscopy (Performed by Laboratory of Eli Sone,
University of Toronto)
Electron microscopy was conducted using a Tecnai 20 TEM (FEI, Hillsboro, OR) with an
AMT 1600 side mount camera and LaB6 filament operating at 200 kV. The ultrathin tissue
sections were remineralized in supersaturated calcium phosphate solution (50 mM TrisHCl, 125 mM NaCl, 9 mM Na2HPO4, 1.7 mM CaCl2, pH=7.4 at 37°C) stabilized with 125
μg/mL of polyaspartic acid (MW=14 kDa, Alamanda Polymers). Grids with sections were
floated on 1 mL of mineralization solution at 37°C and 100% humidity. After
remineralization grids were washed with milliQ water and analyzed with TEM.

Isolation of Human Periodontal Ligament Cells
Human periodontal ligament (hPDL) cells were isolated from samples of healthy
periodontal ligament obtained from 4 patients from 15 to 38 years of age who underwent
routine extractions at the Oral Surgery Clinic at Schulich Dentistry, Western University.
(Patient ID: F15= Female,15 y.o.; F38= Female, 38 y.o.; M24- Male, 24 y.o.; M31= Male,
31 y.o.) The use of this tissue was under informed patient consent and in accordance with
the guidelines of the University's Research Ethics Board for Health Sciences Research
involving Human Subjects (HSREB 4988; Appendix B). hPDL cells were isolated using
an explant technique as described previously by Somerman and colleagues (Somerman et
al. 1988). Briefly, tissue was removed from the middle third of the root surface, rinsed
several times with Dulbecco’s Modified Eagle Medium (DMEM; Gibco, Grand Island,
NY, USA) supplemented with 4.5 g/mL D-glucose (high glucose) and cultured for several
weeks until outgrown cells reached confluence. Cell cultures were maintained in DMEM
supplemented with 10% fetal bovine serum (FBS; Gibco, Grand Island, NY, USA) and 1%
AA (Antibiotic-Antimycotic; 100 U/mL penicillin, 100 µg/mL streptomycin, and 0.25
mg/mL amphotericin B; Gibco, Grand Island, NY, USA). Cultures were maintained in a
5% CO2 atmosphere with 100% relative humidity at 37°C. For passaging and use in
experiments, cells were detached using a 0.05% trypsin and 0.2g/L EDTA⋅4Na solution.
hPDL cells were used between passages 1 and 5 for experiments.
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Cell Treatment
hPDL cells were seeded in DMEM containing 10% FBS at a density of 200,000 cells per
well of a 6-well plate for RNA isolation, and at 50,000-cells per well of a 24-well plate for
the Alizarin Red S assay. The plates were previously coated with either 10 μg/ml collagen
type I (PureCol, Advanced BioMatrix, Carlsbad, CA) in PBS or 10 μg/ml Collagen + 10
μg/ml periostin (rhPSTN) (3548-F2, R&D Biosystems) in PBS. After cells reached
confluency, they were transferred into serum-free DMEM for an additional 16 hours. To
induce osteogenic differentiation, cells were cultured in DMEM with 10% FBS, 1% AA,
containing 14.58 mM Beta Glycerophosphate (Sigma-Aldrich, St. Louis, MO, USA) and
0.284 mM L-ascorbic acid (Sigma-Aldrich, St. 36 Louis, MO, USA). Control samples were
cultured in DMEM with 10% FBS and 1% AA. To investigate the influence of periostin
on the mineralization capacity of hPDL, cells were seeded on plates coated with or without
10 μg/ml rhPSTN and in media supplemented with 100 ng/ml rhPSTN, and media was
changed every 2-3 days for 2 and 4 weeks.

Alizarin Red S Staining
Calcium deposition was visualized with Alizarin Red S staining and elution. Cells were
fixed with 4% paraformaldehyde (PFA) in PBS for 5 minutes, rinsed with PBS 3 times,
followed by thorough washing with deionized water and were dried prior to staining. A 1%
(w/v) solution of Alizarin Red S (Fisher Scientific, Waltham, MA, USA) was applied to
each sample for 30 minutes followed by several rinses with deionized water to remove
excess dye. Matrix calcification was quantified by extracting the dye. A solution of 0.5N
HCl in 5 % Sodium Dodecyl Sulfate (SDS; Sigma-Aldrich, St. Louis, MO, USA) was
applied to dried samples for 10 minutes and absorbance was measured at 415 nm with a
Safire microplate reader (Tecan Group Ltd, Maennedorf, Switzerland).

Quantitative Reverse Transcription Polymerase Chain Reaction
Analysis (RT-qPCR)
Total RNA was extracted using Trizol® reagent (Ambion, Life Technologies, Carlsbad,
CA, USA) and purified using RNeasy mini kits (Qiagen, Valencia, CA). Taqman real-time
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PCR was performed using qSCRIPT XLT one-step real-time quantitative PCR ToughMix
(Quanta Biosciences, Gaithersburg, MD) per the manufacturer’s instructions. All samples
were run in triplicate and normalized to endogenous 18S rRNA (Thermo Fisher Scientific).
Taqman® (Applied Biosystems, Life Technologies, Carlsbad, CA, USA) primers and
probes were used for alkaline phosphatase (ALPL, Hs01029144_m1), and cementum
protein 1 (CEMP1, Hs04185363_s1) All samples were run in triplicate and normalized to
endogenous 18S rRNA (Thermo Fisher Scientific).

RNA sequencing
RNA quality analysis was performed using electrophoresis (Appendix A-4). Raw reads
were trimmed with the TrimGalore wrapper script around the sequence-grooming tool
cutadapt version 0.4.1 (Martin, 2011). The trimmed reads were aligned to the GRCh38
human reference genome from ensembl (version 104) using STAR version 2.7.9a (Dobin
et al., 2013). The count matrix for each gene was computed using featureCounts from the
Rsubread package (Liao et al., 2019). Gene expression values were normalized using the
variance-stabilizing transformation (Anders & Huber, 2010) to then conduct principal
component analysis. We performed differential gene expression analyses adjusted for
patientID and stratified on medium using DESeq2 R/Bioconductor package (Love et al.,
2014). We used the independent hypothesis weighting R/Bioconductor package to weight
P-values (Ignatiadis et al., 2016) and adjust for multiple testing using the BenjaminiHochberg procedure (Benjamini & Hochberg, 1995). We selected genes significantly
associated with rhPSTN treatment for each medium (FDR < 0.1) and conducted pathway
enrichment analyses using the topGO R package (Alexa et al., 2006). The heatmaps depict
the z-score of normalized gene expression across samples from each patient. We ordered
samples according to the average of gene ranks. We first partition genes into 2 groups
around meloids (M1 and M2) using correlation as the distance metric. In a univariate
fashion, each M1 gene is used to rank n samples from the lowest to the highest expression.
Expression values of each gene are then replaced by (1,...,n) ranks. M2 transcripts are
ordered from the highest to lowest expression and ranks are assigned similarly.
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Statistical analysis
All data were analyzed using GraphPad Prism software with Student’s t test (unpaired,
two-tailed) or one-way ANOVA for experiments with one variable or two-way repeatedmeasures ANOVA with post hoc test for experiments with two variables. All results are
depicted as mean ± SD unless indicated otherwise. P values of less than 0.05 were
considered to indicate significance.
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Results
Loss of periostin does not affect the re-mineralization of the
periodontal ligament ex vivo
Ex vivo mineralization using WT and Postn-/- KO dental tissues showed that the
remineralization potential of the tissues was not affected by the absence or presence of
periostin. After 16h of remineralization, dentin and parts of the PDL were remineralizedto different degrees- in both WT and Postn-/- samples, suggesting that the presence of
periostin in the PDL does not prevent mineralization (Fig, 3.1). (Data from our
collaborator Dr. Eli Sone, University of Toronto)
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Figure 3-1 Ex Vivo Remineralization Assay
After 16h of remineralization, dentin and parts of the PDL were remineralized- to different
degrees- in both WT and Postn-/-samples, suggesting that the presence of periostin in the
PDL does not prevent mineralization. (Data from our collaborator Dr. Eli Sone, University
of Toronto)
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Periostin promotes the osteogenic mineralization of hPDL cells
in vitro
Initial assessment of the osteogenic potential of hPDL cells was examined with Alizarin
Red S staining to visualize and quantify calcium deposition in response to culture with
osteogenic media. In all patients, culturing in control (DMEM without Beta
Glycerophosphate and L-ascorbic acid) media did not significantly influence the amount
of matrix-bound calcium, while culture in osteogenic media induced deposition of a
mineralized matrix, as shown in Figure 3.2. In all patients, calcium content at 4 weeks was
significantly higher than the control conditions (p<0.001). The exogenous addition of
periostin resulted in significantly more calcium content at 4 weeks when compared to
osteogenic media alone (P <0.001), suggesting that the exogenous addition of periostin
promotes the functional mineralization ability of hPDL cells under osteogenic conditions.
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Figure 3-2 Alizarin Red S staining of calcium in hPDL cells during osteogenic
differentiation.
Alizarin Red S staining was used to visualize calcium (stained red) deposited by cells at 2
and 4 weeks post-seeding. Dye was subsequently eluted to quantify calcium content. Data
presented as mean ± SD of 3 internal replicates, of 3 patients, from 3 independent
experiments. Two-way ANOVA with Tukey post-test for multiple comparisons was
completed and multiplicity adjusted p-values are reported. (^ P<0.001, *** P<0.001)
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Exploratory analysis of gene expression profiles
To identify transcriptional changes in human PDL cells after exposure to exogenous
periostin or/and osteogenic culture conditions, RNA sequencing analysis was performed
on hPDL cells isolated from four patients (F15, F38, M24, M31-as mentioned in 3.2.4)
cultured in four different experimental conditions: with/without osteogenic media,
with/without exogenous periostin. Initial unsupervised (PCA plot) and supervised
(differential expression) analysis revealed strong patient-specific effects (Fig. 3.4) (Full
table of results in Appendix Table 1).
We therefore conducted similar analyses stratified by patient AND condition which also
showed still very strong patient-specific effect. Due to the relative “closeness” of profiles
from patients F38 and M31 in Figure 3.4 and due to the similarity in age for these two
patients, we reran the analyses restricted to these profiles (Fig. 3.5). One sample in
osteogenic medium was an outlier on the PCA plot and was therefore excluded from the
downstream analyses:
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Figure 3-3 RNA sequencing analysis on hPDL cells in different in vitro conditions
(A) Principal component analysis on PCA plot Genes associated with periostin treatment,
adjusted for patientID, (B) Heatmap Genes associated with rhPSTN treatment adjusted for
patientID and media (C) Venn diagram (Full table of results in Appendix table 1 and 2)
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Unsupervised analysis show a relatively good separation of the samples according to
rhPSTN treatment in each medium (Fig 3.5 A,B). After adjustment on patientID, we
identified 125 and 93 genes altered upon addition of exogenous periostin in hPDL cells in
unsupplemented media and in osteogenic conditions, respectively (FDR < 0.1, Fig. 3.5 CF). We observe very little overlap between the genes differentially expressed by periostin
in osteogenic and unsupplemented medium (Fig. 3.4 C). This result indicates that the effect
of periostin on hPDL cells is strongly dependent on the culture medium. Figure 3.5 C, F
depicts the expression of the medium-specific periostin-altered genes in hPDL cells from
F38 and M31 patients, respectively.
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Figure 3-4 Gene expression analysis on a selective subset of patients (F38, M31)
(A,B): PCA plots (C,D) Heat maps of Genes associated with rhPSTN treatment in DMEM
(F38 & M31) (E, F) : Heat maps of Genes associated with rhPSTN treatment in Osteogenic
media (F38 & M31). (Full table of results in Appendix tables 1 and 2).
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To gain mechanistic insight into gene lists generated from our experimental conditions,
pathway enrichment analysis of differentially expressed genes was used to identify
biological pathways that are enriched in the gene lists more than would be expected by
chance. In cells cultured in DMEM, results from the pathway enrichment analysis revealed
that differentially expressed genes (DEG) by the exogenous addition of periostin were
mainly enriched in “collagen fibril organization, “extracellular matrix organization”,
“endodermal cells differentiation” and “actin filament severing” (Fig. 3.6 A). In hPDL cells
cultured in osteogenic conditions, pathway enrichment analysis of DEG by the exogenous
addition of periostin revealed involvement of “peptidyl-tyrosine autophosphorylation”,
“regulation of bone remodeling”, regulation of receptor internalization”, regulation of focal
adhesion assembly”, regulation of osteoblast differentiation” (Fig. 3.6 B).
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Figure 3-5 Pathway Enrichment Analysis
(A) Pathway enrichment analyses of differentially expressed genes (DEG) by exogenous
periostin treatment in DMEM (DEGDMEM=125) Top significant pathways from gene
ontology analysis. For the barplot, the top40 enrichment was selected where the gene list
had at least 5 genes annotated to a term and the enrichment had a weight01 fisher p-value
< 0.01. Top100 GO enrichment results can be found in Appendix Table 1 (B) Pathway
enrichment analyses of differentially expressed genes by exogenous periostin treatment in
osteogenic conditions (DEGOSTEO = 93). Top100 GO enrichment results can be found in
Appendix Table 2
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Patient’s age effect on hPDL transcriptional profile
Increased age is an important factor that appears to adversely affect biological properties,
including differentiation capacity, of hPDL cells (Li et al., 2020; R.-X. Wu et al., 2015;
Zhang et al., 2012). In our study, we selectively analyzed the dataset from the youngest
donor (F15) separately (Fig. 3.7 A-D). Pathway enrichment analysis of DEG in DMEM
(Fig. 3.7 E) or OSTEO (Fig. 3.7 F) conditions by the addition of periostin revealed
enrichment in different pathways than the dataset from older patients: In DMEM, DEG
from the addition of periostin (DEGDMEM=85) appeared enriched in “regulation of
telomerase activity”,” regulation of smooth muscle cells, “osteoblast differentiation” and
“aging”. In osteogenic conditions, DEG by the addition of exogenous periostin
(DEGOSTEO=202) were enriched in “nuclear-transcribed mRNA catabolic”, “nonsensemediated decay”, “viral transcription”, regulation of RNA splicing”, regulation of
telomerase activity”, and “oncostatin-M-mediated signaling pathway”.
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Figure 3-6 Gene expression analysis on young patient (F15)
(A, B) PCA plots. (C) Heat map of Genes associated with rhPSTN treatment in DMEM.
(D) Heat map of Genes associated with rhPSTN treatment in Osteogenic media. (Full table
of results in Appendix Table 3). (E) Pathway enrichment analyses of differentially
expressed genes in patient F15 (DEG) by exogenous periostin treatment in DMEM
(DEGDMEM=85). (F) Pathway enrichment analyses of differentially expressed genes in F15
by exogenous periostin treatment in OSTEO (DEGOSTEO=202. Top significant pathways
from gene ontology analysis. For the barplot, the top40 enrichment was selected where the
gene list had at least 5 genes annotated to a term and the enrichment had a weight01 fisher
p-value < 0.01. Top100 GO enrichment results can be found in Appendix Table 4
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Discussion
Previous studies have highlighted the role of periostin on the adhesion, survival migration,
proliferation, and differentiation of human periodontal ligament mesenchymal stem cells
in vitro (Matsuzawa et al., 2015; Z. Wu et al., 2018). Interestingly, periostin has been
shown to promote osteogenic differentiation of human periodontal ligament mesenchymal
stem cells under inflammatory conditions (Tang et al., 2017). In this chapter we explored
the potential role of periostin in the maintenance and mineralization of the periodontal
ligament cells in vitro via functional and gene-expression analyses.
Using an ex-vivo tissue-based model of collagen remineralization, we assessed whether
periodontal tissues from WT and Postn-/- animals have the capacity to remineralize. It has
been shown that this ex vivo model can reproduce the finely controlled biomineralization
evident in the periodontium, in fixed sections of mouse mandible, with similar fidelity
(Lausch et al., 2013). This assay results in the preferential mineralization of bone, dentin,
and acellular extrinsic fiber cementum, leaving the ligament relatively unmineralized. This
selective mineralization shows that extracellular matrix factors are capable of controlling
the rate of mineralization in tissue void of cellular and enzymatic activity (Lausch et al.,
2013; Lausch & Sone, 2015; Nudelman et al., 2013). Utilizations of this ex vivo model
allows the investigation of the particular matrix factors responsible for the biological
control of mineral deposition. Here, using this ex vivo mineralization model in
collaboration with Dr Eli Sone at The University of Toronto we showed the fixed,
demineralized extracellular matrix (ECM) of mouse dental and periodontal tissues retains
sufficient molecular memory to direct selective remineralization from metastable calcium
and phosphate-containing solutions. The natively mineralized tissues (dentin, cementum
and bone) remineralize preferentially over the periodontal ligament, with high level of
spatial control, similar to what is observed in vivo. In mandibles dissected from Postn-/mice, we observed similar levels of re-mineralization within the natively mineralized
tissues and the collagen fibers of the PDL when compared to the WT animals, suggesting
that the presence or absence of matrix-bound periostin does not influence mineralization in
the periodontal tissues.
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We next investigated whether the exogenous addition of periostin affect the human PDL
cell mineralization in vitro. It is well established that PDL cells will mineralize when
cultured in osteogenic media, although evidence suggests that this decreases with
increasing age (Li et al., 2020; Morissette Martin et al., 2017). Alizarin Red S staining for
calcium confirmed that isolated hPDL cells readily produced a mineralized matrix in
response to osteogenic culture conditions. The addition of exogenous periostin resulted in
significantly more calcium when compared to osteogenic media alone, suggesting that
extracellular periostin enhances hPDL osteogenic gene expression and mineralization
osteogenic conditions, which is in agreement with previous reports (Z. Wu et al., 2018).
Wu et al. demonstrated that 2 weeks after osteogenic induction, mineralization was
markedly enhanced in hPDL cells treated with 100 ng/mL rhPSTN compared with the
untreated group, as determined by Alizarin Red staining and quantitative calcium
measurements. Further, using RTqPCR and Western blotting they showed that exogenous
addition of 100 ng/ml rhPSTN in hPDL cells from young individuals (aged 16–20) results
in increased the expression of osteogenic gene (OCN, OPN, OSX, RUNX2) levels
compared with untreated hPDLSCs. When PSTN was silenced, mineralization was
significantly inhibited in the POSTN-knockdown hPDL cells compared with the control
group (Z. Wu et al., 2018).
Based on our results we confirmed that exogenous periostin increases mineralization of
PDL cell cultures in vitro, we next investigated transcriptional changes in human PDL cells
after exposure to exogenous periostin and/or osteogenic culture conditions using RNA
sequencing analysis. My goal in these experiments was two fold; how does periostin
influence PDL fibroblast phenotype and how does the addition of osteogenic media alter
this response at the transcriptional level? Recently, a number of studies have utilized RNA
sequencing to investigate gene expression changes in PDL cells following mechanical
stimulus (Kim et al., 2020), or following occlusion establishment (Denes et al., 2019,
2020), as well as differences in gene expression profiles between highly
osteoblastic/cementoblastic and fibroblastic periodontal ligament cell clones (Saito et al.,
2020), and PDL stem cells and dental pulp stem cells (Lee et al., 2022). In this study, cells
lines from 4 different patients were used, and initial analysis regardless of stratifiction
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strategy showed a very strong patient-specific effect. Due to high variability between
patient responses to treatment condition and minimal overlap of common genes
differentially expressed among the 4 patients, we proceeded to analyse and compile the
data from only 2 patients (F28 and M31) that appeared to have similar expression profile
trends.
Using this strategy, results from the pathway enrichment analysis in cells cultured in
DMEM revealed that differentially expressed genes (DEG) by the exogenous addition of
periostin were mainly enriched in “collagen fibril organization, “extracellular matrix
organization”, “endodermal cells differentiation” and “actin filament severing” (Fig. 3.5
A). This observation could suggest that in non-osteogenic conditions periostin contributes
to ECM remodelling and maintenace of the PDL structure. Our results are consistent with
the reported functions of periostin in the literature that it can be involved in ECM assembly
and cross-linking, influencing mechanical properties of the tissues in which it is expressed.
Specifically, it is known that periostin can act as a scaffold for assembly of extracellular
matrix proteins (type I collagen, fibronectin, tenascin-C, and laminin γ2) and accessory
proteins (BMP-1 and CCN3), (Elliott & Hamilton, 2011; Kii & Ito, 2017a, p. 201;
Maruhashi et al., 2010), although the binding site for collagens has not been identified (Kii
& Ito, 2017b; Norris et al., 2007).
Periostin induced transcriptional changes in PDL cells including genes associated with
fibrillar collagen expression (COL11A1, COL5A2, COL1A2, and COL5A1) (Bella &
Hulmes, 2017) and ADAM Metallopeptidase with Thrombospondin Type 1 Motif 2
(ADAMTS2) - an enzyme that processes several types of procollagen molecules- genes
that were differentially expressed when periostin was added exogenously to the cells. The
latter reduces the solubility of the collagen molecules and induces their almost spontaneous
assembly into elongated and cylindrical collagen fibrils (Bekhouche & Colige, 2015),
further highlighting periostin’s likely role is collagen fibril organization. Periostin addition
also resulted in changed of TNXB gene expression levels coding for Tenascin-X, which is
a large extracellular matrix protein that its deficiency in humans is associated with Ehlers–
Danlos syndrome (Schalkwijk et al., 2001), a generalized connective tissue disorder
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resulting from altered metabolism of the fibrillar collagens (Mao et al., 2002). These genes
are known to influence collagen fibril and extracellular matrix organization, and is
consistent with previous studies describing a role for periostin in collagen crosslinking and
stabilization of the ECM (Kudo, 2011; Maruhashi et al., 2010; Norris et al., 2007).
The multi-domain structure of periostin allows proteins with which it binds to assemble
into a large interacting complex. Extracellularly, fibronectin directly binds to the EMI
domain of periostin (Kii et al., 2009; Norris et al., 2007), and tenascin-C binds to the fas 1
domain (Kii et al., 2009). For collagen cross-linking in fibrillogenesis, the interaction of
periostin with fibronectin and tenascin-C is dependent on the association of periostin with
BMP-1 followed by activation of lysyl oxidase (LOX) for the formation of covalent crosslinks in collagen and elastic fibers (Maruhashi et al., 2010). Furthermore, BMP-1 processes
the precursors of laminin 5 (γ2) and collagen type VII, both of which are involved in
securing the epidermis to the underlying dermis. In addition to activation of LOX, BMP-1
functions in processing the C-propeptides of procollagens types I–III to yield the major
fibrous components of vertebrate ECM, and that of NH2- terminal globular domains and
C-propeptides of types of V and XI procollagen chains, to yield monomers that control the
diameters of collagne type I and II fibrils by its incorporation (Ge & Greenspan, 2006).
GREM1, a BMP antagonist from the DAN family, was also identified in the pool of the
differentially expressed genes in response to rhPSTN treatment. GREM1 binds to BMPs
and prevents them from interacting with BMP receptors, thus playing a key role in
regulating the TGF-β/BMP signaling pathway (provided by NCBI Reference Sequences;
https://www.ncbi.nlm.nih.gov/gene/26585). This change in GREM1 expression further
supports periostin in ECM maintenance and homeostasis, as inhibition or induction of
GREM-1 has been shown to change the osteogenic differentiation of PDLSCs under
inflammatory conditions (Xu et al., 2020). Similar results have been reported by Ghuman,
showing that GREM-1 can also limit coronal alveolar bone regenerative potential during
oral and periodontal surgery by inhibiting BMP-induced bone formation (Ghuman et al.,
2019).
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TNF Receptor Superfamily Member 11b gene (TNFRSF11B)- an osteoblast-secreted
decoy receptor that functions as a negative regulator of bone resorption encoding the
protein Osteoprotegerin (OPG)- was also identified to be differentially expressed in
rhPSTN treated hPDL cells. This protein specifically binds to its ligand, OPG-Ligand, both
of which are key extracellular regulators of osteoclast development (Boyce & Xing, 2008).
PDL fibroblasts have the capacity to select and attract osteoclast precursors and
subsequently to retract and enable migration of osteoclast precursors to the bone surface.
There, fusion of precursors takes place, giving rise to osteoclasts. The RANKL-RANK(OPG) axis is considered crucial in this process. PDL fibroblasts produce primarily OPG,
an osteoclastogenesis-inhibitory molecule (Sokos et al., 2015). In totality, this information
demonstrates a critical role for periostin in extracellular matrix organization, homeostasis
and the regulation of cell phenotype.
On the contrary, when hPDL cells were cultured in osteogenic conditions, pathway
enrichment analysis of DEG by the exogenous addition of periostin revealed involvement
of “peptidyl-tyrosine autophosphorylation”, “regulation of bone remodeling”, regulation
of receptor internalization”, regulation of focal adhesion assembly”, regulation of
osteoblast differentiation” , among others (Fig. 3.5 B), suggesting a potential contribution
of periostin in the bone remodeling process. In this study, the gene coding for secreted
frizzled-related protein 1 (sFRP1) was identified to be differentially expressed upon
treatment with osteogenic media supplemented with rhPSTN. sFRP1 is an antagonist of
Wnt signaling, that controls osteoblast and osteocyte apoptosis (Bodine et al., 2005). Our
data are in line with previous observations: in MC3T3-E11 osteoblastic cells,
overexpression of periostin increases cell proliferation and differentiation (Horiuchi et al.,
1999), while injection of an adenovirus overexpressing periostin, increased bone formation
rate and bone mass in rats (Zhu et al., 2009). Our results also revealed DEGs involved in
“regulation of focal adhesion assembly”, which is consistent with effects of periostin on
attachment related to mineralization (Cobo et al., 2016). Evidence suggests that Postn
deletion results in a defective attachment of osteoblasts to the bone matrix, which affects
their differentiation into mature osteoblasts as shown by a severe reduction of the
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expression of type I collagen, osteocalcin, osteopontin and alkaline phosphatase, as well as
a decreased mineralization process in vitro (Bonnet et al., 2012, 2016; Litvin et al., 2004).
In combination, our results suggest that periostin’s presence in the ECM of PDL might not
be directly linked to the mineralization or inhibition, but rather provide a continuous signal
to support ECM organization and homeostasis to maintain a healthy and PDL interface
with surrounding bone remodeling.
Increased age is an important factor that appears to adversely affect biological properties,
including differentiation capacity, of hPDL cells (Li et al., 2020; R.-X. Wu et al., 2015;
Zhang et al., 2012). With increasing age, the proliferation and osteogenic/adipogenic
differentiation ability of hPDL cells decrease (Zhang et al., 2012). In our study, we
selectively analysed the dataset from the youngest donor (F15) separately and we found
unique gene expression patterns, both in unsupplemented and osteogenic media conditions.
It is of great interest that we identified 202 differentially expressed genes (DEGOSTEO) in
osteogenic conditions in the young patient, when compared to 98 DEGs in adult patients,
providing further evidence of the increased differentiation capacity of hPDL cells isolated
from young individuals. It is well established that the PDL- contains among other cells
populations (fibroblasts, pericytes, cementoblasts, osteoblasts)- multipotent mesenchymal
stem cells (Komaki, 2019; Lekic & McCulloch, 1996; Seo et al., 2004). When hPDL cells
are isolated in vitro, approximately 30% of the isolated cells possess crucial stem cell
properties, such as self-renewal and multipotency, and express the mesenchymal stem cell
markers CD105, CD166, and STRO-1 on their cell surface, although there were some
variations (Nagatomo et al., 2006). Thus, our data further support that aging is associated
with reduced differentiation potential of hPDL cells and our results could provide an
important theoretical basis for later cell therapy and tissue regeneration applications.
In conclusion, our current study provides preliminary insights into the effects of periostin
on the mineralization potential of PDL cells under different culture conditions. Our
findings suggest that periostin has condition-specific actions: in non-osteogenic conditions
it contributes to ECM maintenance in the PDL cells, while in osteogenic conditions
periostin further promotes the mineralization capacity of PDL cells and contributes to gene
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expression changes associated with bone remodeling. Further studies are required to be
performed in future to demonstrate the interactions found in the sequencing results. A better
understating of the molecular and cellular effects of periostin on PDL cells could be helpful
for periodontal regeneration and stem cell-targeted therapy.
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Chapter 4
4

Myofibroblast Origin in Palatal Repair: Assessing the
Contribution and the Fate of Foxd1 and NG2 Populations
and Their Progeny During Palatal Development and
Repair
Introduction

During wound healing, extracellular matrix is deposited, and the wound is contracted
through the actions of myofibroblasts (Hinz, 2010). The embryonic origin of resident
fibroblasts in connective tissues such as skin and gingiva during development and in
postnatal tissues from mesodermal origins is well-established. However, the origin of
mesenchymal populations and their contractile counterpart, the myofibroblast, that are
recruited during tissue repair and fibrosis continues to be a subject of intense research and
debate (Gomes et al., 2021; LeBleu et al., 2013). Tissue resident fibroblasts were originally
hypothesized to be a relatively homogeneous cell population in connective tissues,
responsible for producing and remodeling the extracellular matrix. However, recent
advances in technologies, including lineage tracing, have allowed researchers to identify
and investigate subpopulations of fibroblasts, which arise from different lineages of
embryonic precursor cells (Driskell & Watt, 2015; Goss et al., 2021; LeBleu & Neilson,
2020). As myofibroblasts are the main source of extracellular matrix (ECM) production
during tissue injury (Gabbiani et al., 1971, p. 20; Hinz, 2015; Tomasek et al., 2002; Zent
& Guo, 2018), investigation into the cellular origin from whichpopulations originate after
injury is important for development of new strategies to improve wound healing outcomes
while reducing scar formation (Driskell & Watt, 2015).
Potential sources of myofibroblasts progenitors include epithelial cells and endothelial
cells, derived through a process termed epithelial-mesenchymal (Kalluri & Weinberg,
2009) or endothelial-mesenchymal transition (Zeisberg et al., 2007); circulating bone
marrow–derived fibrocytes, tissue-resident fibroblasts, and other mesenchymal cells
related to blood vessels, including pericytes, adventitial cells, and mesenchymal stem cells
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(MSCs) (Crisan et al., 2008; Di Carlo & Peduto, 2018; Hinz, 2010; Zent & Guo, 2018).
Pericytes are peri-endothelial cells found encircling the endothelial cells of the
microvasculature (Greenhalgh et al., 2013). The contribution of pericytes in fibrosis of
different organs remains controversial (Guimarães-Camboa et al., 2017; Kramann et al.,
2013; Lemos & Duffield, 2018). Different markers have been used to detect pericytes,
such as Rgs5, Pdgfrβ, nestin Tbx18, CD146 and NG2 (Neuron-glial antigen 2, which
encodes chondroitin sulfate proteoglycan expressed in oligodendrocytes progenitor,
myeloid, and perivascular cells) (Cathery et al., 2018; Yamazaki & Mukouyama, 2018).
From these, NG2 is widely used not only because it is highly expressed by pericytes, but
also because it consistently labels cells with pericyte features on multiple types of
vasculature in different organs, such as skin, embryonic brain microvasculature, embryonic
heart micro- and macro-vasculature, and retinal microvasculature (Ozerdem et al., 2001;
Ozerdem & Stallcup, 2004). Overall, these studies show that various types of cells can
contribute to cells participating in the wound healing process, with perivascular cells.
Lineage tracing experiments have identified cell populations associated with the
perivascular space which are activated upon tissue injury and exhibit profibrotic
phenotypes, characterized by expression of α-SMA and production of fibrillar collagen
and other ECM proteins (Dulauroy, Di Carlo, et al., 2012). Genetic fate mapping has shown
that resident pericytes in the liver (hepatic stellate cells) (Mederacke et al., 2013), the
kidney (Chen et al., 2011; Humphreys et al., 2010a) and the lungs (Hung et al., 2013)
account for the major sources of myofibroblasts post-injury and contribute significantly to
tissue repair.
Previous research has shown that cell progeny derived from Foxd1 embryonic progenitors
to be myofibroblast precursors following tissue damage. More specifically, as a lineage
tracing marker, resident Foxd1 lineage-derived populations in the kidney and lung
contributed to the myofibroblast populations in induced renal fibrosis following unilateral
ureteral obstruction and ischemia reperfusion injury, as well as bleomycin induced lung
fibrosis, respectively (Humphreys et al., 2010a; Hung et al., 2013). Foxd1 is a transcription
factor expressed primarily during development, in paraxial mesoderm-derived populations
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(Guillaume et al., 2009). Using a Foxd1-Cre knock-in mouse crossed with a Rosa26-loxpstop-loxp(lsl)-lacZ reporter mouse, Humphreys et al. (2010) were able to provide evidence
for a mesenchymal source of myofibroblasts during kidney fibrosis (Humphreys et al.,
2010b). This group used this same model to demonstrate that Foxd1-progenitor– derived
pericytes expand after bleomycin lung injury, and activate expression of collagen-I(a)1 and
the myofibroblast marker α-SMA in fibrotic foci, showing that 68% of α-SMA-expressing
cells in fibrotic lungs are pericyte-derived (Hung et al., 2013). A recent study from our
laboratory using a murine cutaneous wounding model showed that Foxd1-lineage progeny
cells expand upon injury and contribute to the stromal population and α-SMA-positive
myofibroblasts, but did not contribute to perivascular and endothelial cells (Walker et al.,
2021). In summary, these studies do show that Foxd1 lineage derived populations can
contribute to myofibroblast precursors following tissue injury, but the cell of origin varies
depending on the tissue.
Although lineage tracing is a powerful method, it is highly dependent on the gene used to
track cell populations. Previous studies investigating the potential contribution of pericytes
in mice to bleomycin-induced lung fibrosis utilized NG2 as the genetic marker for this cell
type, but did not find any significant contribution of NG2+ pericytes to myofibroblast
populations and the resulting fibrosis even though the pericyte population itself did expand
significantly (Rock et al., 2011). LeBleu et al. (2013) demonstrated in a murine renal
fibrosis model that cells positive for the pericyte markers PDGFRβ and NG2 did not
contribute to ECM production post-injury. Additionally, preventing the expansion of these
pericyte populations did not affect fibrotic tissue formation (LeBleu et al., 2013).
In summary, the totality of the studies to date suggests that multiple subpopulations of
pericytes may exist within different tissues and differentially contribute to myofibroblast
formation and fibrosis. To date, evidence of perivascular cell recruitment and
differentiation into myofibroblasts appears to be organ specific (Di Carlo & Peduto, 2018;
Gomes et al., 2021; LeBleu & Neilson, 2020; Lemos & Duffield, 2018), and, currently,
whether this process occurs within the palatal mucoperiosteum has yet to be tested. Since
myofibroblasts contribute to palatal wound healing and are considered largely responsible
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for fibrotic tissue formation, it is pertinent to analyze their origin and recruitment in palatal
wound healing.
In the present study, using a Cre/Lox lineage tracing system in mice, two distinct lineages
that label perivascular cells, Foxd1- and NG2- lineages of stromal cells were investigated
during palatal development, homeostasis, and excisional wound healing. It was
hypothesized that embryonic progenitors that express Foxd1 and their progeny would
contribute to myofibroblast progenitors within the palatal mucoperiosteum in adult tissues,
and that binary expression of Foxd1 or NG2 could be used to stratify palatal fibroblasts
and cells within the wounded tissue to identify unexplored embryonic lineages of
myofibroblast progenitors present within the adult palatal tissues upon wounding.
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Materials and Methods
Animals
All animal procedures were in accordance with protocols approved by the University
Council on Animal Care at The University of Western Ontario. Animal use protocol #
2015-101).

Foxd1GC

(Foxd1tm1(GFP/Cre)Amc/J),

Foxd1tm2(GFP/Cre/ERT2)Amc/J),
tdTomato)Hze/J),

mTmG

Ai14

Foxd1GCE

(B6;129S4-

(B6.Cg-Gt(ROSA)26Sortm14(CAG-

(B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato,-

EGFP)Luo/J), NG2-cre-GFP (B6;FVB-Ifi208Tg(Cspg4-cre)1Akik/J) and NG2-CreERGFP

(B6.Cg-Tg(Cspg4-cre/Esr1*)BAkik/J) mice were purchased from The Jackson

Laboratory (Farmington, CT). Schematics and brief descriptions of each of the Cre/Lox
models used in this study are provided in Figure 4.1 and 4.2Mice were genotyped as per
The Jackson Laboratory’s instructions. Mice that were heterozygous for the alleles of
interest were used for all experiments.

Murine embryonic tissues
Foxd1-Cre-GFP mice were bred with ROSA26-mTmG/þ mice to produce offspring that
express a Cre-GFP fusion protein under control of the Foxd1 promoter. The reporter used
was mT/mG (membrane-Tomato before Cre/membrane-GFP after Cre) expressed from the
Rosa26 locus. In bigenic mice, cells that expressed Foxd1 at some point in development
are green and cells that never expressed Foxd1 are red. Embryonic tissues were harvested
at E17.5 and sectioned in the frontal plane to include the developing palatal tissues from
the anterior (hard palate) to the most posterior (soft palate) part of the palate. For timed
pregnancy, females were monitored for vaginal plugs and the day following was considered
embryonic day 0.5 (E0.5). Embryos were isolated from pregnant females at E12.5, E14.5,
and E17.5. For all time-points, at least 3 embryos were analyzed from at least 2 independent
litters.
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Figure 4-1 Schematics of Cre/Lox strategies used to track Foxd1 lineage-positive
populations.
(A) A cross between Foxd1GC and Ai14 mice yields tdTomato positive populations in
cells derived from Foxd1-expressing progenitors. (B) A cross between Foxd1GC and
mTmG results in membrane-targeted tdTomato expression in all Foxd1 lineage-negative
populations and membrane-bound eGFP in all Foxd1 lineage-positive populations. (C) A
cross between Foxd1GCE and Ai14 mice is similar to the cross in (A), however the
modified human estrogen receptor (ER) fragment attached to the Cre-recombinase impedes
translocation into the nucleus preventing recombination in the absence of the synthetic ER
ligand, tamoxifen (Metzger and Chambon 2001).
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Figure 4-2 Schematics of Cre/Lox strategies used to track Foxd1- and Ng2 lineagepositive populations
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Palatal wounds
For experiments, mice heterozygous for the alleles Foxd1GC/ Ai14, Foxd1GCE/ Ai14,
NG2-cre-GFP/ Ai14 and NG2-CreER-GFP/ Ai14 (20 weeks of age) were anesthetized with
an intraperitoneal injection of buprenorphine (0.05 mg/kg), followed by an injection of
ketamine (90 mg/kg) and xylazine (5 mg/kg). One full-thickness excisional wound was
made with a 1.5 mm disposable biopsy punch (Integra™ Miltex®, Integra York PA, Inc.)
on the hard palate. The localization of the palatal punch biopsy was standardized with the
anterior edge of the wound to be aligned with the first molar (Keswani et al., 2013) (Fig.
4.2) to avoid traumatizing the palatal arteries which run on either side of the wound. The
animals received 0.05 mg/kg Buprenorphine by subcutaneous injection twice daily for 48
hours post-surgery as an analgesic. Animals were maintained on a standard lab chow
powdered food diet and were allowed food and water ad libitum for the duration of the
experiment. Excised tissue was considered day 0 and was retained as normal healthy tissue.
Animals were euthanized at 6 and 10 days post-wounding by carbon dioxide inhalation.
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Figure 4-3 Experimental wound model
One full-thickness excisional wound was made with a 1.5 mm disposable biopsy punch
(Integra™ Miltex®, Integra York PA, Inc.) on the hard palate. The localization of the
palatal punch biopsy was standardized with the anterior edge of the wound to be aligned
with the first molar to avoid traumatizing the palatal arteries which run on either side of
the wound. B. Coronal view of the palatal tissues: Black arrow indicate the diameter of
the wound. C. Coronal view of palatal wounded tissues. The area of interest is
highlighted in black dashed box (PM: palatal mucoperiosteum, Epi: oral
Epithelium, PDL: periodontal ligament, GT: granulation tissue, A: major palatine artery)
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Tamoxifen Injections
To temporally control Cre-mediated recombination, mice carrying a tamoxifen-inducible
Cre variant, CreERT2, were crossed to Ai14 reporter mice (Figure 2.1C) (Metzger &
Chambon, 2001) Using this strategy, injection of tamoxifen was used to determine the
temporal expression of Foxd1 or NG2 [chondroitin sulfate proteoglycan 4 (Cspg)] in adult
palatal tissues. For all studies, a solution of 10 mg/mL tamoxifen in 90% corn oil (Sigma)
and 10% ethanol was administered. Tamoxifen injection in postnatal mice was performed
on mice heterozygous for both Foxd1GCE and Ai14 alleles, or NG2-CreER-GFP and Ai14
alleles. Directly following wounding, mice were subjected to a tamoxifen regimen of 1 mg
each day for 3 consecutive days. At 6 and 10 days post wounding, the animals were
euthanized, and tissues were collected for histological analyses. Postnatal tamoxifen
injection and wounding was performed on 3 animals per timepoint. Tissues from these
animals were compared to unwounded palatal tissues, and granulation tissue at 6 and 10
days post wounding from constitutively active Foxd1GC/Ai14 mice. Tissues from these
animals were also compared to unwounded and wounded tissues in Foxd1GCE/Ai14, or
NG2-CreER-GFP/Ai14 that did not receive tamoxifen as a negative control (mice were
injected with equal amount of sterile saline).

Tissue Preparation
Isolated embryos, palatal and maxillary tissues were fixed in 10% neutral buffered formalin
(Sigma Aldrich, St. Louis, MO) for 24 hours at 4ºC and decalcified in 20% EDTA
(ethylenediminetetraacetic acid) for 10 days at 4 °C. These tissue samples were then
dehydrated in a sucrose gradient prior to embedding in frozen section compound (Leica).
Samples were frozen on dry ice and were stored at -20ºC. Cryosections were cut to 8 μm
thickness for subsequent histological analysis.

Immunohistochemistry & Immunofluorescence
Unstained sections to investigate only endogenous fluorescent proteins, were washed in
phosphate buffered saline (PBS) and counterstained with Hoechst 33342 dye (1:1000,
Invitrogen, Thermo Fisher Scientific) for nuclei visualization. For antibody labelling, slides
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were first washed with 1% sodium dodecyl sulfate (SDS) for 5 minutes, rinsed three times
in PBS, and incubated for 30 minutes in 10% horse serum in PBS for blocking. Tissue
sections were then incubated with primary antibodies as shown in Table 1. Primary
antibodies were detected using Alexa Fluor IgG secondary antibodies (Invitrogen, Thermo
Fisher Scientific). All sections were counterstained with Hoechst 33342 dye (1:1000,
Invitrogen, Thermo Fisher Scientific) for nuclei visualization. Images were taken on Carl
Zeiss Imager M2m microscope (Carl Zeiss, Jena) using ZenPro 2012 software. Tissue
sections incubated without primary antibodies served as negative controls.

Quantitative Histological Analysis
For all measurements, only the wounded tissue was quantified, and not the epithelium or
the signal from the palatal bone. Quantification of fluorescence staining was performed
using macros in ImageJ software to measure the number of tdTomato-positive cells as a
ratio to the total number of cells (Hoechst positive nuclei), as well as the percentage of
tdTomato-positive cells per field of view (3 different histology sections/ wound, N=3
animals). For specific cell markers colocalization of the signal of interest with tdTomatopositive cells was manually quantified and presented as ratio of marker-tdTomato-positive
cells/total number of tdTomato-positive cells. GraphPad Prism software version 6
(GraphPad, La Jolla, CA) was used to produce graphs. Statistical analyses were performed
using 1-way ANOVA or 2-way ANOVA, followed by a Tukey post hoc test as needed. pvalues <0.05 were considered to be statistically significant.
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Table 1 Antibodies used for histological assessment
Tissue

Antibody ID

Dilution

investigated
α-SMA

Adult

Ab5694 (Abcam)

1:100

GFP

Embryonic/Adult

Ab6673 (Abcam)

1:200

PDGFRα

Adult

AF1062 (R&D

1:100

systems)
PDGFRβ

Adult

AF1042 (R&D

1:50

systems)
CD31

Embryonic/Adult

Ab28364 (Abcam)

1:200

Vimentin

Adult

Ab92547 (Abcam)

1:500

CD146

Embryonic/Adult

Ab75769 (Abcam)

1:500

S100β

Adult

Ab52642 (Abcam)

1:500

p75NTR

Embryonic/Adult

Ab52987 (Abcam)

1:50

CD105

Embryonic/Adult

MAB1320 (R&D

1:100

systems)
SOX10

Embryonic

Ab155279
(Abcam)
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1:500

Results
Foxd1-lineage-positive (FLP) cells are present at the
developing secondary palate during embryogenesis
Using a lineage tracing strategy to track Foxd1 derived populations (schematic shown in
Figure 4.1A), we investigated the contribution of this lineage to cell populations during
early maxillofacial development. Foxd1-lineage-positive (FLP) cells were present within
the head, especially at the anterior area/hard palate (median palatine process and nasal
process) (Fig. 4.3 B). Within the developing orofacial tissues, FLP cells contributed to
various mesenchymal and ectomesenchymal tissues. FLP cells were associated with the
mesenchyme within meninges, nasal process of the secondary palate (Fig. 4.3 i, iv),
whisker follicles, nasal cartilage (Fig.4.3 iii), the dental mesenchyme, the dental papilla
and dental follicle of developing teeth (Fig. 4.3 ii, 4.3 vii), the eye retina and fiber bundles
in the extraocular muscles (Fig. 4.3 vi), and the tongue (Fig. 4.3 v). These FLP cells,
however, were selective in the cartilages they contribute to, as they were absent from
Meckel’s cartilage in the mandible (Fig. 4.3 ii). FLP cells were sparsely distributed in
lateral maxillary processes, that fuse together with the nasal process to form the secondary
palate. FLP cells were not observed in the tissues of the soft palate.
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Figure 4-4 Foxd1-positive progenitor cells in the developing embryos contributed to
FLP cells within the developing orofacial tissues
(A) Foxd1GC mice were crossed with an mTmG reporter to investigate FLP (Green) and
FLN (Red) contributions to orofacial tissues during embryonic development. (B)
Embryonic tissues were harvested at E17.5 and sectioned in the frontal plane to include the
developing palatal tissues from the anterior (hard palate) to the most posterior (soft palate)
part of the palate. FLP cells are present within the head, especially at the anterior part/hard
palate, but are not present in the area of the soft palate. Representative images from at least
3 embryos are shown. White arrowheads indicate the developing tooth germs. Yellow
arrows indicate the Meckel’s cartilage. The areas highlighted in the white rectangle are
magnified in the panels i-vi below. NP= nasal process, MC= Meckel’s Cartilage, P= Palate,
NS= Nasal Septum, B= Brain, T=Tongue, TG= Tooth Germ, DL= Dental Lamina,
EE=Enamel epithelium, DP=Dental Papilla. Scale bar: 200 μm
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Foxd1-lineage-positive (FLP) cells contribute to vascular cell
populations within the developing secondary palate
To determine the type of cells that are FLP during the various stages of the palatal
embryonic development, tissues from embryos heterozygote for both Foxd1GC and Ai14
alleles were labelled for different cell markers associated with vasculature structures and
neural crest cells. High magnification images were taken of tissues labelled for CD105
(Fig. 4.4), CD31 (Fig. 4.5) and CD146 (Fig. 4.6) markers for vascular cell lineages. From
E12.5 to E17.5 tdTomato positive cells (FLP) show considerable overlap with all tested
vascular markers, although Foxd1-lineage-negative (FLN) cells were also noted to label
for these markers. Nevertheless, these observations demonstrate that Foxd1-lineage
progeny cells are a major contributor to pericytes and endothelial cells for the
neovascularization of the developing palatal tissues.
At early stages of murine embryogenesis (E12.5-E14.5) tdTomato-positive cells appear to
be negative for SOX10 and p75NTR neural crest markers, indicating that Foxd1-lineage
positive cells are not of neural-crest origin (Fig.4.7, 4.8)
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Figure 4-5 Foxd1-positive progenitor cells in the developing embryos contributed to
vascular endothelial cells within the secondary palate.
Tissues were stained for CD105 to detect vascular endothelial cells within the palatal
tissues from E12.5 to E17.5. Scale bar: 200μm. On the left- Schematic representation of
murine orofacial tissues at E12.5-E17.5, highlighting with blue the areas that contribute to
secondary palate development (palatal processes/shelves). The area in black dashed box
indicates the area of interest. (PS: Palatal shelve, NS: Nasal Septum)
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Figure 4-6 Foxd1-positive progenitor cells in the developing embryos contributed to
vasculature cells within the secondary palate.
Tissues were stained for CD31 to detect vascular endothelial cells within the palatal tissues
from E12.5 to E17.5. Scale bar: 200μm.
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Figure 4-7 During development, FLP cells (red) contribute to vascular cells.
Tissues were stained for CD146 to detect pericytes and endothelial cells within the palatal
tissues from E12.5 to E17.5. Scale bar: 200μm.
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Figure 4-8 During development, FLP cells (red) are not associated with markers of
neural crest-derived cell populations.
Tissues were stained for p75NTR to detect post-migratory neural crest cells within the
palatal tissues from E12.5 to E14.5. Scale bar: 200μm.
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Figure 4-9 During development, FLP cells (red) are not associated with markers of
pre-migratory neural crest cell populations.
Tissues were stained for SOX10 to detect neural crest-derived cells within the developing
palatal tissues from E12.5 to E14.5. Scale bar: 200μm.
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Foxd1-expressing cells are rare in postnatal tissue during
homeostasis and following wounding
We employed two different mouse strains to identify perivascular cell localization and
lineage tracing within wounded tissue. Both B6;129S4-Foxd1tm1(GFP/cre)Amc/J, and the
inducible

B6;129S4-Foxd1tm2(GFP/cre/ERT2)Amc/J

strains

were

bred

with

B6.CgGt(ROSA)26Sortm14 (CAG-tdTomato)Hze/J. Non-inducible mice containing both
the Foxd1 driven, Cre-GFP fusion protein, and the Rosa26 driven, tdTomato preceded by
a loxp flanked stop codon, express GFP in any cells actively expressing Foxd1, and
tdTomato in any cell derived from a Foxd1 positive precursor cell (Foxd1-lineage-positive
cells; FLP cells). The inducible strain adds the ability to temporally control when the Cre
recombinase is functional through the injection of tamoxifen. Wound repair was assessed
following excisional wounding in the palatal mucoperiosteum of these mice and
histological analysis was performed to investigate the contribution of Foxd1 positive cells
and their progeny in wound healing.
To determine whether Foxd1 is expressed in normal adult palatal mucoperiosteum, palatal
tissues were harvested from heterozygote Foxd1GC/Ai14 mice. Recombination in Foxd1Cre-GFP is constitutively active in cells expressing the Foxd1 promoter, inducing
expression of tdTomato driven by the ubiquitously expressed Rosa26 promoter. Foxd1
expression was not observed within the healthy/unwounded palatal samples taken, as
indicated by the absence of GFP/Foxd1 signal (Fig. 4.9 B). In the unwounded palatal
mucoperiosteum, tdTomato signal was seen in certain cells that were mainly associated
with blood vessels and the perineurium of nerves, suggesting that these cells are derived
from Foxd1 positive precursors during development [Foxd1-lineage-positive cells (FLP
cells)] (Fig. 4.9 B). To determine more specifically which populations these FLP cells were
contributing to within the palatal tissues, adult mouse palate was labeled with several
markers including the smooth muscle and myofibroblast marker α-SMA (Fig. 4.9 C), the
endothelial/pericyte marker CD146 (Fig. 4.9 D), and S100β to identify Schwann cells
(Fig.4.9 E). Immunolabelling with α-SMA, CD146 and S100β showed that FLP cells are
in close association with blood vessels, where they give rise to some smooth muscle cells
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of peripheral veni, pericytes and some endothelial cells. FLP cells also constitute cells of
the perineurium of nerves as well as some cell population within the endoneurium
(endoneural fibroblasts/pericytes).
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Figure 4-10 Foxd1-positive progenitors give rise to perivascular and perineural
populations within the adult palatal mucoperiosteum
To characterize the differentiated populations represented by the Foxd1 lineage, the
constitutively active Foxd1GC line crossed to the Ai14 reporter was assessed. A. Schematic
diagram: Coronal view of the palatal tissues. PM: palatal mucoperiosteum, Epi: oral
Epithelium, PDL: periodontal ligament. B. Within the unwounded palatal mucoperiosteum
Foxd1 positive (green) cells were absent. Derivatives of this population (red -FLP) are
sparse in in the unwounded palatal mucoperiosteum and mainly associated with blood
vessels and the perineurium of nerves. The area highlighted in the white rectangle is
magnified on the right. Adult mouse palatal tissues were labeled for the smooth muscle
and myofibroblast marker α-SMA (C), the endothelial marker CD146 (D), and S100βmarker for Schwann cells (E). Scale Bar: 100μm.
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Foxd1-expressing cells are absent in postnatal palatal
mucoperiosteum following injury
To determine whether Foxd1 expressing cells participate in palatal wound healing, fullthickness excisional wounds were created in the palates of constitutively active
Foxd1GC/Ai14 mice. Tissues were harvested at days 6 and 10 post-wounding and the
tissues were subjected to histological analysis (N=3 animals/time-point). Upon wounding,
GFP-positive cells were absent from the granulation tissue. Our observations were further
confirmed by the absence of signal of anti-GFP (Fig. 4.10 A). tdTomato-positive cells (FLP
cells) begin to appear at 6 days post wounding within the granulation tissues and increase
in density over time to 10 days post wounding (Fig. 4.10 B, C ).
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Figure 4-11 Foxd1-expressing cells are absent in postnatal palatal mucoperiosteum
following injury
(A) Anti-GFP antibody was used to detect GFP signal in the wounded tissues. Absence of
signal verified that GFP (Foxd1) is not expressed in adult tissues upon injury. White arrows
indicate the leading edge of the wound. White dashed line indicates the border between the
epithelium and the granulation tissue. Scale bar: 100μm. (B) Quantification analysis of the
tdTomato-positive cells present within the wounded tissues revealed that FLP cells appear
at 6 days post wounding within the granulation tissues and increase in density over time to
10 days post wounding. Quantification presented as percentage of FLP cells/total cells
(tdTomato/DAPI). (C) Quantification presented as percentage of FLP cells/field of view.
(D) Schematic representation: Coronal view of palatal wounded tissues. The area of interest
is highlighted in black dashed box (Epi: oral Epithelium, PDL: periodontal ligament, GT:
granulation tissue, A: major palatine artery)
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Foxd1-lineage-positive cells contribute to diverse populations in
adult palatal mucoperiosteum upon injury
To determine more specifically which populations these cells were contributing to, adult
mouse wounded palatal tissues from Foxd1GC/Ai14 mice were labeled with smooth
muscle and myofibroblast marker α-SMA, several markers expressed in fibroblasts
(vimentin, PDGFRα, PDGFRβ), the endothelial marker CD31, the pericyte marker CD146,
as well as neural crest-derived cell markers p75NR and S100β (Schwann cells). The FLP
cells within the wound tissue were present in the granulation tissue but did not show any
overlap with vimentin (Fig. 4.11), PDGFRα, PDGFRβ (Fig. 4.12) and p75NTR markers
(Fig. 4.13). Quantification of the α-SMA-positive FLP cells showed that only minimal
fraction of FLP cells contribute to the myofibroblast population (unwounded <3%; day 6
<3%; day 10 <4%, N=3 animals/timepoint) (Fig. 4.14).
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Figure 4-12 FLP cells within day-6 and -10 granulation tissue are not associated
with Vimentin
FLP cells (tdTomato positive) do not overlap with staining for Vimentin (green) within the
granulation tissue. Nuclei are stained with Hoechst dye (blue). Representative images are
shown from a sample of 3 mice. White arrows indicate the leading edge of the wound.
White dashed lines indicate the border between the epithelium and the granulation tissue.
Scale bar: 100μm
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Figure 4-13 FLP cells within day-6 and -10 granulation tissue are not labelled with
fibroblast markers
FLP cells (tdTomato positive) do not overlap with staining for fibroblast markers PDGFRα
and PDGFRβ (green) within the granulation tissue. Nuclei are stained with Hoechst dye
(blue). Representative images are shown from a sample of 3 mice per timepoint. Arrows
indicate leading wound edge. White dashed lines indicate the border between the
epithelium and the granulation tissue. Scare bar: 100μm.
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Figure 4-14 FLP cells are not associated with p75NTR-positive cell populations.
Immunofluorescent staining for neural-crest derived cells p75NTR (green) at normal,
unwounded palatal tissues (A), days 6- (B) and 10- (C) post wounding, did not reveal any
overlap between tdTomato and p75NTR suggesting that FLP cells are not neural-crest
derived. Representative images are shown from a sample of 3 mice per timepoint. Arrows
indicate leading wound edge. White dashed lines indicate the border between the
epithelium and the granulation tissue. Scare bar: 100μm
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Figure 4-15 FLP cells are not a significant contributor to the myofibroblast
population during wound repair.
(A) In normal, unwounded palatal tissues derivatives of this population (red) are sparse and
mainly associated with blood vessels, as shown by the co-localization of the signal with αSMA. Foxd1-lineage-positive cells begin to appear at 6 days post wounding at the wound
edge and increase in density over time to 10 days post wounding. These cells do not
contribute to the myofibroblast population as shown by the absence of overlap between
tdTomato and α-SMA. White arrows indicate the leading edge of the wound. White dashed
lines indicate the border between the epithelium and the granulation tissue. Scale bar:
100μm. (B) Schematic representation: Coronal view of palatal wounded tissues. The area
of interest is highlighted in black dashed box (Epi: oral Epithelium, PDL: periodontal
ligament, GT: granulation tissue, A: major palatine artery). (C) Quantification presented
as percentage of α-SMA-positive FLP cells/total FLP cells showed that only minimal
fraction of FLP cells contribute to the myofibroblast population (unwounded < 3%; day 6
< 3%; day 10 < 4%, N=3 animals/timepoint)
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To determine whether FLP cells contribute to emerging populations of neural cells that
enter the granulation tissue as it matures, we used the Schwann marker S100β. The
histological analysis revealed that S100β+ cells are absent within the granulation tissue
(Fig. 4.15A, B). Quantification analysis of S100β+FLP cells distal to the wound, in close
proximity to the neurovascular bundle of the palate, showed that S100+FLP cells constitute
only a minor part of the FLP population in normal tissue and at early stages of wound
healing-day 6 (<3%, N=3 animals/timepoint), while their density increased by day 10 (9%,
N=3 animals/timepoint).
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Figure 4-16 S-100 β immunofluorescent staining
S100 β -positive cells emerge from the distal side of the wound and are absent from the
granulation tissue and FLP cells only minimally contribute to S100β+ populations distal
to the wound. Immunofluorescent staining for S100β (green) at days 6 (A) and 10 post
wounding (B). White arrows indicate the leading edge of the wound. White dashed lines
indicate the border between the epithelium and the granulation tissue. White arrowheads
indicate FLP cells positive for S100β marker, as indicated by the colocalization of the
signal. Scale bar: 100μm. Quantification presented as percentage of S100-positive FLP
cells/total FLP cells. N=3 animals/timepoint.
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Foxd1 lineage progeny contribute to vascular cell populations
during wound repair
To determine which populations these cells were contributing to, adult mouse wounded
palatal tissues were labeled with markers for vascular cells (endothelial cells, pericytes). In
unwounded tissues less than 3% of FLP cells were positive for CD31 marker. Interestingly,
post-wounding a significant overlap between tdTomato (FLP cells) and CD31 was
observed, suggesting that FLP cells significantly contribute to the increasing endothelial
population post-wounding (>40% of FLP cells were found to be CD31 positive) (Fig. 4.16).
However, it was evident that the FLP population only give rise to a subset of these
populations, with FLN cells also contributing.
Similar observations were made when the pericyte -CD146 and Endoglin-CD105 markers
were utilized (Fig. 4.17-4.18).
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Figure 4-17 FLP cells within day-6 and -10 granulation tissue contribute to CD31+
populations within the wounded tissues
Immunofluorescent staining for CD31 (green) at days 6 (A) and 10 (B) post-wounding.
Scale bar: 100 μm. Quantification presented as percentage of CD31-positive FLP cells/total
FLP cells. Data were analyzed using 1-way ANOVA and Tukey post hoc test. N=3 (*** P
< 0.001)
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Figure 4-18 FLP cells within day-6 and -10 granulation tissue contribute to CD146+
populations within the wounded tissues
Immunofluorescent staining for CD146 (green) at days 6 and 10 post-wounding. White
arrowheads indicate representative cells with dual labeling between FLP cells and CD146positive cells Scale bar: 100 μm. Quantification presented as percentage of CD146-positive
FLP cells/total FLP cells. Data were analyzed using 1-way ANOVA and Tukey post hoc
test. N=3 (* P < 0.05, *** P < 0.001)
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Figure 4-19 FLP cells within day-6 and -10 granulation tissue contribute to CD105+
populations within the wounded tissues
Immunofluorescent staining for CD105 (green) at days 6 and 10 post-wounding. White
arrowheads indicate representative cells with dual labeling between FLP cells and CD105positive cells. Scale bar: 100 μm. Quantification presented as percentage of CD105positive FLP cells/total FLP cells. N=3
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Figure 4-20 Overall contribution of FLP cells
Quantification presented as percentage of selected-marker-positive FLP cells/total FLP
cells at normal and wounded palatal tissues at days 6 and 10 post-wounding.
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Foxd1-linage-positive cells can adopt a fibrotic phenotype in
culture
To determine whether these populations could be further investigated in a controlled
culture environment, explant cultures from adult palatal mucoperiosteum from
Foxd1GC/Ai14 mice were established and the effect of culturing on substrates of different
elastic modulus was investigated. First, we tested whether tdTomato+ cells can be detected
and expanded in culture. Quantification analysis of tdTomato+ (FLP) and tdTomato(FLN) cells after expansion in explant cultures for 2 weeks did not reveal any differences
in expansion potential,as both FLP and FLN cells were present in similar numbers in
culture (FLP 46.41%, FLN 53.59%, N=3). It is interesting that even though in adult,
unwounded tissues these cells compose a small percentage of cells, in culture they are able
to expand.
To explore the contribution of microenvironment stiffness on cellular behavior, cells were
seeded on silicone substrate with high Young’s elastic modulus (0.2 kPa) and tissue culture
plastic (low elastic modulus, high stiffness; TCP), and α-SMA expression and localization
on the stress fibers was evaluated using immunolabeling. Both FLP and FNL populations
assumed a fibroblastic phenotype in culture, with incorporation of α-SMA in the stress
fibers. After 24h, FLP and FNL cells assumed differentiated myofibroblast characteristics
with α-SMA-positive stress fibers when cultured on a high stiffness tissue culture plastic
(TCP), while on low stiffness (0.2 kPa) substrates the cells were characterized by poor
spreading and exhibited no contractile bundles (Fig. 4.20).
These observations indicate that FLP cell populations do not maintain their characteristics
when in culture but rather they can differentiate into myofibroblasts in an environment of
increased stiffness.
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Figure 4-21 FLP and FLN cells in vitro assumed a fibroblastic phenotype
Cells were cultured on silicon substrates with 0.2 kPa Young’s modulus of elasticity top
rows) or TCP (bottom rows) and stained for α-SMA protein (green). Nuclei were labelled
with Hoechst (blue), F-actin in white Scale bar is 20 μm.
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FLP populations in adult palate and granulation tissue were not
derived from de novo Foxd1 expression in postnatal tissue.
To determine if postnatal expression of Foxd1 was contributing to the FLP populations
observed in these tissues, recombination in a tamoxifen inducible Cre model was
investigated by crossing the Foxd1GCE line with the Ai14 reporter. Tamoxifen was
delivered to postnatal mice after wounding and tissues were harvested for histological
assessment of recombination at days 6 and 10 post-wounding. Histological images revealed
the absence of recombination, as indicated by the lack of cells expressing tdTomato (N=2)
(Fig. 4.21).
Combined with the expression patterns observed during embryogenesis, these data suggest
that the FLP cells present within the palatal mucoperiosteum were primarily derived from
embryonic precursors that expressed Foxd1, and that de novo expression of Foxd1 in
postnatal palate during homeostasis and wound healing was absent.
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Figure 4-22 FLP populations in granulation tissue were not derived from de novo
Foxd1 expression in postnatal tissue
In a tamoxifen inducible model utilizing the Foxd1GCE/Ai14 cross, tamoxifen injection
into postnatal tissue did not yield any tdTomato positive cells (N=2) Scale bar= 100 μm
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NG2-lineage-positive cells contribute to mesenchymal cells and
myofibroblast populations within the wounded palatal
mucoperiosteum
In the palate, the two greater palatine arteries contribute to the blood supply of the hard
palate. Observations from our current data suggest that Foxd1-positive-lineage cells have
higher density near the greater palatine arteries, at the proximity of the wound. Thus, we
hypothesize that these arteries could be a potential source for these cells. To investigate
whether arterial endothelial cells contribute to wound healing in the palate, NG2-cre-GFP
and the inducible NG2-CreERT2-GFP mouse strains was used. Cspg4 – or NG2, is a cell
surface chondroitin sulfate proteoglycan identified as a marker for vascular pericytes
(Bergers & Song, 2005; Cooke et al., 2012; Ozerdem et al., 2001; You et al., 2014)
In normal unwounded palatal tissues, NG2-positive (GFP-positive) cells are absent and
NG2-lineage-positive cells (in red) appear throughout the connective tissue. Upon
wounding, GFP-positive cells are absent from granulation tissue at day 6 post-wounding,
while NG2-lineage-positive cells appear throughout the palatal connective tissue, vascular
structures within the maxillary bone and the granulation tissue (Fig. 4.22).
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Figure 4-23 NG2-lineage-positive cells gave rise to most of the cell populations within
the connective tissues of the adult palatal mucoperiosteum.
Unwounded and wounded tissues 6 days post-wounding palatal tissues were isolated from
mice expressing NG2-cre-GFP and Ai14 alleles. Merged images show tdTomato (NG2lineage-positive) cells in red and nuclei are labelled with Hoechst in blue. The area
highlighted in the white rectangle is magnified on the right. Epi= oral Epithelium, GT=
Granulation Tissue. Scale bar= 100 μm. (N=2)
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To determine more specifically which populations these cells were contributing to within
the dermis, palatal wounded tissues were labeled with mesenchymal cell marker vimentin,
and the smooth muscle and myofibroblast marker α-SMA. Both markers partially
overlapped with tdTomato expression, however tdTomato negative populations were also
noted to label for these markers (Fig. 4.23). Schwann cells are glial cells that produce the
myelin sheath around nerve axons of the peripheral nervous system and are essential in
maintaining normal nerve function (Jessen & Mirsky, 2005). Schwann cell reprogramming
and differentiation are required for neuronal regeneration and re-myelination to occur
following injury to peripheral nerves (Gonçalves et al., 2019). Minimal overlap between
tdTomato and p75NTR and S100β markers was observed, suggesting that NG2-lineagepositive cells were not a major contributor to the neural cell (Schwann cells) populations
and the re-innervation of the damaged tissue (Fig. 4.24). Similar pattern was observed
between tdTomato and Sox10 signal overlap (Fig. 4.25). As constitutive NG2-Cre mice
reveal extensive labeling when crossed with Ai14, it was deemed not useful for imaging
and further analysis.
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Figure 4-24 NG2-lineage-positive cells contribute to mesenchymal and myofibroblast
cell populations within the wounded palatal mucoperiosteum
Upon wounding, GFP-positive cells are absent from granulation tissue at day 6 postwounding NG2-lineage-positive cells appear throughout the palate and granulation tissue,
where partial overlap was observed between NG2-lineage-positve cells and Vimentin and
α-SMA markers. Merged images show tdTomato (NG2-lineage-positive) cells in red and
nuclei are labelled with Hoechst in blue. White dashed lines indicate the border between
the epithelium and the granulation tissue. White arrows indicate the leading edge of the
wound. Scale bar= 100 μm. (N=2)
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Figure 4-25 NG2-lineage-positive cells contribute minimally to peripheral nerve
populations within the wounded palatal mucoperiosteum
White arrowheads indicate representative cells with dual labeling between NG2-lineagepositive cells and S100β- or p75NTR-positive cells. Merged images show tdTomato (NG2lineage-positive) cells in red and nuclei are labelled with Hoechst in blue. White dashed
lines indicate the border between the epithelium and the granulation tissue. Yellow
arrowhead indicates the nerve bundle adjacent to the major palatine artery. White arrows
indicate the leading edge of the wound Epi= oral/palatal epithelium, A= Major Palatine
Artery. Scale bar= 100 μm. (N=2)
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Figure 4-26 NG2-lineage-positive cells are not of neural-crest origin.
Yellow arrowheads indicate representative cells with dual labeling between NG2-lineagepositve cells and Sox10-positive cells. Merged images show tdTomato (NG2-lineagepositive) cells in red and nuclei are labelled with Hoechst in blue. White dashed lines
indicate the border between the epithelium and the granulation tissue. White arrowheads
indicate representative Sox10-positive, NG2-negative cells. White arrows indicate the
leading edge of the wound. Scale bar= 100 μm. (N=2)
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NG2-lineage-positive cell populations in adult palate and
granulation tissue were not derived from de novo Ng2
expression in postnatal tissue.
To determine if postnatal expression of Ng2 was contributing to the positive populations
observed in these tissues, recombination in a tamoxifen inducible Cre model was
investigated by crossing the Ng2GCE line with the Ai14 reporter (NG2-CreERT2-GFP).
Tamoxifen was delivered to postnatal mice (Ng2-ERT-CRE/Rosa) immediately after
wounding and a histological assessment of recombination was performed in 3 mice at day
6 post wounding (Fig. 4.26). Tamoxifen injection into postnatal tissue resulted in a low
level of recombination, resulting in few tdTomato positive cells in the palate and the
granulation, which were primarily associated with blood vessels (N=3). Experimental
control conditions were also performed, as seen in Figure 4.27 (N=1 animal/control
condition).
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Figure 4-27 NG2 expressing cells exhibit minimal contribution in healing of adult
palatal tissues
Tamoxifen was delivered to postnatal mice (Ng2-ERT-CRE/Rosa) right after wounding and
a histological assessment of recombination was performed in 3 mice at day 6 post
wounding. Merged images show tdTomato (NG2-lineage-positive) cells in red and nuclei
are labelled with Hoechst in blue. White dashed lines indicate the border between the
epithelium and the granulation tissue. White dotted lines indicate the border between the
palatal bone and the granulation tissue. Scale bar= 100 μm.
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Figure 4-28 Control experimental conditions
(A) Tamoxifen was delivered to postnatal mice (Ng2-ERT-CRE+/-/Rosa-/-) right after
wounding. Ηistological assessment 6 days post-wounding did not reveal any
recombination. (B) Ng2-ERT-CRE+/-/Rosa+/- mouse was injected with sterile saline
(instead of tamoxifen) right after wounding and histological assessment of recombination
was performed at day 6 post-wounding. White dashed lines indicate the border between
the epithelium and the granulation tissue. White dotted lines indicate the border between
the palatal bone and the granulation tissue. ΜΒ= maxillary bone, GT= granulation tissue,
Epi= epithelium. Scale bar= 100 μm.
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Figure 4-29 NG2-expressing cells contribute endothelial cells during repair.
Immunofluorescent staining for CD146 (A), CD105 (B) and p75NTR (C) was performed
at day 6 post-wounding. White arrowheads indicate representative cells with dual labeling
between tdTomato+ cells and CD146-positive cells. A= artery Scale bar: 100 μm.
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Discussion
Using a lineage tracing approach, embryonic progenitors that differentially expressed
Foxd1 or NG2 were investigated in a murine model. In our study we identified two distinct
lineages of cells that are committed to different cell types in adult palate, uniquely
contributing to palatal mucoperiosteum homeostasis and wound repair: The Foxd1-lineage
progeny expanded after injury and contributed to the formation of neovascular structures,
while the NG2-lineage progeny contributed to most of the fibrotic cells present in the
wounded tissues. Interestingly, the Foxd1-lineage progeny and NG2-lineage progeny
populations described here do not directly overlap with distinct embryonic lineages that
have been previously identified within different organs in murine models, such as in skin,
kidney, lung, liver (Chen et al., 2011; Humphreys et al., 2010b; Hung et al., 2013; Rock et
al., 2011; Walker et al., 2021).
Due to the different healing patterns evident when comparing the oral cavity and the skin,
here we investigated the embryonic origin of cells that contribute to palatal
mucoperiosteum wound healing. Evidence suggests that identification of fibroblast
lineages could be used to a degree as a predictor of cell function, but that this is likely only
true within a specific tissue location. In fact, lineage itself may simply predict a cell's
location, which in turn defines its phenotype (Walker et al., 2021). In the palatal
mucoperiosteum palatal soft tissue is a rigid mucoperiosteum; mucosa and the periosteum
are merged and tightly attached to the palatal bone, leading to excessive scarring upon
wounding (Nanci, 2013). Here, we explored whether binary expression of Foxd1 during
embryogenesis could be used as a new potential marker of fibroblasts within the oral cavity
and the repair process in the palatal mucoperiosteum, and to compare our findings with
evidence from murine skin healing. We investigated the contribution of Foxd1 lineage to
cell populations during early maxillofacial development, and we found that FLP cells are
not of neural crest origin and are a major contributor to pericytes and endothelial cells for
the neovascularization of the developing palatal tissues. Further, the contribution of Foxd1and NG2-lineage cells was also assessed in homeostasis and would healing of the adult
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murine palatal mucoperiosteum, where we identified that they give rise to distinct lineages
of cells that are committed to different cell types.
Our group has previously shown that in skin Foxd1-derived progeny account for a subset
of dermal fibroblasts and myofibroblasts during wound healing (Walker et al., 2021). In
excisional wounds in skin FLP and FLN fibroblasts were both found to produce α-SMA
contributing to activated myofibroblasts during tissue repair. Interestingly, these cell
populations appeared to have unique expression profiles, with FLP cells showing enhanced
expression of genes associated with ECM synthesis and remodelling, while FLN
populations are associated with signalling/microenvironment, indicating that they have
unique specializations and potentially work together in concert during homeostasis and
repair (Walker et al., 2021)
The hard palate is an area of the mouth which results from the fusion of different embryonic
facial processes: the palatal shelves (arising from the maxillary processes) grow vertically
down the sides of the tongue, at E12. They begin as vertical (dorsoventral) projections down
the sides of the developing tongue and around E14 elevate to a horizontal position above
the tongue and continue to grow horizontally, until they contact and fuse along the midline.
A transient epithelial seam is formed which is gradually replaced by continuous
mesenchyme (Vaziri Sani et al., 2005). The secondary palate fuses with the primary palate
and the nasal septum, thereby creating the separation between the oral cavity and the two
nostrils (Paiva et al., 2019). Here, we showed that Foxd1-lineage positive cells contribute
to various mesenchymal and ectomesenchymal tissues within the developing orofacial
tissues, such as mesenchyme within meninges, nasal process of the secondary palate,
whisker follicles, nasal cartilage, cells within the dental mesenchyme, the dental papilla
and dental follicle of developing teeth, the eye retina and fiber bundles in the extraocular
muscles, and the tongue, all of which are of neural crest- or mesodermal origin.
More detailed analysis of this cell population revealed that Foxd1-lineage positive cells
were also sparsely distributed in lateral maxillary processes contributing to cells of the
neovasculature. It is of interest that angioblasts are the only cells of mesodermal origin so
far identified that move into the stream of migrating neural crest cells, apparently as soon
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as the neural crest cells have formed as a mesenchymal population lateral and rostral to the
mesodermal mesenchyme. This early incursion of mesodermal angioblasts into an
apparently otherwise pure neural crest cell population enables blood vessels to form equally
quickly within the neural crest-derived and mesoderm-derived mesenchyme of the head
(Yoshida et al., 2008). Evidence from lineage tracing studies suggest that in the craniofacial
region of mouse embryos the endothelial cells of blood vessels are of mesodermal origin
and the muscular components of the vessel walls (pericytes) are derived from neural crest
(Yoshida et al., 2008). Our findings further support this evidence, as here we show that
within the developing palate, the vasculature structures arise from the Foxd-1 embryonic
lineage and do not express neural-crest markers SOX10 and p75NTR.
In the adult mouse, the cell populations arising from Foxd1-lineage positive cells contribute
to a relatively small proportion of cells in the quiescent adult palatal mucoperiosteum,
mainly associated with blood vessels, where they give rise to some smooth muscle cells of
peripheral veni, pericytes and some endothelial cells. FLP cells also constituted to cells of
the perineurium of nerves as well as some cell populations within the endoneurium
(endoneural fibroblasts/pericytes). However, our data shows that upon experimental
wounding, this population is activated contributing to cells mainly associated with
neovascularization of the wound. While CD31+FLP cells were sparse in the unwounded
tissues, upon wounding more than 40% of FLP cells were CD31+. In contrast, no significant
overlap with any fibroblast or myofibroblast markers was identified. This finding is in
direct contrast with evidence of the Foxd1-lineage positive cell population in dermal wound
healing. In skin the Foxd1 lineage represented 50%-70% of the dermal fibroblasts and
contributed to myofibroblast progenitors, and only minimally to vascular cells (Rinkevich
2015, Walker et al., 2021), providing further evidence about differences between oral and
skin healing characteristics. Revascularization of the wound is essential for the repair and
regeneration of the tissue. Functional and persistent neoangiogenic activity has been shown
to result in favorable wound healing outcomes across different tissues, such as the
myocardium (Broughton et al., 2018) and skin (Moreira & Marques, 2022). Among other
factors described in Chapter 1, this evidence of the distinct roles of Foxd1 progeny in skin
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and palatal tissues could also be considered a contributing factor of the oral mucosa to heal
without scarring.
Foxd1-derived populations in skin have been shown to display enhanced fibrogenic
potential compared to their lineage-negative counterparts, as shown by FACS sorting, gene
expression and functionality assays (Walker et al., 2021). Our data show that in the palate
Foxd1-derived populations do not contribute to the population of myofibroblasts that
populate the granulation tissue of the wound. These marked differences could point to
unique healing potential between the two tissues: Foxd1-derived populations are present
and expand at different extent in both skin and the palatal mucoperiosteum, but they
contribute to different cells upon wounding, suggesting that tissue specificity and cellextrinsic factors within their unique location are likely to influence their lineage
determination.
We utilized the NG2 embryonic marker to investigate the contribution of perivascular cells
in the wound healing process, as the blood supply in the soft and hard tissues of the palate
is provided by the major palatine arteries, and surrounding branches and capillaries. Thus,
we hypothesized that these arteries and associated microcirculation could be a potential
source for activated and migrating cells that contribute to wound healing. In our study we
found that NG2-lineage progeny cells are present in adult palatal tissues, and they expand
upon wounding contributing to the mesenchymal cells and myofibroblasts within the
granulation tissue. Based on our observations in the palate, it appears that the NG2-progeny
marks a distinct cell population with more fibrotic profile, while the Foxd1-progeny is
restricted to cells with vascular role. Our findings could lead to the development of model
system that allows separation of vascular entities and pro-fibrotic myofibroblast behaviors
in the same healing model. Since poor wound healing and scarring are associated with
reduced vascularization and vascular stability, this model could be utilized to assess
changes in vascular/fibrotic balance, and the final healing outcome.
Extensive evidence indicates that NG2 is highly expressed by pericytes (Armulik et al.,
2011; Ozerdem et al., 2001; Ozerdem & Stallcup, 2004). In various different organs
pericytes can differentiate into myofibroblasts and contribute extensively to tissue repair
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(Chen et al., 2011, p. 201; Humphreys et al., 2010b). Pericyte function could be tissuespecific as it be influenced by the organ in which the cells reside: In lung two pericyte
populations arise from the same Foxd1 progenitor, one of which co-expresses fibroblast
and pericyte markers (Col1+ Pdgfrα+ Pdgfrβ+ Ng2+) (Barron et al., 2016). Type-1
pericytes (Nestin-negative, NG2-positive), produce collagen and contribute to fibrosis in
skeletal muscle, but not in the kidney or the heart (Birbrair et al., 2014). In the skin, lineage
tracing showed that NG2-positive cells did not give rise to any dermal fibroblast
subpopulations during wound healing (Goss et al., 2021), contrary to other perivascular
populations (Dulauroy, Carlo, et al., 2012). NG2-positive cells remained associated only
with blood vessels, restricted to forming NG2+ blood vessel associated cells, most of which
express Pdgfrα and/or Pdgfrβ. (Goss et al., 2021). The same study also showed that NG2positive perivascular cells were primarily derived from interfollicular papillary and
reticular fibroblasts during skin development as well as during regeneration, supporting a
potential relationship between pericyte and fibroblast lineages (Goss et al., 2021).
In recent years, a plethora of research has demonstrated that the ECM physical and
chemical properties are important determinants of cell behaviours and soft tissue healing
(Argentati et al., 2019; Wells et al., 2016). Building on our previous studies (Elliott et al.,
2012; Kim et al., 2019; Nikoloudaki et al., 2020), the differences observed in skin, gingival
and palatal healing processes suggest that the ECM of these tissues may possess different
levels of stiffness. Changing the stiffness of the cell substrate is an efficient method to
control cell behavior in vitro (Pakshir & Hinz, 2018; Talele et al., 2015; Tomasek et al.,
2002). To first determine whether Foxd1-lineage positive cells could expand in vitro, a
compliant collagen gel was used as a culture substrate to selectively stimulate
myofibroblast activation. Here, we found that both Foxd1-lineage-positive and -negative
cells from the palatal mucoperiosteum are able to expand in culture, giving rise to
fibroblast-like cells. When cells of both populations were seeded on substrates of increased
stiffness (GPa) they developed distinct stress fibers, in which α-SMA was incorporated,
indicating myofibroblast differentiation, while when they were seeded on very soft (0.2
kPa) substrates the cells were characterized by poor spreading and exhibited no contractile
bundles. Even though these are preliminary data, these findings point to the importance of
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the cell microenvironment, among other extrinsic factors, as determinants of cell
differentiation and lineage commitment. To determine the functional characteristics of the
FLP and FNL cells, as well as the interactions between the two populations, cell isolation
via FACS analysis and gene expression analysis is required.
In the present study, Foxd1 expression by embryonic progenitors enabled the tracking of
distinct cells that contribute to the vasculature of the developing palatal tissues and that
maintained their spatial differences into adulthood and regeneration. NG2 progeny tracking
allowed the identification of different cell populations that contribute to healing, that are
not only restricted to blood vessel formation unlikely to the skin. Our findings further
support that cell populations across different tissues, although they originate from common
embryonic lineages, they present different phenotypes in mature and wounded tissues. This
observation points to the significance of cell-extrinsic factors (extracellular environment,
from

tissue-specificity

perspective,

ECM

composition

and

microenvironment

biomechanical properties) as determinants of cell fate and behaviour across different
tissues, and that could further explain the different healing patterns among them.
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Chapter 5
5.1 Summary of the thesis
In this thesis, I investigated how cell origin/lineage and the composition of the extracellular
matrix influences processes required for tissue homeostasis and repair. While considerable
research has focused on skin, less has been directed towards the oral tissues, and
specifically the palatal mucoperiosteum and the periodontal ligament. My goal was to
investigate how both cell-intrinsic and extrinsic factors influence processes underlying
successful wound repair (palatal mucoperiosteum) and maintenance of tissue homeostasis
(periodontal ligament). Using a novel palatal repair model in 6 different strains of
genetically modified mice (Postn-/- perilacZ null mice, Foxd1-Cre-GFP/ ROSA26-mTmG/þ
Foxd1GC/ Ai14, Foxd1GCE/ Ai14, NG2-cre-GFP/ Ai14 and NG2-CreER-GFP/ Ai14), I
showed that 1) the influence of periostin on cell behaviour is tissue-specific, 2) periostin is
involved in maintenance of PDL matrix stability, but can also enhance PDL fibroblast
mineralization under osteogenic conditions, and 3) in the palate there are two distinct cell
populations of different embryonic origin with minimal overlap, one expanded after injury
and contributed to the formation of neovascular structures, while the other appeared more
fibrogenic and contributed to most of the cells present on the wounded tissues.
My work shows that both cell-intrinsic and cell-extrinsic factors influence healing in the
palatal mucoperiosteum, information that furthers our understanding of how differences in
the cellular and molecular composition of tissues combine with specific physical properties
in defining healing outcomes. I also demonstrated specific cell populations and
extracellular matrix (ECM) constituents involved in wound repair in palatal tissues. These
findings could lead to the development of an experimental system that allows separation of
the distinct cell lineages so that vascular and pro-fibrotic behaviors can be studied in the
same mice, while allowing us to alter the vascular/fibrotic balance, and ultimately guide
the final healing outcome.
As will be discussed below, my thesis increases our understanding of how cells and ECM
composition influence repair processes in the oral cavity. This knowledge can then be
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applied in the rationale development of novel biomaterials with specific biochemical and
biomechanical properties targeted to accelerate and enhance the healing process, while
suppressing scarring and fibrosis, after dental and maxillofacial surgical procedures.

5.2 Key findings and knowledge contribution
5.2.1 Periostin and Matrix Stiffness Combine to Regulate Myofibroblast
Differentiation and Fibronectin Synthesis During Palatal Healing
Matricellular proteins are temporally regulated throughout the wound repair process, and
their expression has been linked to a range of important functional outcomes, including the
regulation of inflammation, angiogenesis, and fibrogenesis (Walker et al., 2015). The first
aim of this thesis focused on the matricellular protein periostin as a possible extrinsic
mediator of cell behavior in the repair of the palatal mucoperiosteum.
Periostin is a secreted ECM protein that our research group has shown is transiently
expressed during normal cutaneous (Elliott et al., 2012a) and gingival wound repair (Kim
et al., 2019). However, it persists and is overexpressed in abnormal scar tissue and other
benign fibroses that are characterized by fibroblast proliferation and myofibroblast
differentiation (Crawford et al., 2015; Elliott & Hamilton, 2011; Zhou et al., 2010). Using
the Postn-/- mouse model (H. Rios et al., 2005), I demonstrated that periostin is required for
normal healing of the palatal mucoperiosteum; loss of periostin results in delayed palatal
wound-closure kinetics. In agreement with cutaneous healing, the myofibroblast marker αSMA/Acta2 was significantly reduced in the granulation tissue of Postn-/- mice at day 6
when compared with that in WT controls. However, although reduced, α-SMA was still
expressed and myofibroblasts were present which suggested that stiffness of the
microenvironment in the palate is sufficient to drive myofibroblast differentiation.
Similarly, in cutaneous wounds in murine skin, deletion of periostin did not affect α-SMA
expression in high-tension areas at the wound edge, but α-SMA is completely absent in the
relatively low-tension granulation tissue, suggesting that the stiffness of the cellular
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microenvironment is a key driver for myofibroblast differentiation and contraction (Elliott
et al., 2012b).
In the palate, specific structural features are present that can alter the wound healing process
that are not present in skin, specifically the underlying bone. Since the role of periostin in
fibrosis is well-established, in this thesis I focused on the extracellular effects of periostin
in palatal healing taking into account the stiffness of the microenvironment as a driving
factor for cellular responses. The palatal soft tissue is a rigid mucoperiosteum that is
attached to the palatal bone and it much stiffer than buccal mucosa and contains less elastin
fibers (Bourke et al., 2000). Defining the mechanical characterisation of living human oral
tissues has been difficult, and due to the lack of standardisation in the methodology the
reported compressive modulus data is variable (J. J. E. Choi et al., 2020; Gasik et al., 2021).
Understanding further the mechanical environment and how it impacts on periostin
expression upstream of α-SMA expression could provide a means to alter wound healing
and reduce scarring.
Although the free gingival graft palatal wound will usually heal within 2–4 weeks
(Farnoush, 1978; Keskiner et al., 2016), despite the presence of denuded palate, problems
persist with repair that directly influence the microenvironment of the cells. In cleft-palate
reconstructive surgeries, mucoperiosteal flaps are created on the palate close to the cleft,
leaving areas of denuded bone. However, a specific feature associated with the healing of
open wounds in palatal mucoperiosteum is the deposition of callus-like cancellous bone on
the palate. The granulation tissue and collagen fibers of palatal bone acquires an osteogenic
potential and new bone is formed (Wijdeveld et al., 1987). Most of the collagen fibers of
the forming scar are oriented in a transverse direction but many fibers also show a vertical
orientation. These vertical fibers become embedded in cancellous palatal bone as Sharpeys'
fibers, generating a strong attachment of scar tissue to the underlying palatal bone. The
transverse fibers appear to be continuous with the cervical periodontal ligament providing
mechanical connection between scar and teeth, which results in palatal tipping of erupting
of the teeth and restriction of maxillary growth (Berkowitz, 1977; Kuijpers-Jagtman &
Long, 2000; Von Den Hoff et al., 2006; Wijdeveld et al., 1991). My data shows that the
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stiffness of the palate is sufficient to drive myofibroblast differentiation even in the absence
of periostin demonstrating that reduction of scar formation post-surgery is not a simple
task. However, the further investigation and comparison of distinct healing patterns among
skin, gingiva and the palatal mucoperiosteum could provide a deeper understanding of how
differences in molecular composition and physical properties of these tissues lead to the
different healing outcomes.
Using an in vitro model of palatal fibroblasts to investigate these findings further, cells
from Postn-/- animals had a significant reduction in their ability to contract anchored
collagen gel, although proliferation rate was similar to cells isolated from WT animals.
Addition of exogenous rhPSTN, however, fully rescued the phenotype of the Postn-/fibroblasts suggesting that extracellular localization of periostin is both necessary for, and
sufficient to, induce gel contraction through induction of a contractile myofibroblast
phenotype. As stated previously, palatal fibroblasts mirror observations our group has
shown in dermal fibroblasts isolated from Postn-/- mice (Elliott et al., 2012a). However, in
human gingival fibroblasts the exogenous addition of rhPSTN does not increase α-SMA
protein nor induce gel contraction (Kim et al., 2019), further supporting the behavioral and
phenotypic differences between gingival, palatal and dermal fibroblasts observed in vitro.
Increased matrix stiffness is also a trigger for fibroblast to myofibroblast transition by
inducing maturation of focal adhesions (Tomasek et al., 2002a), which further supports the
possibility that healing gingival tissue ECM may not possess the same level of stiffness that
granulation tissue has in skin or the palatal mucoperiosteum. Interestingly, the presence of
periostin in gingival tissue is not sufficient to induce α-SMA, suggesting that the maturity
of focal adhesions and a lack of adhesive signaling in human gingival fibroblasts more
likely results in an absence of myofibroblasts during healing (Kim et al., 2019).
This observation motivated me to investigate further the role of ECM stiffness and adhesive
signaling as potential modulators of periostin-induced myofibroblast differentiation and
mechanotransduction pathways in palatal fibroblasts (Hinz, 2015a; Pakshir & Hinz, 2018;
Rousselle et al., 2019; Zent & Guo, 2018). Activated TGF-β1 binds to the TGF-βR complex
stimulating intracellular signaling that promotes α-SMA production. In parallel, ECM-to272

cell mechanical transduction through the integrin/focal adhesion (FA) pathway activates
RhoA, leading to assembly of α-SMA stress fibers. Changing the stiffness of the cell
substrate is an efficient method to control myofibroblast activation in vitro (Pakshir & Hinz,
2018; Talele et al., 2015; Tomasek et al., 2002b). In cultured differentiated myofibroblasts,
using collagen and polyacrylamide gel substrates of varying stiffness, α-SMA expression
levels increases with increasing matrix rigidity (Arora et al., 1999; Hinz, 2010b). In vivo,
mechanically preventing wound closure by splinting the edges of experimental wounds
accelerates expression of α-SMA compared with normally healing wounds, while stress
release by removing the splint leads to reduced α-SMA expression (Hinz et al., 2001) . Well
established evidence indicates that we can mimic the stiffness of the wound environment
using different in vitro model systems: it has been shown that the stiffness of the provisional
ECM of early wounds is comparable with the elastic modulus of ∼10–100 Pa of newly
polymerized collagen gels (Kaufman et al., 2005) and fibroblasts seeded into these gels are
devoid of contractile fibers and organize actin filaments (Tamariz & Grinnell, 2002). On
the contrary, in mechanically restrained gels, tension is gradually increasing and first
induces the formation of α-SMA-negative stress fibers (Tamariz & Grinnell, 2002), which
is similar to the de novo appearance of proto-myofibroblast in 5- to 6-day-old rat wound
granulation tissue (Hinz, 2007; Hinz et al., 2001). The threshold stiffness for de novo
expression of α-SMA in stress fibers ranges around 20 kPa as demonstrated for contractile
wound granulation tissue and for myofibroblasts cultured on elastic substrates (Goffin et
al., 2006).
In this work, I showed that myofibroblast differentiation of murine palatal fibroblasts is
stimulated by culture on stiff culture substrates but suppressed on substrates mimicking
normal tissue (8 kPa) or granulation tissue (0.2 kPa) ECM stiffness, which is in agreement
with other reports (Achterberg et al., 2014). Differences of matrix stiffness also affected
the expression of fibronectin; on very stiff substrates (1 GPa), fibronectin synthesis was
down-regulated while on low stiffness (0.2 kPa) fibronectin synthesis was up-regulated.
Loss of periostin resulted in lower expression Acta2/α-SMA levels suggesting impaired
myofibroblast differentiation capacity when compared to WT cells. However, this was most
evident on rigid, collagen-coated tissue culture plates which have a stiffness of 1 GPa.
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Lastly, myofibroblast differentiation in Postn-/- cells was rescued with the addition of Rac
inhibitor, suggesting that periostin modulates myofibroblast differentiation in stiff matrices
via RhoA/ROCK pathway.
Our observations from the in vivo experiments in the palate showed that α-SMA is still
present but reduced in the granulation tissue of Postn-/- wounds, indicating that the loss of
periostin is partially compensated by the stiffness of ECM environment which is sufficient
to drive myofibroblast differentiation in Postn-/- wounds. Loss of periostin also resulted in
significantly reduced fibronectin expression compared to WT cells. This observation
further supports our previous finding, where human gingival fibroblasts cultured in the
presence rhPSTN had increased fibronectin production, an effect which was attenuated by
pharmacological inhibition of FAK and JNK signaling (Kim et al., 2019).

These

observations indicate that in palatal fibroblasts periostin modulates myofibroblast
differentiation and fibronectin synthesis in cases of extreme stiffness and in very compliant
microenvironments.
Cells are subjected to mechanical stresses and receive and respond to stimuli from the ECM
through integrins (Moore et al., 2010; Schwarz & Gardel, 2012). In this study we found
that focal adhesion formation and size are increased with an increase in the stiffness of the
cell microenvironment, and that the genetic deletion of periostin resulted in a significant
defect in focal adhesion formation in Postn-/- cells. This finding provides a possible
explanation of the reduced contractility and fibronectin synthesis in the absence of
periostin. Collectively, we found that in the absence of periostin, the formation of both focal
and fibrillar adhesions is defective demonstrating the direct functional role of periostin in
adhesion properties of the cells.
The fist aim of this thesis provides further evidence that periostin and the stiffness of the
ECM act as modulators of matrix synthesis and myofibroblast differentiation during palatal
healing. These findings could provide new insights for the development of novel
approaches and biomaterials with specific biochemical and biomechanical properties
targeted to accelerate and enhance the healing process (Urbanczyk et al., 2020), while
suppressing fibrosis, after dental and maxillofacial surgical procedures.
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In summary, I provide further evidence based on previous work from our lab, that the tissuespecific expression patterns and extracellular effects of periostin in the palate represents a
combination of defined effects in skin and gingiva.

5.2.2 Role of periostin in the maintenance and mineralization of the
periodontal ligament
In the second aim of my thesis, I investigated the effect of periostin on PDL fibroblast
phenotype and how this could contribute to observed PDL responses in orthodontic injury
and wound healing. In mice, periostin deletion manifests in a loss of the architecture and
functional disruption of several collagenous-based tissues, particularly those subject to
constant mechanical loading (H. Rios et al., 2005). Postn-/- mice exhibited significant
damage to the periodontal tissues following exposure to a masticatory force, but placing
the animals on a soft diet was sufficient to reduce the mechanical strain on the PDL and
could partially rescue both the enamel and periodontal disease-like phenotypes (H. F. Rios
et al., 2008). On the contrary, in the absence of mechanical stress, the PDL of Wistar rats
undergoes degradation concomitantly with a marked decrease in periostin and CTGF
mRNA levels in the PDL (J. W. Choi et al., 2011), suggesting that periostin is essential for
maintaining the integrity of the PDL under physiological occlusal and mastication forces.
It has been postulated that this relates to collagen cross-linking (Merle & Garnero, 2012;
Norris et al., 2007; Tanabe et al., 2010).
Here, using an ex vivo mineralization model, we show that genetic loss of periostin in Postn/-

murine periodontal tissues does not increase or decrease the re-mineralization of the

periodontal ligament ex vivo, suggesting that the presence of periostin in the PDL does not
act to prevent mineralization. RNAseq and pathway enrichment analysis of PDL cells
isolated from adults of 28 and 31 years of age and cultured in DMEM in the presence of
exogenous periostin were mainly enriched in genes associated with collagen fibril
formation and extracellular matrix organization. The clinical significance of these findings
has many implications for PDL regeneration and in particular highlights a potential
important role for periostin in orthodontic tooth movement. This is a process in which the
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application of a mechanical force induces bone resorption on the pressure side and bone
apposition on the tension side (Krishnan & Davidovitch, 2006), while maintaining the
presence of the PDL. During orthodontic movement, periostin is involved in the process of
periodontium remodeling in response to mechanical force (Lv et al., 2014; Rangiani et al.,
2016; Wilde et al., 2003). Application of orthodontic forces induces divergent changes of
periostin mRNA levels between the pressure and tension sites of rat PDL, with increased
levels in the compressed side of the ligament when compared to tension sites (Wilde et al.,
2003). The tissue in the compressed sides require a dramatic re-organization to maintain its
width for normal tooth function, thus increased expression of periostin is in response to the
need for rapid ECM re-organization and collagen re-arrangement. In Postn-/- mice, during
application of orthodontic forces, the distance of the tooth movement and mineral
deposition rates are significantly reduced when compared to WT mice, exhibiting impaired
arrangement, digestion, and integrity of collagen fibrils (Rangiani et al., 2016). In
combination with the RNAseq data presented in this thesis, it is apparent that periostin is
essential for the PDL in response to physiological periodontium remodeling and
orthodontic tooth movement, and my findings provide evidence of periostin’s role in ECM
organization and collagen fiber formation.
In vitro studies in human periodontal ligament mesenchymal stem cells have shown that
periostin affects key functional aspects: Periostin promotes cell motility, adhesion, survival
(Matsuzawa et al., 2015), migration, proliferation, and differentiation (Wu et al., 2018). In
addition to regulation of processes involved in matrix formation and stability, previous
studies have shown a role for periostin in the regulation of matrix mineralization (Galli et
al., 2014; F. Zhang et al., 2015). Although in vitro and not representing the
microenvironment of the in situ PDL, it nevertheless suggests that in certain conditions,
periostin may act to promote mineralization of osteogenic cell populations including PDL
cells. This is consistent with the phenotype of the Postn-/- mouse (H. Rios et al., 2005). In
this chapter we show that the exogenous addition of periostin to human PDL cell cultures
results in significantly more calcium content when compared to osteogenic media alone,
suggesting that exogenous periostin promotes or enhances the mineralization of hPDL cells
under osteogenic conditions. Our findings are in agreement with previous reports (Tang et
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al., 2017; Wu et al., 2018). The potential of exogenous periostin’s role as a therapy could
be applied in clinical practice to enhance osseointegration of dental implants. Using tissue
engineering, stimulating cells to differentiate to the right phenotype with the purpose of
regenerating lost tissue requires an environment capable to provide the same factors that
govern cellular processes in vivo. Thus, exogenous periostin coating of dental implants or
biomaterials for guided-tissue regeneration can be a viable approach to improve cell
adhesion and osteogenic differentiation of PDL cells on implantable biomaterials.
In adult tissues, periostin is mainly localized in areas rich in progenitor cells, such as the
basement membrane, periosteum, chondrocytes of developing bone and the PDL (Cai et
al., 2019; Jackson-Boeters et al., 2009; Zhou et al., 2010). An increasing body of research
also supports a role for periostin in the regulation and differentiation of stem cells
(Tkatchenko et al., 2009), such as hematopoietic stem cells (Khurana & Verfaillie, 2013;
Tanaka et al., 2016), adipose-derived stem cells (Qin et al., 2015), and human PDL stem
cells (Tang et al., 2017; Wu et al., 2018). The periodontium is rich source of periodontal
ligament stem cells (PDLSCs), that have gained great attention for guided dental tissue
regeneration, bone grafting, and enamel matrix reconstruction, as they pose the capacity to
differentiate into osteoblasts, cementoblasts, adipocytes and neural crest- like cells (Zhu &
Liang, 2015). Human cultures of PDL cells are known to be heterogenous in nature
(Morissette Martin et al., 2017), which somewhat mirrors the in vivo cellular composition.
Understanding extrinsic factors that guide their differentiation remains of importance from
a clinical standpoint.
Here, we investigated transcriptional changes in human PDL cells after exposure to
exogenous periostin or/and osteogenic culture conditions using RNA sequensing analysis.
One of the most striking findings of this set of analyses was the very strong patient-specific
effect, as observed by the high variability between patient responses to treatment condition
with minimal overlap of common genes differentially expressed among the 4 patients.
Focused analysis on the youngest patient (15 years old) revealed higher mineralization
potential (as shown by the Alizarin Red assay) and unique gene expression patterns, both
in unsupplemented and osteogenic media conditions, which is in agreement with previous
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reports (Li et al., 2020; J. Zhang et al., 2012). It has previously been shown that cell-donor
age also affects stem cells, as PDLSCs obtained from aged donors (mean age 54 y.o.) had
less regenerative capacity compared with those from young donors (mean age 15 y.o.)
(Zheng et al., 2009). Zhang and coworkers compared biological features of PDLSCs
obtained from donors at different ages and found that proliferation and migration ability
and differentiation potential of PDLSCs decreased as donor age increased (J. Zhang et al.,
2012). Moreover, PDLSCs in aged groups (older than 41 years) expressed less Stro-1 and
CD146 than young donors and failed to form cementum-PDL-like structures in vivo,
indicating that the number and regenerative ability of stem cells decreased with increasing
donor age (J. Zhang et al., 2012). These observations are of great clinical importance, as
autologous transplantation of PDLSCs from older individuals might be of limited
effectiveness given the compromised regenerative capacity of aged PDLSCs.
In this thesis, we also showed that when hPDL cells were cultured in osteogenic conditions,
pathway enrichment analysis of DEG by the exogenous addition of periostin revealed
involvement of pathways associated with bone remodeling and osteoblast differentiation.
This indicates that PDL cells can dramatically switch their phenotype dependent on the
local microenvironment. Since periostin is localized in the periosteum and periodontium,
which undegoes continous physiological remodeling, my results highlight another potential
role: in bone alveolar bone remodeling. This process consists of bone formation by
osteoblasts and bone resorption by osteoclasts, while the osteocytes serve as
mechanosensors and orchestrators during the bone remodeling process (Florencio-Silva et
al., 2015). The expression of periostin was first identified in the mouse osteoblastic cell line
MC3T3-E1 and found in the alveolar bone surface in vivo, suggesting its role in regulation
of osteoblasts function (Horiuchi et al., 1999). Consistent with these observations, other
studies of long bone osteoblasts show that periostin mutations caused impeded attachment
of osteoblasts to the bone matrix, as well as significant reduction in expression of type I
collagen, osteocalcin, osteopontin, and alkaline phosphatase. These alternations result in
inhibition of their differentiation into mature osteoblasts, as well as the decrease in
mineralization processes in vitro (Bonnet et al., 2012; Litvin et al., 2004).
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In summary, the findings of this thesis show that periostin has condition-specific actions:
in non-osteogenic conditions it contributes to ECM maintenance through modification of
PDL cell phenotype, while in osteogenic conditions periostin promotes the mineralization
capacity of PDL cells and contributes to gene expression changes associated with bone
remodeling. Further studies are required to confirm information identified in the sequencing
results. Critically, continuation of this work will enhance our understanding of the
molecular and cellular effects of periostin on PDL cells could be helpful for periodontal
regeneration and stem cell-targeted therapy.

5.2.3 Myofibroblast Origin in Palatal Repair: Assessing the
Contribution and the Fate of Foxd1 and NG2 Populations and Their
Progeny During Palatal Development and Repair
The third aim of this thesis focused investigating cell lineages that contribute to palatal
repair, with a focus on understanding which populations contribute to healing of the
connective tissue underlying the mucosa. In this thesis, I used the constitutive expression
of Foxd1 in palatal progenitor populations during development to examine how cells
derived from Foxd1-expressing progenitors contribute to murine embryonic orofacial
tissues and adult palatal wound repair. In addition, I also investigated the role of NG2lineage progeny in homeostasis and would healing of the adult murine palatal
mucoperiosteum.
Based on previous lineage tracing studies in kidney fibrosis (Humphreys et al., 2010), lung
fibrosis (Hung et al., 2013) and in skin healing (Walker et al., 2021), here the Foxd1-gene
was used as a marker of pericytes and progenitors of fibroblasts/myofibroblasts during
murine embryonic facial development and in palatal healing through lineage tracing. A
number of studies have suggested that multiple subpopulations of pericytes may exist
within different tissues and differentially contribute to myofibroblast formation and fibrosis
specific (Di Carlo & Peduto, 2018; Gomes et al., 2021; LeBleu & Neilson, 2020; Lemos &
Duffield, 2018). In this thesis we explored whether binary expression of Foxd1 during
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embryogenesis could be used as a new potential marker of fibroblasts within the oral cavity
and the repair process in the palatal mucoperiosteum, and to compare our findings with
evidence from murine skin healing.
During the early stages of maxillofacial development, I found that Foxd1-lineage positive
(FLP) cells are not of neural crest origin but represent a major lineage that gives rise to
pericytes and endothelial cells in the neovascularization of the developing palatal tissues.
My results show that during development Foxd1-lineage positive cells that are sparsely
distributed in lateral maxillary processes are mainly contributing to cells of the
neovasculature. Angioblasts are the only cells of mesodermal origin so far identified that
move into the stream of migrating neural crest cells, apparently as soon as the neural crest
cells have formed as a mesenchymal population lateral and rostral to the mesodermal
mesenchyme (Yoshida et al., 2008). This early incursion of mesodermal angioblasts into
an apparently otherwise pure neural crest cell population enables blood vessels to form
equally quickly within the neural crest-derived and mesoderm-derived mesenchyme of the
head (Yoshida et al., 2008). Evidence from lineage tracing studies suggest that in the
craniofacial region of mouse embryos the endothelial cells of blood vessels are of
mesodermal origin and the muscular components of the vessel walls (pericytes) are derived
from neural crest (Yoshida et al., 2008). Overall, limited information or analysis of cell
populations through lineage tracing experiments has been performed in the oral cavity or
the hard palate. Utilizing lineage tracing techniques in Wnt1-Cre;Zsgreenfl/fl mice it was
demonstrated that all the tendons and mesenchyme embedding the soft palate muscles are
neural crest-derived, proposing that the posterior attachment of the soft palate to the
pharyngeal wall is an interface between the neural crest- and mesoderm-derived
mesenchyme in the craniofacial region (Grimaldi et al., 2015). Although regional clonal
diversity was also recently demonstrated in the cells of the epithelium that covers the hard
palate in mice (Byrd et al., 2019; Jones et al., 2019; Yuan et al., 2019), there is limited
analysis of the stromal cells of the palatal mucoperiosteum. Lineage tracing experiments
have identified that neural crest-derived cells persist in adult tissues in some areas of the
oral mucosa and that Lgr51-lineage-positive cells participate in the maintenance of the
stroma (Boddupally et al., 2016). My findings not only provide further evidence about the
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mesodermal origin of the vasculature structures within the developing palate- as they do
not express neural-crest markers SOX10 and p75NTR, but also point to the mesodermal
origin of the Foxd1- embryonic lineage.
In adult palatal tissues, Foxd1-lineage positive cells contribute to a relatively small
proportion of cells, mainly associated with blood vessels, where they give rise to some
smooth muscle cells of peripheral veni, pericytes and certain populations of endothelial
cells. Upon wounding, the Foxd1-derived population becomes activated; shows
significantexpansion with the cells mainly associated with neovascularization processes in
the developing granulation tissue. In contrast to evidence from dermal would healing where
Foxd1-derived progeny contributed to a significant portion of mesenchymal matrix
producing cells (Walker et al., 2021), in the palate Foxd1-derived progeny show no
significant overlap with any fibroblast or myofibroblast markers, providing further
evidence about differences between oral and skin healing characteristics. My findings
suggest that even though this population has a common embryonic signature, the functional
properties of its terminally differentiated progeny is largely dependent on the physicomechanical characteristics of the mature tissue: in skin, a tissue prone to scarring, this
population accounts for almost 50% of the fibroblasts, while in the palate, a tissue that does
not typically scar (unless major cleft-palate reconstruction surgery is performed), Foxd1
progeny only gives rise to vasculature-related cells advancing the healing outcome via
neovascularization of the granulation tissue.
Interestingly, I found that NG2-lineage progeny cells are present in adult palatal tissues,
but in contrast to Foxd1 progeny, they do expand upon wounding contributing to the
mesenchymal cells and myofibroblasts within the granulation tissue. Based on our
observations in the palate, it appears that the NG2-progeny marks a distinct cell population
with a more fibrotic profile, while the Foxd1-progeny is restricted to cells with vascular
role. For the first time, we have identified the two distinct major cell populations that
orchestrate the wound healing process, and investigation into their specific characteristics,
behaviour and balance can lead to a more thorough understanding of the different healing
outcomes evident and how it can be altered through activation of certain cell populations.
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The work presented in this thesis contributes to a growing understanding of fibroblast
heterogeneity and provides insight into how divergent populations might cooperate during
wound repair. Our findings further support that cell populations across different tissues,
although they originate from common embryonic lineages, they present different
phenotypes in mature and wounded tissues. This observation points to the significance of
cell-extrinsic factors (extracellular environment, from tissue-specificity perspective, ECM
composition and microenvironment biomechanical properties) as determinants of cell fate
and behaviour across different tissues, and that could further explain the different healing
patterns among them.

5.3 Experimental Limitations
In this thesis, an excisional wound of 1.5 mm diameter was created in the posterior area of
the hard palate. The limiting factors in the size of experimental defect that could be created
was the relatively small size of the palate available to wound and the presence of the greater
major palatine arteries on other side of the hard palate. Injury of either of these arteries
would be detrimental for the recovery of the animals. The small size of the wound resulted
in rapid healing and optimal clinical outcomes, as excessive scarring could not be observed.
Availability of Postn-/- rat model would permit for a larger critical defect that scarring could
be observed and biomaterials to be tested on the site of injury, better replicating the clinical
conditions.
In Chapter 3, the data obtained from the RNA sequencing analysis need to be interpreted
with caution. When assessing variability within the dataset, it is preferable that the
intergroup variability, representing differences between experimental conditions in
comparison with control conditions, is greater than the intragroup variability, representing
technical or biological variability. Our results show significant variability among the
different patients, and minimal overlap between commonly differentially expressed genes.
Further studies will focus on sample size, number of conditions to be compared, depth of
sequence reads and promoter RNA sequencing analysis.
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5.4 Future Directions
5.4.1 Harnessing exogenous factors to guide wound healing in palatal
healing
Even though common dental procedures, such as palatal tissue harvesting for free gingival
graft, result in optimal healing outcome in the palate (Keskiner et al., 2016), cleft-palate
reconstructive surgeries result in excessive scarring, misalignment of erupting of the teeth
and restriction of the maxillary development in transversal width when the patient is in their
growing phase, leading to serious functional and aesthetic problems (Larjava, 2013).
In this thesis, we report the first description of palatal wound healing models in Postn-/mice and the functional properties of isolated murine palatal cells from transgenic mice.
Moreover, I show how the composition and mechanical tension of the ECM and
surrounding microenvironment affect cellular responses. My data shows that periostin is at
the forefront of granulation tissue development in the palate and the modulation of cell
phenotype. With respect to extracellular matrix changes during palatal healing, we show
that periostin modulates cell contractility and in combination with tissue stiffness,
influences fibronectin synthesis. However, the overexpression and persistence of periostin
in the ECM is associated with abnormal scars and other benign fibroses (Crawford et al.,
2015; Elliott & Hamilton, 2011; Zhou et al., 2010). Therefore, any approach using periostin
to facilitate repair would need to be tightly controlled in a spatiotemporal manner, taking
into account the mechanical properties not only of the native tissue environment, but also
of the proposed biomaterial.
Exogenous delivery of periostin in palatal wounds, in an environment of high tension, could
have adverse effects on the healing outcome, as it would enhance the profibrotic response
of the cells, leading to increased myofibroblast activity and matrix synthesis. Our lab has
previously shown that delivery of recombinant periostin in an electrospun form is viable in
murine skin healing, where it stimulated α-SMA expression in the granulation tissue of
Postn-/- wounds (Elliot et al.,2012). More recently, we also demonstrated, in a murine
model of diabetic wounds, that the addition of periostin and CCN2 in a scaffold form
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increases closure rates of full-thickness skin wounds in diabetic mice, concomitant with
enhanced angiogenesis (Elliott et al., 2019). The results of this thesis provide evidence of
the significance not only of the chemical composition of the wound microenvironment, but
also its mechanical properties in the cellular responses. Thus, when designing biomaterials
it is necessary to take into account the mechanical properties of the wound
microenvironment, as a major contributor to the final healing outcome.
The palatal mucoperiosteum is tightly attached to the underlying bone, leading to excessive
stress forces during wound healing. During cleft palate reconstruction surgeries, flaps of
palatal tissues are raised to close the oro-nasal communication, resulting in areas of
denuded maxillary bone, and subsequent the deposition of callus-like cancellous bone on
the palate, where most of the collagen fibers of palatal bone acquires an osteogenic potential
and new bone is formed (Wijdeveld et al., 1987). The collagen fibers become embedded in
cancellous palatal bone, generating a strong attachment of scar tissue to the underlying
palatal bone. The mechanical stress exerted by the stiffness of ECM due to this attachment
positively feedbacks on the development and progression of fibrotic conditions by directly
promoting myofibroblast activation and persistence through various mechanotransduction
pathways (Achterberg et al., 2014; Goffin et al., 2006; Hinz, 2015b; Pakshir & Hinz, 2018;
Rousselle et al., 2019). In this thesis we showed that changing the stiffness of the cell
substrate is an efficient method to control palatal myofibroblast activation and fibronectin
synthesis in vitro. Thus, design of novel biomaterials for cases of cleft-palate surgeries
should aim to reduce stresses developed within the wounded area, and, as a result, to create
an environment that is not conducive to scarring. This can be achieved by designing a
material that is able to reduce the stiffness of the area that it is applied, and that it can
maintain its mechanical properties after its application on to the wounded area for a
prolonged period of time, sufficient to allow the formation of a granulation tissue that is
not in direct contact with the denuded bone or the callus-like osteogenic bone.
Alternatively, using this current evidence, biomaterials can be designed in a way that they
block the physical contact between the granulation tissue and the bone surface, preventing
the collagen fibers to be embedded in the cancellus bone, thus reducing the stress of the
wounded tissues and scarring.
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Taking into account the totality of this knowledge, efforts should focus on improving
biomaterial design, in terms not only of their chemical composition and delivery of
matricellular proteins/growth factors, but also their mechanical properties with the aim to
guide the cellular response towards an optimal healing outcome. Such an approach could
help reduce the problems associated with maxillary growth and teeth eruption prevalent in
children following cleft palate repair.

5.4.2 Investigating the functional relevance of Foxd1- and Ng2progeny in palatal tissues
Our work has revealed two distinct embryonic-progeny populations that contribute to
palatal wound healing in mice: Foxd1- expressing cells and their progeny expand and form
the neovascular structures of the wounded tissues, while NG2-progeny are more fibrogenic
and contributed to most of the contractile cells present in the granulation tissue of the
wounds. To further investigate the functional differences of Foxd1- and NG2-lineage,
palatal cells isolation and gene expression assays are needed. The isolated cells can be
sorted into Foxd1-lineage positive and negative, an NG2-lineage positive and negative and
assess differential gene expression profiles among these populations. In skin, Foxd1
lineage-positive and lineage-negative dermal fibroblasts were identified to have divergent
gene expression patterns, with FLP cells showing more fibrotic gene expression patterns
(Walker et al., 2021).
Future studies should focus on further probing how these genetic differences impact cell
function. Functional differences between FACS-sorted cells should be assessed in vitro and
in vivo. In vitro experiments could focus on assessing functional differences of the sorted
cell populations, such as gel contraction, migration and invasion assays as well as
vasculogenesis assays. In vivo, an effective strategy to assess cell function is through
transplantation studies using FACS-sorted populations. Using this strategy, Driskell et al.
identified a role of papillary fibroblasts in hair follicle formation (Driskell et al., 2013).
Additionally, Rinkevich et al. and Jiang et al. provided evidence of scarring potential in the
engrailed-1 lineage of fibroblasts over the lineage-negative population using
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transplantation studies (Jiang et al., 2018; Jiang & Rinkevich, 2021; Rinkevich et al., 2015).
However, with cell transplantation studies, the lineages are not assessed in isolation of each
other due to the contribution of cells endogenous to the recipient. Nevertheless, such
experiments can provide important information on cell function.
Another method that allows for the assessment of specific lineages in vivo is cell ablation
using a diphtheria toxin (DT)/ DT receptor (DTR) approach (Dulauroy et al., 2012;
Rinkevich et al., 2015). This method results in the selective ablation of cells, controlled by
Cre/Lox recombination or cell-specific promoters, inducing cell death through inhibition
of protein synthesis (Saito et al., 2001). However, because the Foxd1 and NG2 lineages are
not specific to only one cell population, using this approach could have severe health
consequences for the animal if not controlled by additional cell-type specific promoters, or
localized DT delivery. However, results from cell ablation studies should be interpreted
with caution as the effects of it could be due to a loss in total fibroblast number and not
specifically the cells of interest. Exploring further the use of lineage tracing technology,
how well this would work in practice is uncertain. To my knowledge, such an approach has
not been explored. Overall, with the current state of available methods, cell transplantation
studies offer a more robust model for in vivo exploration of functional differences between
fibroblast lineages.
My results show for the first time that two distinct embryonic-progeny populations
contribute to palatal wound healing in separate and unique ways: one involving vascular
regeneration and the other associated with fibrotic processes. This points to a new
technology where we can investigate these aspects of healing individually and/or combined
together, opening the possibility to explore the influence of the one over the other. Such
experimental model would allow us to finetune the balance between neovasculogenesis and
matrix production, to examine the inverse correlation between scarring and vascularization,
and ultimately determine the parameters for optimal healing outcome. For this model, a
multicolor reporter system that combines two or more recombination systems for genetic
targeting of more than one cell population (usually two) could be used to trace
simultaneously Foxd1- and NG2-progeny. Intersectional dual-reporter systems, such as
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RC::Fela, R26::FLAP, RC::RLTG, and R26NZG, can be used to label two distinct cell
populations (Plummer et al., 2015; Yamamoto et al., 2009). In addition, sequential and
exclusive double-reporter systems are also explored for labeling specific cell types more
precisely (Zhao & Zhou, 2019). However, because of the exclusive nature of recombination
design, these genetic tools only allow simultaneous labeling of two (sub)populations in
tissue. Development of a multicolor reporter system capable of labeling three distinct cell
populations by noninterfering recombination is useful for studying the behavior of more
diverse cell types simultaneously in vivo (Liu et al., 2020).
Further exploration of functional differences could help to identify underlying cell- intrinsic
mechanisms that regulate palatal repair and shed more light on the differences between oral
and skin healing. Moreover, a better understanding of how diverse fibroblast populations
interact, and the major mechanisms coordinating their interactions could potentially
identify important targets for future investigation in the context of guided tissue
regeneration in the oral environment.
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5.5 Conclusions
First, the role of the matricellular protein periostin in the context of palatal healing was
investigated and it was determined to be associated with fibronectin production,
myofibroblast differentiation and infiltration of macrophages in wounded palatal tissues.
Our findings provide further evidence that periostin and the stiffness of the ECM act as
modulators of matrix synthesis and myofibroblast differentiation during palatal healing.
Next, progress is made to determine the role of periostin in the homeostasis of the
periodontal ligament under normal and osteogenic conditions, highlighting the diverse and
tissue-specific bioactivity of periostin. Finally, a cell lineage tracing strategy was utilized
and provided evidence for the presence of two distinct populations contributing to palatal
wound healing, one predominately vasculogenic and one more fibrotic, providing further
evidence about the intrinsic differences of cell populations that lead to distinct healing
patterns among different tissues.
Through these diverse studies, insights into effects of the ECM microenvironment in the
context of palatal repair and the intrinsic cell differences of populations contributing to the
healing process have been made. Application of this translatable knowledge could be
utilized in the future for development of biomaterials that can be targeted and guided to
enhance healing outcomes while inhibiting undesired effects, such as scarring and fibrosis
in a tissue-specific manner.
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Appendix A: Supplemental Figures and Tables

Figure A–1: Excisional Palatal Wound- One full-thickness excisional wound was made
with a 1.5 mm disposable biopsy punch (Integra™ Miltex®, Integra York PA, Inc.) on the
hard palate. The localization of the palatal punch biopsy was standardized with the anterior
edge of the wound to be aligned with the first molar to avoid traumatizing the palatal
arteries which run on either side of the wound as shown in red.
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Figure A- 2: Fibronectin matrix assembly requires RhoA pathway. (A) mPFBs were
cultured on TCP (A, C) or silicon substrates with 0.2 kPa Young’s modulus of elasticity
(B, D), treated with pharmacological inhibitors for RhoA, Y-27632 (10μM), and Rac1,
Z62954982 (50μM), and analysed for Fibronectin synthesis using immunofluorescence and
Western Blotting. Western blot was used to assess Fibronectin protein level of WT and
Postn-/- mPFBs on TCP (C) and 0.2 kPa substrate (D), respectively. GAPDH was used as
a loading control. Values are given as mean±SD from 3 independent experiments. Data was
analyzed using ANOVA. Scale bar: 20μm.
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Figure A-3: WT (Left) and KO (Right) mPFBs were seeded on silicone substrates of
different stiffness and treated with FAK inhibitor PF-573,228 (10 mM), or DMSO (1:1000)
which served as a control. Fibronectin expression was quantified using RTqPCR (A) and
Western Blotting (B) Acta2/αSMA expression was quantified using RTqPCR (C) and
Western Blotting (D) Values are given as mean±SD from 3 independent experiments. Data
was analyzed using ANOVA .
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RNA quality analysis was performed using electrophoresis (Related to 3.2.8)
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Figure A-4: RNA quality analysis was performed using electrophoresis for all
samples submitted for RNAsequencing.
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Figure A- 5: PCA plots stratified from patientID and osteogenic/non- osteogenic
conditions showing strong effect of patient ID
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Tables
Table A- 1: Top100 GO enrichment results of Pathway enrichment analysis in
DMEM media
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Table A-2: Top100 GO enrichment results of Pathway enrichment analysis in
osteogenic media
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0.75

0.00092

0.00092

HMCN1 PALLD

07156

cell adhesion

FAT1 PCDHGC3

via plasma

CDH11

membrane
adhesion
molecules
GO:00

response to

11

2

0.05

0.00105

0.00105

FOSL1 PKM

09629

gravity

GO:00

bleb assembly

11

2

0.05

0.00105

0.00105

MYLK EMP3

GO:00

activation of

13

2

0.06

0.00148

0.00148

ANGPT1 GREM1

07171

transmembrane

52

3

0.23

0.00161

0.00161

S100A10 SFRP1

32060

receptor
protein
tyrosine kinase
activity
GO:00

positive

51496

regulation of

TPM1

stress fiber
assembly
GO:00

negative

45668

regulation of

53

3

0.24

0.0017

0.0017

TWIST2 SFRP1
GREM1

osteoblast
differentiation
GO:00

negative

33689

regulation of

15

2

0.07

osteoblast
proliferation

342

0.00198

0.00198

SFRP1 GREM1

GO:00

cell adhesion

1474

22

6.56

3.10E-07

0.00199

07155

HMCN1 S100A10
ALCAM PALLD
FAT1 EDIL3
PCDHGC3
VEGFA THBS2
CAV1 SFRP1
ANGPT1 PLAU
KITLG NTN4
GREM1 TPM1
CDH11 ADGRE5
TRIOBP COL6A2
COL6A1

GO:00

negative

43116

regulation of

16

2

0.07

0.00226

0.00226

VEGFA ANGPT1

16

2

0.07

0.00226

0.00226

CAPG SVIL

208

5

0.93

0.00237

0.00271

LMNA VEGFA

vascular
permeability
GO:00

actin filament

51014

severing

GO:00

cellular

71456

response to

AQP1 SFRP1

hypoxia

PTGIS

GO:00

positive

90190

regulation of

18

2

0.08

0.00286

0.00286

VEGFA GREM1

20

2

0.09

0.00353

0.00353

VEGFA

branching
involved in
ureteric bud
morphogenesis
GO:00

positive

32793

regulation of

CAMK1D

CREB
transcription
factor activity
343

GO:00

negative

45019

regulation of

20

2

0.09

0.00353

0.00353

CAV1 PTGIS

359

9

1.6

3.10E-05

0.00387

LMNA VEGFA

nitric oxide
biosynthetic
process
GO:00

response to

01666

hypoxia

CAV1 AQP1
SFRP1 PLAU
PKM PTGIS CST3

GO:00

mitotic

00281

cytokinesis

GO:19

negative

03019

regulation of

72

3

0.32

0.00407

0.00407

SPTBN1 SNX18
CIT

22

2

0.1

0.00427

0.00427

PTX3 CST3

403

10

1.79

1.20E-05

0.00508

VEGFA THBS2

glycoprotein
metabolic
process
GO:00

regulation of

45765

angiogenesis

AQP1 ADGRA2
SFRP1 NIBAN2
GREM1 PKM
PTGIS ADAMTS1

GO:00

regulation of

08360

cell shape

GO:00

neutrophil

43312

degranulation

156

4

0.69

0.0052

0.0052

VEGFA SYNE3
TPM1 CDC42EP4

487

7

2.17

0.00599

0.00599

QSOX1 PTX3
TUBB4B PLAU
PKM CST3
ADGRE5

GO:00

sprouting

02040

angiogenesis

196

5

0.87

0.00183

0.00607

VEGFA ADGRA2
ANGPT1 GREM1
PKM

344

GO:00

positive

31954

regulation of

27

2

0.12

0.0064

0.0064

VEGFA GREM1

87

3

0.39

0.0069

0.0069

SPRY1 PEG10

protein
autophosphory
lation
GO:00

negative

30512

regulation of

CAV1

transforming
growth factor
beta receptor
signaling
pathway
GO:00

response to

09615

virus

GO:19

regulation of

05603

blood-brain

349

4

1.55

0.07037

0.00784

HMGA1 CHRM2
FOSL1 SAMHD1

7

2

0.03

0.00041

0.00878

VEGFA ANGPT1

98

4

0.44

0.00096

0.00909

SPRY1 VEGFA

barrier
permeability
GO:00

ureteric bud

01657

development

GO:00

axon guidance

SFRP1 GREM1
284

6

1.26

0.00168

0.01033

07411

SPTBN1 ALCAM
PALLD VEGFA
NIBAN2 NTN4

GO:00

negative

786

11

3.5

0.00071

0.01101

LMNA SPRY1

08285

regulation of

HMGA1 CAV1

cell population

SFRP1 NIBAN2

proliferation

FOSL1 GREM1
TPM1 KANK2
ADAMTS1

345

GO:00

extracellular

395

10

1.76

1.00E-05

0.01104

QSOX1 PTX3

30198

matrix

CAV1 NTN4

organization

GREM1 LOXL1
CST3 COL6A2
ADAMTS1
COL6A1

GO:00

epithelial cell

03382

morphogenesis

GO:00

monocyte

30224

differentiation

GO:19

positive

00026

regulation of

36

2

0.16

0.01119

0.01119

PALLD FAT1

38

2

0.17

0.01241

0.01241

VEGFA FASN

38

2

0.17

0.01241

0.01241

S100A10 TRIOBP

109

3

0.49

0.01274

0.01274

VEGFA CAV1

substrate
adhesiondependent cell
spreading
GO:00

positive

33138

regulation of

ANGPT1

peptidyl-serine
phosphorylatio
n
GO:00

positive

90343

regulation of

23

2

0.1

0.00466

0.01315

LMNA HMGA1

357

3

1.59

0.21266

0.01323

LMNA HMGA1

cell aging
GO:00

nuclear

51169

transport

GO:00

negative

10719

regulation of

ANGPT1
40

2

0.18

epithelial to
mesenchymal
transition
346

0.01369

0.01369

SPRY1 SFRP1

GO:00

positive

32467

regulation of

40

2

0.18

0.01369

0.01369

SVIL CIT

536

8

2.39

0.00265

0.01387

MYLK VEGFA

cytokinesis
GO:00

wound healing

42060

CAV1 DGKI
PLEC PLAU
TPM1 PPL

GO:00

embryo

58

3

0.26

0.0022

0.01472

VEGFA PTGIS

07566

implantation

GO:00

positive

30335

regulation of

VEGFA CAV1

cell migration

ADGRA2

CST3
567

10

2.52

0.00021

0.0148

TWIST2 MYLK

ANGPT1 PLAU
CAMK1D KITLG
ADAMTS1
GO:00

positive

428

8

1.91

0.00064

0.01548

S100A10 EDIL3

45785

regulation of

VEGFA CAV1

cell adhesion

SFRP1 ANGPT1
TPM1 TRIOBP

GO:00

bicarbonate

15701

transport

GO:00

calcium-

16339

dependent cell-

43

2

0.19

0.01572

0.01572

SLC4A2 AQP1

43

2

0.19

0.01572

0.01572

PCDHGC3
CDH11

cell adhesion
via plasma
membrane cell
adhesion
molecules
GO:00

regulation of

1617

16

7.2

43067

programmed

VEGFA CAV1

cell death

AQP1 SFRP1
347

0.00187

0.0159

LMNA TWIST2

ANGPT1 NIBAN2
FOSL1 CAMK1D
KITLG PHLDA1
GREM1 PTGIS
CST3 KANK2
GO:00

cell-substrate

07044

junction

VEGFA SFRP1

assembly

PLEC GREM1

GO:00

chemotaxis

99

655

6

12

0.44

2.92

5.20E-06

3.20E-05

0.01673

0.01685

06935

S100A10 TNS1

SPTBN1 ALCAM
PALLD VEGFA
ADGRA2
ANGPT1 NIBAN2
FOSL1 PLAU
CAMK1D NTN4
GREM1

GO:00

establishment

30952

or maintenance

9

2

0.04

0.00069

0.01749

LMNA AQP1

39

2

0.17

0.01305

0.01752

NTN4 CST3

46

2

0.2

0.01786

0.01786

CAV1 FOSL1

47

2

0.21

0.0186

0.0186

HMCN1 ALCAM

of cytoskeleton
polarity
GO:00

salivary gland

07431

development

GO:00

response to

32570

progesterone

GO:00

heterophilic

07157

cell-cell
adhesion via
plasma
membrane cell
adhesion
molecules

348

GO:00

ovarian follicle

57

3

0.25

0.00209

0.01969

PTX3 VEGFA

01541

development

GO:00

lactation

49

2

0.22

0.02012

0.02012

VEGFA CAV1

GO:00

negative

49

2

0.22

0.02012

0.02012

SPRY1 DGKI

34260

regulation of

50

2

0.22

0.0209

0.0209

PLEC PPL

50

2

0.22

0.0209

0.0209

FASN LSS

142

5

0.63

0.00043

0.02118

SPRY1 VEGFA

KITLG

07595

GTPase
activity
GO:00

intermediate

45104

filament
cytoskeleton
organization

GO:00

regulation of

45540

cholesterol
biosynthetic
process

GO:00

kidney

72073

epithelium

SFRP1 GREM1

development

KANK2

GO:00

negative

34104

regulation of

22

4

0.1

2.50E-06

0.0213

SFRP1 TMEM119
GREM1 CST3

tissue
remodeling
GO:00

regulation of

14910

smooth muscle

86

3

0.38

0.00668

0.02164

PLAU TPM1
ADAMTS1

cell migration
GO:00

membrane raft

01765

assembly

12

2

0.05

349

0.00126

0.02181

S100A10 CAV1

GO:00

axon extension

48846

involved in

37

2

0.16

0.01179

0.02184

ALCAM VEGFA

195

4

0.87

0.01123

0.02191

VEGFA ANGPT1

axon guidance
GO:00

positive

50731

regulation of

KITLG GREM1

peptidyltyrosine
phosphorylatio
n
GO:00

purine

09217

deoxyribonucl

5

1

0.02

0.02207

0.02207

SAMHD1

5

1

0.02

0.02207

0.02207

CST3

5

1

0.02

0.02207

0.02207

AQP1

5

1

0.02

0.02207

0.02207

LOXL1

5

1

0.02

0.02207

0.02207

TRIOBP

5

1

0.02

0.02207

0.02207

AQP1

eoside
triphosphate
catabolic
process
GO:00

negative

10716

regulation of
extracellular
matrix
disassembly

GO:00

carbon dioxide

15670

transport

GO:00

peptidyl-lysine

18057

oxidation

GO:00

actin

30047

modification

GO:00

establishment

30950

or maintenance
of actin
cytoskeleton
polarity
350

GO:00

extracellular

35426

matrix-cell

5

1

0.02

0.02207

0.02207

NTN4

5

1

0.02

0.02207

0.02207

VEGFA

5

1

0.02

0.02207

0.02207

VEGFA

5

1

0.02

0.02207

0.02207

SFRP1

5

1

0.02

0.02207

0.02207

KITLG

5

1

0.02

0.02207

0.02207

SAMHD1

signaling
GO:00

vascular

36324

endothelial
growth factor
receptor-2
signaling
pathway

GO:00

positive

38033

regulation of
endothelial cell
chemotaxis by
VEGFactivated
vascular
endothelial
growth factor
receptor
signaling
pathway

GO:00

negative

45578

regulation of B
cell
differentiation

GO:00

positive

45636

regulation of
melanocyte
differentiation

GO:00

dATP

46060

metabolic
process
351

GO:00

negative

48550

regulation of

5

1

0.02

0.02207

0.02207

CAV1

5

1

0.02

0.02207

0.02207

PTX3

5

1

0.02

0.02207

0.02207

MYLK

5

1

0.02

0.02207

0.02207

PLAU

5

1

0.02

0.02207

0.02207

KITLG

5

1

0.02

0.02207

0.02207

SFRP1

5

1

0.02

0.02207

0.02207

SFRP1

5

1

0.02

0.02207

0.02207

VEGFA

5

1

0.02

0.02207

0.02207

GREM1

pinocytosis
GO:00

negative

52405

regulation by
host of
symbiont
molecular
function

GO:00

aorta smooth

60414

muscle tissue
morphogenesis

GO:00

smooth muscle

61302

cell-matrix
adhesion

GO:00

mast cell

70662

proliferation

GO:00

cellular

71504

response to
heparin

GO:00

axis elongation

90245

involved in
somitogenesis

GO:00

regulation of

90259

retinal
ganglion cell
axon guidance

GO:00

regulation of

90289

osteoclast
proliferation
352

GO:19

negative

00158

regulation of

5

1

0.02

0.02207

0.02207

GREM1

5

1

0.02

0.02207

0.02207

GREM1

5

1

0.02

0.02207

0.02207

KITLG

5

1

0.02

0.02207

0.02207

VEGFA

5

1

0.02

0.02207

0.02207

CAV1

5

1

0.02

0.02207

0.02207

SFRP1

bone
mineralization
involved in
bone
maturation
GO:19

positive

01228

regulation of
transcription
from RNA
polymerase II
promoter
involved in
heart
development

GO:19

positive

01534

regulation of
hematopoietic
progenitor cell
differentiation

GO:19

regulation of

03391

adherens
junction
organization

GO:19

regulation of

03596

gap junction
assembly

GO:19

regulation of

04956

midbrain
dopaminergic

353

neuron
differentiation
GO:19

positive

05605

regulation of

5

1

0.02

0.02207

0.02207

ANGPT1

52

2

0.23

0.02249

0.02249

SFRP1 GREM1

208

5

0.93

0.00237

0.02379

VEGFA AQP1

blood-brain
barrier
permeability
GO:00

negative

30514

regulation of
BMP signaling
pathway

GO:00

positive

45766

regulation of

GREM1 PKM

angiogenesis

PTGIS

GO:00

generation of

48699

neurons

1570

13

6.99

0.02107

0.02471

CRABP2 SPTBN1
ALCAM PALLD
MAN2A1 VEGFA
SFRP1 NIBAN2
CAMK1D NTN4
CIT CDH11
TRIOBP

GO:00

collagen fibril

30199

organization

55

2

0.24

354

0.02498

0.02498

GREM1 LOXL1

Table A-3. Top100 GO enrichment results of Pathway enrichment analysis in
DMEM for patient F15
GO.ID

Term

GO:005

positive

1973

regulation of

Annota

Signifi

Expec

classicFi

weight01F

ted

cant

ted

sher

isher

36

4

0.15

1.70E-

1.71E-05

05

common

XRCC5 HNRNPD
HNRNPA2B1

telomerase

GREM1

activity
GO:001

negative

4912

regulation of

38

4

0.16

2.10E-

4.01E-05

05

SERPINE1 IGFBP3
PRKG1 LRP1

smooth
muscle cell
migration
GO:000

osteoblast

1649

differentiation

231

7

0.99

6.10E-

6.51E-05

05

IL6ST GPNMB
IGFBP3 PENK
GREM1 FASN
RPS15

GO:004

response to

2493

drug

397

9

1.7

5.10E-

7.41E-05

05

TXNIP CENPF
XRCC5 HMGB2
FYN ABCA1 GAS6
TIMP2 SREBF1

GO:000

ribosomal

0028

small subunit

21

3

0.09

9.60E-

9.61E-05

05

XRCC5 RPS19
RPS15

assembly
GO:004

receptor-

6813

mediated

5

2

0.02

0.00018

0.00018

LRRC15 GAS6

5

2

0.02

0.00018

0.00018

LAMB2 LRP1

virion
attachment to
host cell
GO:004

axon

355

8677

extension
involved in
regeneration

GO:006

negative

0266

regulation of

5

2

0.02

0.00018

0.00018

GRN RPS19

5

2

0.02

0.00018

0.00018

GREM1 RFLNB

319

9

1.37

9.00E-

0.00019

YBX1 MME

respiratory
burst involved
in
inflammatory
response
GO:190

negative

0158

regulation of
bone
mineralization
involved in
bone
maturation

GO:000

aging

7568

06

PDGFRB
SERPINE1 PENK
GSN LRP1 TIMP2
SREBF1

GO:005

positive

0918

chemotaxis

GO:006

retinal blood

1304

vessel

67

4

0.29

0.0002

2.00E-04

HMGB2 GPNMB
LRP1 HMGB1

6

2

0.03

0.00027

0.00027

CYP1B1 COL4A1

32

3

0.14

0.00035

0.00035

H3C2 H4C3 H4C8

morphogenesi
s
GO:000

DNA

6335

replicationdependent
nucleosome
356

assembly
GO:003

DNA

2392

geometric

HNRNPA2B1

change

HMGB1

GO:015

amyloid-beta

0094

clearance by

116

4

0.5

0.00157

0.00036

XRCC5 HMGB2

7

2

0.03

0.00038

0.00038

MME LRP1

5350

40

22.97

4.90E-

0.00042

PLPP3 LEPR YBX1

cellular
catabolic
process
GO:004

cellular

4267

protein

05

CTSK MGAT5

metabolic

XRCC5 NCL CBLB

process

LAMB2 HNRNPD
IL6ST PDGFRB
STC2 FYN H3C2
H4C3 H4C8
SERPINE1 GPNMB
IGFBP3 PENK
PAPPA GSN
ABCA1 CFL1
PSAP LRP1
HSP90B1 HMGB1
GAS6 TNFRSF19
GREM1 CEMIP
TIMP2 GRN
SREBF1 RPS19
RPS15 FBLN1
TIMP3

GO:190

negative

5049

regulation of

18

3

0.08

5.90E-

0.00049

05

LRP1 TIMP2
TIMP3

metallopeptid
ase activity
GO:000

Notch

195

6

0.84
357

0.00019

5.00E-04

YBX1 IL6ST CDH6

7219

signaling

S1PR3 POSTN

pathway

RPS19

GO:005

negative

1045

regulation of

8

2

0.03

0.0005

5.00E-04

TIMP2 TIMP3

8

2

0.03

0.0005

5.00E-04

HMGB2 HMGB1

32

3

0.14

0.00035

0.00063

PENK POSTN

membrane
protein
ectodomain
proteolysis
GO:005

DNA ligation

1103

involved in
DNA repair

GO:007

cellular

1295

response to

GAS6

vitamin
GO:000

DNA

6265

topological

9

2

0.04

0.00064

0.00064

HMGB2 HMGB1

9

2

0.04

0.00064

0.00064

GREM2 GREM1

40

3

0.17

0.00067

0.00067

H3C2 H4C3 H4C8

10

2

0.04

0.0008

8.00E-04

GREM2 GREM1

141

6

0.61

3.20E-

0.00093

TXNIP HNRNPD

change
GO:004

determination

8263

of dorsal
identity

GO:000

rDNA

0183

heterochromat
in assembly

GO:003

sequestering

5581

of
extracellular
ligand from
receptor

GO:003

response to

2355

estradiol

05

H2AZ1 PDGFRB
PENK POSTN

358

GO:007

cellular

1310

response to

2756

36

11.83

1.00E-

0.00097

10

LEPR YBX1
GREM2 CYP1B1

organic

XRCC5 NCL MME

substance

HNRNPD H2AZ1
HMGB2 IL6ST
PDGFRB SLIT3
STC2 FYN H3C2
HLA-C SERPINE1
HNRNPA2B1
PENK GSN
ABCA1 CFL1
PSAP LRP1
HSP90B1 HMGB1
POSTN COL4A1
GAS6 TNFRSF19
GREM1 NFAT5
FASN SREBF1
TIMP3

GO:004

positive

8680

regulation of

11

2

0.05

0.00098

0.00098

LRP1 GRN

126

5

0.54

0.00021

0.00115

H2AZ1 H3C2 H4C3

axon
regeneration
GO:004

negative

5814

regulation of

H4C8 HMGB1

gene
expression,
epigenetic
GO:004

neutrophil

3312

degranulation

487

8

2.09

0.00115

0.00115

XRCC5 MME
HLA-C GSN PSAP
HMGB1 TIMP2
GRN

GO:003

negative

3629

regulation of

12

2

0.05

0.00117

0.00117

CYP1B1
SERPINE1

359

cell adhesion
mediated by
integrin
GO:190

negative

0025

regulation of

13

2

0.06

0.00138

0.00138

POSTN FBLN1

14

2

0.06

0.0016

0.0016

MME SERPINE1

15

2

0.06

0.00184

0.00184

HMGB2 HMGB1

554

9

2.38

0.00061

0.00208

PDGFRB GPNMB

substrate
adhesiondependent cell
spreading
GO:009

replicative

0399

senescence

GO:003

V(D)J

3151

recombination

GO:004

positive

3410

regulation of

IGFBP3 PSAP
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post-
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regulation of
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TXNIP CENPF

fragmentation
GO:004

negative

5892

regulation of

YBX1 XRCC5

transcription,

H2AZ1 HMGB2

DNA-

TENM2 H3C2

templated

H4C3 H4C8
HNRNPA2B1
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regulation of
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apoptotic cell
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regulation of
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0.89
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signaling
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37
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process
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regulation of
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regulation of
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apoptotic
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regulation of
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containing
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response to
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ethanol
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PSAP
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response

TIMP2 GRN
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cellular
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response to
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0.016

0.016

FYN LRP1
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8
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0.01602

STC2 PENK GSN

amyloid-beta
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response to
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extracellular
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stimulus
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GO:006

actin filament
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bundle
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4
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0.01657

PHLDB2 SYNPO2
HSP90B1 RFLNB

organization
GO:003

response to
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progesterone

GO:000
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signal

PDGFRB ABCA1

transduction

CFL1
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positive
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regulation of

46
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Table A-4: Top100 GO enrichment results of Pathway enrichment analysis in
osteogenic for patient F15
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mediated
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TIMP2
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0.00135
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0.00188

MME LRP1

18

3

0.17
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0.00323

RPSA RPL24 RPLP0

change
GO:004

positive

5762

regulation of
adenylate
cyclase
activity

GO:006

relaxation of

0087

vascular
associated
smooth
muscle
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Appendix C: Animal Ethics Approval
2019-142:1:
AUP Number: 2019-142
AUP Title: Molecular Mechanisms underlying palatal healing.
Yearly Renewal Date: 07/01/2022
The annual renewal to Animal Use Protocol (AUP) 2019-142 has been approved by the
Animal Care Committee (ACC), and will be approved through to the above review date.
Please at this time review your AUP with your research team to ensure full understanding
by everyone listed within this AUP.
As per your declaration within this approved AUP, you are obligated to ensure that:
1. This Animal Use Protocol is in compliance with:
o

Western's Senate MAPP 7.12 [PDF]; and

o

Applicable Animal Care Committee policies and procedures.

2. Prior to initiating any study-related activities—as per institutional OH&S
policies—all individuals listed within this AUP who will be using or potentially
exposed to hazardous materials will have:
o

Completed the appropriate institutional OH&S training;

o

Completed the appropriate facility-level training; and

o

Reviewed related (M)SDS Sheets.

Submitted by: Cristancho, Martha on behalf of the Animal Care Committee
Animal Care Committee Chair
Animal Care Commitee
The University of Western Ontario
London, Ontario Canada N6A 5C1
519-661-2111 x 88792
auspc@uwo.ca | ACC Website
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